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SUMMARY
It is well established that uraemia impairs the in vivo 
cell-mediated immune responses while the in vitro lymphocyte 
responses oF patients on maintenance dialysis have been 
reported to be impaired or normal. The work in this thesis 
deals predominantly with production oF immunoglobulin in 
vitro by peripheral blood mononuclear cells obtained From 
normal and uraemic subjects.
The protein A plaque Forming cell assay was utilised to 
enumerate immunoglobulin secreting cells and several 
parameters aFFecting its perFormance were examined. Thus, it 
was Found that plaque Forming cell numbers were dependent on 
the concentrations oF sheep red blood cells, anti-serum, 
DEAE-dextran and complement while PEG BOOO was shown to 
improve the quality oF the plaques. The optimal conditions 
For storing the cells beFore plating and incubating them 
aFter plating were also established and in addition, it was 
shown that cryopreservation does not aFFect plaque Forming 
cell activity.
The optimal conditions For both proliFeration and 
immunoglobulin production in response to mitogenic 
stimulation were also examined and once again the 
suitability oF cryopreserved peripheral blood mononuclears 
For use in mitogen-stimulated cultures was conFirmed. A 
normal range For both spontaneous and mitogen induced plaque 
Forming cells was established and it was shown that pokeweed 
mitogenCPUIM1 was the most eFFective polyclonal B cell 
activator in inducing plaque Forming cells while
Epstein-Barr-UirusCEBUinduced similar Igh-PFC as PWM. 
Co-stimulation of control peripheral blood mononuclear cells 
with Concavalin ACConA) showed that both PWM and 
Staphylococcus Aureus Cowan ICSAC3 cultures were suppressed 
although the Former proved to be much more sensitive. 
Steroids are known to inhibit suppressor T cells and when 
methyl-prednisolone was added in PWM and SAC cultures oF 
control peripheral blood mononuclear cells, PWM induced 
production oF immunoglobulin was more readily enhanced. I 
propose that these polyclonal B cell activators diFFer in 
their susceptibility to regulation by suppressor T cells. 
When indomethacin was added in the cultures to inhibit 
prostaglandin synthesis, it was observed that SAC responses 
were slighty but non-signiFicantly enhanced.
Uraemia was not Found to have a signiFicant eFFect on the 
number or proportion oF lymphocyte populations but it 
impaired the proliFerative’ responses to PHA and PWM.
However, the relative in vitro immunosuppressive eFFect oF 
steroids was not Found to be stronger in these cultures. EBU 
and PWM induced plaque Formation was normal in uraemic 
patients while both spontaneous and SAC induced 
immunoglobulin production were reduced. In addition, the 
combination oF PWM and SAC did not produce the synergistic 
eFFect Found in control cultures. Pre-incubation oF control 
cells with uraemic serum aFFected the quality and suppressed 
slightly the numbers oF PWM-induced plaque Forming cells. 
Addition oF methyl-prednisolone to SAC cultures did not 
produce the enhancing eFFect Found in controls indicating 
that the reduced SAC responses in uraemia were not caused by
increased suppressor T cell activity. However, the SAC 
responses oF uraemic peripheral blood mononuclear cells 
seemed to beneFit more by the addition oF indomethacin than 
the SAC responses oF control cells. My results indicate 
strongly that the reduced production oF immunoglobulin in 
uraemia is not due to reduced numbers oF lymphocytes but 
reFlects a true Functional abnormality and the observed 
reduced proliFerative responses oF uraemic peripheral blood 
mononuclears to T cell mitogens indicate that T lymphocyte 
Function is impaired. The studies using polyclonal B cell 
activators suggested that B cell Function and T-B cell 
co-operation remained intact in uraemic patients and 
indicated that the deFective immunoglobulin responses in 
both the spontaneous and SAC system were due to a Functional
-abnormality oF the heloer T cell.
Third party blood transfusions were shown to reduce
PWM-driven B cell differentiation and to enhance(in some 
patients) the spontaneous PFC responses. SAC induced PFC 
responses were not affected and since SAC responses are 
less affected than PWM
responses by suppressor T cell activity, it was concluded 
that the differential inhibitory effects oF blood 
transfusions on B cell differentiation into immunoglobulin 
secreting cells was due to an increase in suppressor T cell 
activity.
In studies of spontaneous immunoglobulin production in 
transplanted patients, IgG-PFC were Found to increase during 
rejection episodes. Furthermore, a greater number of 
azathioprine treated patients had increased plaque Forming 
cell activity compared with cyclosporins A treated 
recipients and this correlated very well with the number of 
rejection episodes in the two groups.
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CHAPTER I
INTRODUCTION
URAEMIA AND ITS TREATMENT
The kidneys are the organs responsible For the regulation 
of Fluid and electrolyte balance, the retention and 
production of substances vital to body economy and the 
elimination oF metabolic waste products, including many 
endogenous toxins and drugs. The most important of these 
wastes are the breakdown products oF protein metabolism, 
such as urea and creatinine, which became toxic if they 
accumulate in large amounts due to renal failure. Renal 
failure may arise when the renal parenchyma is damaged 
either directly by disease or drugs or, indirectly, when 
extrarenal disorders affect adequate renal blood flow, or 
when obstruction at any point of the urinary tract prevents 
the outflow of urine. The impairment of renal function may 
be of variable severity and it may be acute or chronic. If 
untreated, the syndrome which results presents a serious 
clinical problem and may be life-threatening. Although the 
term "uraemia" is used to describe this syndrome, the 
symptoms of renal failure are not only attributable to the 
retention of urea but also to disturbances of water and 
electrolyte balance, to the accumulation of other toxic 
products, and to arterial hypertension. In this thesis, 
"uraemia” is used as a general term to describe the clinical 
state associated with chronic renal failure.
The principal methods of treatment of chronic renal 
failure are haemodialysis, continuous ambulatory peritoneal 
dialysisCCAPDl and transplantation. Both haemodialysis and
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CAPD are used to preserve the lives of uraemic patients by 
allowing uraemic toxins to diffuse across a semipermeable 
membrane from high concentrations in the patient's blood to 
low concentrations in dialysis fluid. In haemodialysis this 
semipermeable membrane is a synthetic membrane while in CAPD 
the patient’s peritoneum is employed as the dialysis 
membrane. Although both these methods of treatment are 
effective means of rehabilitation, they do not offer a 
permanent solution to the problem. If the patient is 
suitable for transplantation they are also used as a 
maintenance therapy until a suitable graft is found.
The first kidney transplantations were performed in dogs 
and goats by UllmannCHamilton, 1384) and the first recorded
kidney transplantations in humans were performed when 
Jaboulay implanted pig or goat xenografts in the arm and 
thigh of uraemic patientsCJaboulay, 1308). Many unsuccessful 
attempts were made in the following fifty years and the 
breakthrough came in the early 1350s when cadaver kidneys 
were transplanted into patients with end-stage chronic renal 
failureCHume et al, 1355). Although, some kidneys never 
functioned, others functioned well for a time and most of 
the symptoms and signs of uraemia were reversed. However, 
after three to five months most of the transplanted kidneys 
were rejected due to an immunological reaction against 
foreign antigens of the graft. Cortisone and ACTH were 
administered to suppress these rejection episodes but it was 
believed that the co-existing uraemia also produced
20
immunosuppression and that this was mainly responsible For 
the eventual favourable outcome. Although most of these 
early conclusions were later confirmed, rejection reactions 
limited the use of organ transplantation and until 1959 very 
few operations were performed. Around that time total body 
irradiation and B-mercaptopurineCB-MP) were successfully 
introduced as means of suppressing the rejection 
episodesCCalne, 1950 & Zukoski et al, I960) and, shortly
afterwards azathioprineCCalne et al, 19G2, Murray et al, 
13B3) and prednisolone in combination with B-MPCKuss et al, 
1952) were first used for this purpose. Since then, the 
results have improved progressively and transplantation has 
become an accepted method of treatment of uraemic patients.
IMMUNE ABNORMALITIES IN URAEMIA
Uraemic patients have abnormalities of virtually every 
organ system and in the last three decades many 
immunological studies have shown that the immune response is 
also impaired. Clinically, this is evidenced by a high 
incidence of malignanciesCMatas et al, 1975) and 
infectionsCMerri11, 19B0) and the latter is a very common
cause of morbidity and death. Many workers have examined 
cellular and humoral immunity of uraemic subjects in vivo 
and, more recently, attention has been given to the study of 
lymphocyte function in vitro and to the study of possible 
immunosuppressive factors in the uraemic serum. Although 
many different abnormalities have been described, it is
21
generally agreed that there is a decrease in the intensity 
of cellular and humoral responses both in vivo and in vitro. 
In addition, several immunosuppressive Factors have been 
detected and some of these have been isolated.
l.IN UlUg STUDIES OF IMMUNITY IN URAEMIA
The First indications that uraemic patients had 
suppressed immune responsiveness in vivo came From studies 
by Hume et alC1955) who reported prolonged kidney allograFt 
survival in patients with end-stage chronic renal Failure 
and, as noted above it was suggested that immunosuppression 
due to the uraemia was responsible For this Finding. In 
1957, Dammin et al observed prolonged skin allograFt 
survival in six uraemic patients and similar observations 
were subsequently made in dogsCMannick et al, 1950) and in 
rabbitsCSmiddy et al, 1951). Following this, Kirkpatrick et 
alC19B4) Found that both delayed and immediate cutaneous 
hypersensitivity were depressed in patients with renal 
Failure. In 1959 Huber et al, studying delayed dermal 
hypersensitivity, conFirmed that 50% oF uraemic patients 
were anergic and Selroos et alC1973) then showed that the 
degree oF skin test response decreased with increasing 
severity oF uraemia. Boulton-Jones et alC1973) then showed 
that both delayed type hypersensitivity skin reactions and 
antibody responses were depressed and, although, one report 
CKauFFman et al, 1975) suggested that 70% oF the uraemic 
patients had intact delayed dermal hypersensitivity, most
22
recent studies have confirmed the depressed cutaneous 
hypersensitivity in uraemiaCRolley, 1970, Cascianni et al, 
1970, Ala-Houhala et al, 1979).
When antibody responses were First examined in uraemia, 
early reports by Balch et alC1955) and StolloF et alC1950) 
suggested that uraemic patients had normal antibody 
responses to Foreign antigens such as tetanus toxoid and 
diphtheria toxoid. However, Wilson et alC19B5) reported 
that the production oF humoral antibodies to typhoid vaccine 
was depressed in patients with renal Failure while Weeks et 
alC1971) Found that one third oF haemodialysis patients had 
low levels oF immunoglobulins in the serum. Subsequently, it 
was shown that IgA and IgM levels in uraemic patients were 
within the normal range but IgG levels were variable and IgE 
levels were lowCCascianni et al, 1970). The Finding oF low 
IgE levels has since been confirmed, but interestingly, does 
not appear to be a correlation between IgE levels and length 
of dialysis treatmentCHalIgren et al, 1902).
Studies of antibody responses in experimental animals 
with uraemia have produced conflicting results and Gowland & 
SmiddyC19B2) Found that the primary but not the secondary 
response to bovine serum albuminCBSA) was decreased in 
uraemic rabbits* SouhamiC1973) showed that both primary and 
secondary antibody responses to sheep red blood cellsCSRBC) 
and BSA were decreased in mice. In contrast, Nelson et 
alClSBO) showed that the humoral response of uraemic animals 
was comparable to that of sham operated or control animals
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by challenging uraemic rats with bacterial, viral, T-cell 
dependent and T-cell independent antigens. A possible 
explanation of these discrepancies may come From the study 
oF Mezzano et alClSBE) who Found that while primary antibody 
responses to BSA were reduced in uraemic rats irrespective 
oF the route of immunisation or the adjuvant used, the 
secondary antibody response was depressed only iF antigen 
was given with a weak adjuvant. Interestingly, these authors 
also showed that it was easier to suppress the primary 
antibody response oF uraemic rats by intravenous 
administration oF soluble BSA and that only uraemic animals 
had suppression of their secondary antibody responses under 
these conditions.
In summary, while it is clear that delayed type 
hypersensitivityCDTH) is impaired in uraemic subjects there 
is still controversy over the humoral immune status of these 
subjects, Although several reports do indicate that antibody 
responses are impaired, it seems that this may aFFect the 
primary and secondary responses differently and may vary 
with the type of antigen and the route by which it is 
encountered. Furthermore, although studies discussed above 
have contributed to defining the immunosuppression of 
uraemia, they have not provided information about individual 
cells or the mechanisms responsible For the altered immune 
responsiveness reported in uraemia. Therefore, more recent 
studies have investigated lymphocyte number and Function in 
vitro in an attempt to analyse and explain in more detail 
the immune defects associated with uraemia.
24
2.STUDIES OF LYMPHOCYTE POPULATIONS
A. BACKGROUND
Lymphocytes,macrophages,and granulocytes are the major 
cellular components of the immune response and abnormally 
low numbers of white blood cells may be associated with 
reduced immunological responsiveness. For many years, total 
white blood cell and lymphocyte counts provided the only 
information about immune status and these tests are still 
used routinely as a rapid means of screening the immune 
status of patients with disorders like chronic renal 
Failure. Nevertheless, in recent years, the ability to 
differentiate between lymphocyte populations has led to more 
detailed investigations of the mechanisms involved.
Lymphocytes population can be divided into two major 
classes of immunocompetent cells: The TCthymus-derived) and 
BCbursa or bone marrow-derived) lymphocyte. T lymphocytes 
differentiate under the influence of thymus in Foetal life 
and, after sensitisation act either directly as cytotoxic 
lymphocytes or indirectly through the cellular products 
called lymphokines. In addition, several classes of 
regulatory T cells are essential For the normal maturation 
and control of the immune response, the most important being 
the helper T cells and the suppressor T cells. These 
populations differ in phenotype and as they can be 
enumerated separately, this has greatly helped the diagnosis 
and investigation of various immunodeficiency states.
In mammals, B lymphocytes probably differentiate in the 
bone-marrow and their role in the immune response is
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mediated entirely by their secreted cellular products, the 
antibodies. In addition, cell surface antibody also acts as 
an antigen-specific receptor which determines triggering and 
activation of the B cell. As noted above, the production of 
antibody is not only dependent on B cells, but also requires 
functional helper T cells for efficient proliferation and 
differentiation of antibody secreting cells. In addition, 
suppressor T cells may have a negative effect on antibody 
production.
T and B lymphocytes are morphologically identical but 
can be differentiated by the presence of specific surface or 
cytoplasmic markers. B lymphocytes are identified by the 
presence of surface immunoglobulin while, T lymphocytes can 
be identified by their ability to form rosettes with sheep 
red blood cellsCSRBC) or by the DKT3 monoclonal antibody. 
Within the T cell population, helper T cells and suppressor 
T cells are differentiated by using the 0KT4 and OKT0 
monoclonal antibodies respectively. During the last ten 
years these techniques have been used extensively to 
investigate the immune status of uraemic patients.
B. LYMPHOCYTE COUNTS IN URAEMIA
Lymphopenia was first recognised as a complication of 
acute renal failure by Jensson et alClSSB) and this was 
later confirmed for patients with chronic renal failure by 
Riis et alC105S). Subsequently Wilson et alC19B5) found that 
advanced uraemia reduces the number of circulating
26
lymphocytes, despite a normal number of neutrophils. 
Subsequently, Boulton-Jones et alClS73) showed that patients 
with severe renal failure were lymphopénie and this was not 
improved by dialysis. Since then, the association of 
lymphopenia has been suggested by many groups, although its 
exact incidence may vary from 14% to virtually all 
patientsCKauffman et al, 1975, Cascianni et al, 1978, Lortan 
et al, 1982, Raska et al, 1903).
In recent years studies of lymphocyte numbers in uraemia 
have Focussed on which lymphocyte population accounts For 
the reduced immune response. In the first study of this 
type, it was shown that only two of the twenty eight uraemic 
patients had diminished numbers of proportions of T cells, 
as assessed by their ability to Form rosettes with 
SRBCCKauffman et al, 1975). Using the same technique, 
Quadracci et alC1976) found that the total number of both T 
and B lymphocytes was significantly reduced in the 
peripheral blood of uraemic patients and the proportion of B 
cells was also reduced. Although, Kunori et alC190O) 
confirmed that the proportion of T cells was normal, they 
found also normal proportions of B cells. The first study 
using monoclonal antibodies to enumerate T lymphocytes also 
reported an absolute T and B cell lymphopenia in most 
uraemic patients and found a significant reduction in the 
number of T4+ cellsChelper). The number of T0+Csuppressor) 
cells was not different from that found in normal controls 
although their percentage was slightly higher than
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□□ntralsCLortan et al, 1982), In a more extensive study, 
Raska et alC1903) used monoclonal antibodies to study T cell 
subpopulations in uraemic patients in relation to age and 
the duration oF haemodialysis. In patients under thirty 
years of age and over sixty, the absolute number oF helper T 
cells was markedly reduced, whereas the number of 
suppressor/cytotoxic T cells was not changed. In contrast, 
both subpopulations were reduced in patients between thirty 
and sixty years old. The absolute number of T cells and the 
absolute count of helper T cells were lower in patients on 
dialysis For more than one year.
In summary, these studies indicated that uraemic patients 
have lymphopenia which affects particularly the numbers of B 
lymphocytes and helper/inducer T cells and it is still 
unclear whether or not suppressor/cytotoxic T cells are also 
depleted.
3.STUDIES OF LYMPHOCYTE FUNCTION IN VITRO
I . T CELL FUCTIDN
Response to Mitooens
While counts of lymphocyte numbers can provide some 
information on immune status, this can be achieved more 
readily by assays of lymphocyte function. Many different 
techniques are currently being used to assess the function 
of both T and B cells the majority of which measure the
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ability of lymphocytes to proliferate in response to an 
antigenic or mitogenic stimulus. Phytohaemagglutinin ACPHA) 
has been used most widely to study T lymphocyte 
responsiveness in uraemic patients and many workers have 
shown that PHA responses of uraemic lymphocytes are 
depressedCHuber et al, 1969, Nakhla & Goggin, 1973, Kauffman 
et al, 1975, Quadracci et al, 1976, Holdsworth et al, 1970, 
Kunori et al, 1980, Alevy et al, 1981, Alevy et al, 1983, 
Langhoff S Ladefoged, 1904, Raskova et al, 1984). Although 
others have found that PHA responses may remain 
unaffectedCKasakura & Lowenstein, 1967, Daniels et al, 1971, 
Boulton-Jones et al, 1973, Sengar et al, 1975) the response 
of uraemic peripheral blood lymphocytes to Concavalin 
ACConA) has consistently been shown to be 
depressedCQuadracci et al, 1976, Stewart S Miller,
1980,Alevy et al, 1981,Alevy et al, 1903). Therefore, these 
studies of T lymphocyte activation indicate that T 
lymphocyte function in vitro may be impaired in uraemic 
patients and it is likely that the discrepancies between 
different reports are because chronic renal failure has many 
aetiologies while lymphocyte function may be affected by the 
different treatment regimes, such as chemotherapy, 
haemodialysis, CAPD, blood transfusions, surgery and renal 
transplantation. This is supported by a report from 
Holdsworth et alC197B) who found that the poor 
responsiveness of uraemic lymphocytes was corrected for 
around 20 hours after each session of haemodialysis. Thus, 
it is clear that the time at which the sample was taken 
could markedly influence the results of in vitro tests. In
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addition, Byron et alC197G) found that the blastogénie 
response to PHA in uraemic patients appeared to be delayed 
relative to the controls and suggested that differences in 
the pattern of response may account for inconsistencies in 
reports.
Alloantioen Responses
Although only a minute proportion of T cells will respond 
to the majority of specific antigens, up to 10% of T cells 
will respond to alloantigens coded by the major 
histocompatibility complexCMHC). This unusually high number 
means that alloreactive T cell responses provide another 
convenient means of assessing T cell reactivity in vitro.
The one way mixed lymphocyte reactionCMLR) system has been 
used to investigate the reactivity of lymphocytes from 
patients with uraemia. Kasakura & LowensteinC19B7), Kunori 
et alC19B0),and Alevy et alC19B4) have shown that uraemic 
lymphocytes respond poorly to alloantigens and these 
findings correlate well with the depressed mitogen responses 
discussed above.
Antigen Responses
Whereas mitogens stimulate a significant proportion of 
the lymphocyte population, antigens stimulate only those 
lymphocytes which are sensitised to the antigen employed. In 
the majority of cases, the antigens employed to study 
lymphocyte activation in vitro have been those used for skin
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testing in vivo, including tetanus tcxcidCTT), Candida 
albicans, streptckinase/streptodornaseCSKSD), keyhole limpet 
hemocyaminCKLH) and purified protein derivative of 
tuberculinCPPD). In 1373, Boulton-Jones et al, Selroos et 
al, and Nakhla & Goggin, reported that the lymphocytes from 
uraemic patients responded poorly to antigens like PPD, SKSD 
or KLH and Selroos et al also found that there was no 
correlation between in vivo skin test reactivity and in 
vitro blast transformation to PPD.
All these studies provided information about T cell 
function in vitro and it is generally agreed that the 
proliferative responses of uraemic T lymphocytes in response 
to antigens, mitogens, and alloantigens coded by the MHC, 
are impaired.
II. B CELL FUNCTION
A.BACKGROUND
POLYCLONAL B CELL ACTIVATION
The provision that studies of lymphocyte number and 
phenotype provide only limited information on their 
behaviour in vivo is especially relevant when considering B 
cell function because the phenotype of functional B cell 
subpopulations is poorly defined. Therefore, considerable 
efforts have been made to develop sensitive assays which can 
dissect B cell function in vitro. These assays all rely 
heavily on the use of polyclonal B cell activators which
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stimulate B cells in different ways to produce 
immunoglobulin. Many authors use the term polyclonal B cell 
activator instead of the term mitogen since mitogenesis is 
hot regarded by some as a prerequisite for B cell 
activationCCoutinho & Mailer, 1975, Janossy & Greaves,
1975). As with T cell mitogens, polyclonal B cell activators 
are substances which stimulate a large proportion of B cells 
and so their use allows a large proportion of the total B 
cell population to be studied. Although there is a wide 
range of polyclonal B cell activators, including 
lipopolysaccharideCLPS), anti-IgM etc, only a small group is 
particularly useful in dissecting mechanisms of B cell 
activation and differentiation under clinical conditions.
Pokeweed Mitogen
The first polyclonal B cell activator to be used in human 
studies was the mitogen obtained from pokeweedCPUlM) . In 
19BB, Chessin et al and, in 19B7, Douglas et al found that 
PWM induces plasma blast development and it was shown 
subsequently that PWM induced both immunoglobulin synthesis 
and secretion as well as B cell proliferationCGreaves & 
Janossy, 1972, Ulu et al, 1973, Ulaldmann et al, 1974). Early 
studies also indicated that T cells contributed to the 
response to the PWM and it is known that there is an 
absolute requirement for T cell help in the proliferation 
and differentiation of B cells in response to PWMCJanossy & 
Greaves, 1975, Fauci et al, 197G). Thus, PWM is a useful 
means of examining T cell dependent B cell function.
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StaahuIdcoccus Aureus Cowan I
Another polyclonal B cell activator which has been used 
increasingly in recent years is Staphylococcal protein A 
following work which showed that an insoluble preparation of 
protein A when presented on formalinised Staphylococcus 
aureus Cowan Type I bacteriaCSAC) stimulated purified human 
B cellsCFqrsgren et al, 1S7G) . Ringden & Rynnel-DagooC1970) 
presented evidence that the soluble form of protein A was 
mitogenic for both T and B cells and it has also been shown 
that T cell depleted peripheral blood mononuclear cells 
proliferate in response to SAC. Nevertheless, there is no 
differentiation into immunoglobulin secreting cells unless 
autologous T cells are added to the T cell-depleted 
populationCFalkoff et al, 1982). Thus, the proliferative 
response of B cells to SAC is entirely T cell independent 
but differentiation into immunoglobulin secreting cells is T 
dependent. For these reasons, Cowan I bacteria are used In 
human immunological studies to analyse the regulation of 
both B cell proliferation and differentiation.
Epstein-Barr virus 
The final polyclonal B cell activator in the group of major 
clinical importance is Epstein-Barr virusCEBU) , All 
peripheral blood B cells bind EBV via a receptor whose 
structure is similar but not identical to the C3b 
receptorCGreaves et al, 1975), and blast transformation and 
DNA synthesis occur shortly after expression of Epstein-Barr 
virus nuclear antigenCEBNA, Einhorn & Ernberg, 1978). As
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activation of B cells by EBV is not dependent on T cells and 
is not regulated by suppressor T cellsCBird & Britton,
1379a), EBV has been widely used as an entirely T cell 
independent polyclonal B cell activator.
REGULATION OF IN VITRO B CELL FUNCTION BY
CORTICOSTEROIDS AND PROSTAGLANDINS
Most B cell studies have been performed within the 
framework of the polyclonal induction of B cell responses 
and these systems have been also widely used to examine the 
in vitro effect of potent drugs on human B lymphocyte 
functions. Many commonly used drugs, such as corticosteroids 
and indomethacin, have a wide range of effects on virtually 
every phase and component of the human immune and 
inflammatory responses.
Corticosteroids
In addition to their in vivo effects, pharmacological 
doses of corticosteroids suppress most immune functions in 
vitro including proliferative responses to antigen-, PHA-, 
ConA-, and PUJM C Hei Iman, 1972, Ulebel & Ritts, 1977, Gordon & 
Nouri, 1981, Heilman et al, 1973) as well as the allogeneic 
and autologous mixed lymphocyte reactivityCUlebel & Ritts, 
1977, Ilfield et al, 1977) and NK cell activityCParrillo & 
Fauci, 1978b). Nevertheless one possible exception to this 
is suggested by reports that immunoglobulin production in 
vitro may increase in the presence of corticosteroids, 
despite the suppressive effects of steroids on antibody 
production in vivoCButler S Rossen, 1973, Posey et al.
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1378). Thus, it has been shown that immunoglobulin 
production as detected in the supernatant of cultures with 
Fetal calf serumCFCS) is significantly increased by in vitro 
corticosteroidsCSmith et al, 1972), and also that there is 
an increase in the number of immunoglobulin secreting cells 
in the same culturesCGrayson et al, 1981). An increase in 
supernatant immunoglobulin production was also shown when 
cells were cultured with FCS and PUJMCCooper et al, 1979) and 
this finding was confirmed by other workers who found an 
increase in the number of plaque forming cells in PWM 
cultures with human serumCFauci et al, 1977). Therefore it 
has been suggested that corticosteroids increase 
immunoglobulin production in the PWM system by abrogating 
suppressor cell activityCHaynes B Fauci, 1979).
Prostaglandins
Mononuclear phagocytes have been shown to be an essential 
cellular component in the induction of human lymphocyte 
responses and have also been shown to suppress human B 
lymphocyte differentiation in vitroCKnapp & Baumgartner, 
1978). One possible mechanism by which macrophages exert 
their effect is through cyclooxygenase pathway products of 
arachidonic acid metabolism, such as prostaglandin 
E2CGoodwin B Webb, 1980). Prostaglandin E2CPGE2) has been 
reported to inhibit PHA- and ConA-induced blastogenesis but 
it had a minimal effect on PWM-induced blastogenesisCGoodwin 
et al, 1977). The authors suggested that PGE2 suppressed T 
cell but not B cell blastogenesis since PWM is more
35
effective in stimulating B cells. In contrast to this study, 
PGE2 has been found to inhibit human B lymphocyte colony 
responsesCWhisler et al, 1382) while animal studies have 
shown that the in vivo antibody response of mice can be 
markedly increased by the administration of a cyclooxygenase 
inhibitor such as indomethacinCWebb S OsheroFf, 1976).
B. B CELL FUNCTION IN URAEMIA
As discussed above, studies of humoral immunity in vivo 
have produced conflicting resultsCGowland B Smiddy, 1962, 
Wilson et al, 1965, Boulton-Jones et al, 1973, Souhami,
1973, Byron et al, 1976, Mezzano et al, 1382, Balch et al, 
1955, Btoloff et al, 1958, Nelson et al, 1980). There has 
been very little work on B cell function in vitro in uraemic 
patients or animals, despite the conflicting results 
obtained from studies of humoral immunity in vivo.
Although the First such study reported normal 
proliferative responses to PWMCSengar et al, 1975) 
subsequent studies have found depressed responses to the B 
cell mitogen rabbit anti-human b2 microglobulin in 
manCQuadracci et al, 1976) and to LPS in ratsCAlevy et al, 
1981). The status of immunoglobulin secreting cells in 
uraemia is also controversial. Thus, Kunori et alC1980) 
showed that the number of SAC stimulated immunoglobulin 
secreting cells was decreased in uraemic patients, while a 
recent study showed that the number of circulating 
immunoglobulin secreting cells was normal in uraemic
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patients, although uraemics had a wider scatter of 
valuesCHorsburgh et al, 1983). Very little work has been 
done on human B cell responses in vitro in uraemia and 
nothing is known about how uraemic B lymphocytes respond to 
different polyclonal B cell activators which differ on their 
dependence on T cells. It is also not known whether 
inhibition of immunoglobulin production by uraemic B cells 
is due to reduced numbers of B cells, reduced function, or 
both. One further aspect of B cell function which may be 
unusual in uraemia is the possibility that uraemic B cell 
differentiation may be particularly sensitive to the 
regulatory effects of corticosteroids. Nelson et alC1980) 
showed that the immune responsiveness of the uraemic host is 
normal and speculated that uraemia potentiates the 
pharmacological activity of some drugs which depress immune 
mechanisms. Very recently, the intra-individual consistency 
of uraemic lymphocyte responses to the in vitro suppressive 
effect of corticosteroids has been studied by measuring DNA, 
RNA, and protein synthesis by PHA-stimulated lymphocytes and 
it was found to be relatively stronger in uraemic 
culturesCLanghoff B Ladefoged, 1984). As corticosteroids may 
selectively inhibit the effect of suppressor T cells on 
immunoglobulin production in vitro, it would be interesting 
to examine the relative steroid sensitivity of mitogen 
stimulated immunoglobulin production of uraemic and control 
cells.
Finally, it has been shown that the activity of spleen 
cells from uraemic rats to PHA, ConA, and LPS is
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significantly suppressed compared with cells from control 
animals and that this suppression is mediated by a 
glass-adherent suppressor cellCAlevy et al, 1901). Further 
studies by the same authors showed that the suppression is 
mediated by an adherent cell that differs from adherent 
cells present in control animals by being la-negative and 
indomethacin-insensitiveCAlevy S Slavin, 1901). They 
speculated that the suppression in uraemic rats is either 
not mediated by prostaglandins or may be mediated by 
preformed prostaglandin synthetase products. The effects of 
PBEE on uraemic B cell function have not been studied. 
Monocytes may suppress B cell function by release of PGE2 
and indomethacin may increase B cell responses in vivo and 
in vitro. As noted above, uraemia may induce a population of 
adherent suppressor cells which inhibit T cell function in 
vitro and it would be interesting to determine whether the 
inhibition of immunoglobulin production in uraemia is PGE2 
mediated.
III. THE ROLE OF IMMUNOSUPPRESSIVE SERUM FACTORS IN
URAEMIA
The data discussed above show clearly that lymphocyte 
function may be markedly reduced in patients with uraemia, 
but it is difficult to distinguish whether this impairment 
in lymphocyte function is due to a primary defect at the 
level of cellular differentiation or whether uraemic serum 
can inhibit the expression of effector lymphocyte functions
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in vitro. Many workers have attempted to determine whether 
the metabolites which accumulate in chronic renal Failure 
are toxic to lymphocytes in vitro and have begun to identify 
these factors. Although several studies of this nature have 
been performed in humans, the results have been conflicting 
presumably due to the variety of causes leading to the 
uraemic state and to different therapeutic regimens. Thus it 
has been reported that uraemic serum depresses PHA responses 
of control peripheral blood lymphocytesCSiIk, 19G7, Newberry
S Sanford, 1971, Sengar et al, 1975, Holdsworth et al, 1978, 
Raskova B Raska, 1901, Langhoff B Ladefoged, 1904) whereas 
others found that PHA responses were not affected by uraemic 
serumCKasakura B Lowenstein, 1907, Ulebel et al, 1974, 
Kauffman et al, 1975). In contrast, all workers agree that 
the MLR is greatly depressed if performed in the presence of 
uraemic serumCKasakura B Lowenstein, 1967, Sengar et al, 
1975, Raskova B Morrison, 1970, Raska et al, 1900, Raskova 8 
Raska, 1901) and it has also been shown that ConA responses 
of control rat spleen cells are suppressed by uraemic serum 
from ratsCStewart & Miller, 1900, Mezzano et al, 1984). 
Mezzano et al also showed that uraemic serum suppressed 
antibody formation to bovine serum albuminCBSA) in vitro but 
interestingly, the response to sheep red blood cells was not 
affected. This indicates that uraemic serum may suppress one 
mechanism of antibody production while leaving others 
unaff ected.
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In view of these Findings, many attempts have been made 
to identify the factors in uraemic serum which are 
responsible for the immunosuppressive activity but not 
definitive conclusion has been obtained. In addition, very 
little is known about the possible effect of uraemic serum 
on in vitro immunoglobulin secretion by normal B cells in 
response to polyclonal B cell activators.
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IMMUNOLOGICAL ASPECTS OF BLOOD TRANSFUSIONS IN RENAL
TRANSPLANTATION
The medical treatment of uraemia without resort to renal 
transplantation does not alter the progress of the 
underlying disease but can improve the overall condition of 
the patient. As noted earlier, haemodialysis or peritoneal 
dialysis form the mainstay of these regimes but special care 
must also be given to treating co-existing complications 
such as anaemia. Until the demonstration of the harmful 
effects of lymphocytotoxic antibodies in renal 
transplantationCTerasaki et al, 1971), uraemic patients were 
routinely transfused when their haematocrit dropped below 
normal levels. When it was realised that blood transfusions 
were the main cause of generation of lymphocytotoxic 
antibodies in these patients, it was decided to restrict the 
number of blood transfusions in pretransplant patients. 
However, over the next few years it became apparent that 
limiting pretransplant blood transfusions was actually 
accompanied by a decrease in graft survival and patients who 
received blood transfusions before kidney transplantation 
had an improved renal allograft survivalCOpelz et al,
1973a). Despite initial scepticism, this finding was 
confirmed by many studies in the following yearsCDpelz & 
Terasaki, 1974, Murray et al, 1974, Gpelz S Terasaki, 197B, 
Persijn et al, 1977, Walter et al, 1977, Solheim et al,
1977, Briggs et al, 1978, Blarney et al, 1970), and there is
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now general agreement that blood transfusions in uraemic 
patients improve the chances of survival of a subsequent 
kidney transplant. However, there is confusion about the 
best protocol to use, with considerable disagreement over 
the use of third party or donor specific transfusions, whole 
blood or packed cells as well as over the number of 
transfusions and the optimal time interval between each 
transfusion. There are two principal approaches using third 
party blood transfusions. Opelz and co-workers recommend 
that at least five units of third party blood transfusions 
are required every 2-3 months while Persijn et al have shown 
that one third party blood transfusion is sufficient and 
that its effect is long lastingCUan Rood, 1303). Other 
regimes which have been described include the use of blood 
transfusion which are HLA-,A,B,C matched with the 
recipientCNube et al, 1001), or fully HLA-matched with the 
kidney donorCCochrum et al, 1073). In addition, transfusions 
of pure platelets from random donors have also been shown to 
improve graft survival in rhesus monkeysCUan Rood, 1303). 
However, third party blood transfusion protocols are used 
most commonly and usually five units of packed red blood 
cells are given every 2-4 weeks, followed by one unit every 
0 months until transplantation. This large number of 
different transfusion protocols and the fact that graft 
survival depends on many other additional factors, have made 
it difficult to determine the exact mechanism of the blood 
transfusion effect.
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It has been suggested that one possible mechanism of the 
apparent improved progress of transfused patients is that in 
many centres the patients responding to transfusion with the 
production of lymphocytotoxic antibodies are frequently 
excluded from transplantation. This possibility has been 
supported by a study in which one third of uraemic patients 
given five units of third party blood developed 
lymphocytotoxic antibodiesCmostly against B cells) but the 
overall in vitro cellular immune reactivity remained 
unchangedCFehrman et al, 1303). The authors suggested that 
since fewer patients with antibodies received grafts, blood 
transfusion seemed to have led to a selection effect. 
Although, this selection theory has gained considerable 
support in protocols using donor specific blood transfusions 
it has been discarded by most of the workers as a possible 
mechanism in patients receiving cadaver transplants 
unrelated to the transfusionCOpelz & van Rood, 1303). Most 
other proposed mechanisms attribute the benefits of blood 
transfusion on the host immune response and early studies 
showed a depression of skin test reactivity which correlated 
with the administration of blood transfusionsCWatson et al, 
1373) . Blood transfusion induced anti-idiotypic antibodies 
reacting with T cell antigen receptors have been also 
suggested as a possible protective mechanismCSingal et al, 
1303) while non-cytotoxic Fc-receptor blocking antibodies 
developed after blood transfusion have been shown to 
correlate with good graft outcomeCMcLeod et al, 1383). A 
non-specific,immunosuppressive mechanism which relates the
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blood transfusion effect to the red cell breakdown has also 
been proposedCde Sousa, 1983), based on previous Findings 
that ferritin suppresses T cell responses to 
mitogensCMatzner et al, 1979) and that there is an inverse 
correlation between serum ferritin levels and ratio of 
helper T to suppressor T cells in the blood of 
multi-transfused dialysis patientsCDupont et al, 1983). 
Similarly, Keown B DescampsC1979) have suggested that 
non-specific suppression of cell mediated responses could 
occur due to impaired function of mononuclear phagocytes 
caused by increased uptake of altered red cells. There are 
also two cellular mechanisms which have been proposed to 
explain the effects of blood transfusion to the immune 
system. First, it has been suggested that pre-transplant 
blood transfusion prime the recipient to donor antigens and 
when the renal graft is implanted, rapidly proliferating 
lymphocytes mount a secondary response and these are 
uniquely sensitive to the immunosuppressive therapy which 
the patient receivesCTerasaki, 1904).
The graft enhancing mechanism though which is favoured by 
the majority of investigators is the activation or 
generation of suppressor cells. Since the first 
demonstration that the blood transfusion-induced suppression 
of cellular immunity is caused by a non-specific suppressor 
cellCFisher et al, 1900), many workers have described the 
presence of both monocyte/macrophage-like cells and 
suppressor T cells in transfused uraemic patients. Soon
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after transfusion monocytes and IaCDR)-positive cells appear 
transiently in the peripheral blood and MLR activity is 
non-specifically suppressedCLenhard et al, 1982a). Removal 
of adherent mononuclear cells restores MLR responses to 
normal. At later times suppressor T cell activity increases 
although this is not accompanied by an increase in the 
number of suppressor/cytotoxic T cells as measured by 
immunofluorescenceCSmith et al, 1981, Lenhard et al, 1982b). 
The effect of planned blood transfusion on MLR to both donor 
and unrelated cells has been examined and a marked decrease 
in MLR activity was observed after the first blood 
transfusion in 38% of the patients and after the second or 
third blood transfusion in an additional 24% of the 
patientsCKlatzmann et al, 1903). Other patients had only a 
transient decrease, but otherwise MLR were normal or even 
increased. In the majority of patients with decreased MLR, 
peripheral blood lymphocytes were able to inhibit the MLR 
response of autologous cells taken before blood transfusion 
when they were mixed together in three-cell experiments. 
Since these suspensions were not cytotoxic to the 
stimulating cells the observed inhibition was attributed to 
suppressor cells. Although patients with reduced 
alloreactive responses exhibited suppressor cells which 
inhibited both MLR and the generation of allospecific 
cytotoxic T lymphocytes, the role of blood transfusion 
induced suppressor cells and their exact nature is still 
controversial .
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As suppressor T cells regulate immunoglobulin production 
by polyclonal B cell activator-driven B-cells one possible 
means of assessing the role of suppressor cells under 
clinical conditions would be to examine the production of 
immunoglobulin by peripheral blood lymphocytes in response 
to polyclonal B cell activators which differ in their 
dependence on regulation by suppressor T cells. Although 
both PWM and SAC depend on T cell help for full B cell 
differentiationCFalkoff et al, 1982), SAC induced B cell 
differentiation has been reported not to be regulated by 
suppressor cellsCPryJma et al, 1990). Therefore, one aim of 
this study was to assess the effect of third party blood 
transfusion on the in vitro immune response of prospective 
renal allograft recipients by measuring immunoglobulin 
secretion by peripheral blood lymphocytes both spontaneously 
and after stimulation with PWM or SAC.
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IMMUNOLOGIC MONITORING IN RENAL TRANSPLANTATION
1. MECHANISMS OF ALLOGRAFT REJECTION
Transplantation of allogeneic tissue stimulates a series 
of immunological reactions which usually result in the 
rejection of the graft. The realisation that clinical 
transplant rejection constituted an immune response 
necessitated the development of immunological tests which 
could predict or confirm this unwanted complication. In 
addition, these assays are required to monitor the degree of 
immunosuppressive therapy .
Rejection can be defined as the process by which the 
host’s immune system recognises, becomes sensitised against, 
and attempts to eliminate the antigenic differences 
presented by the donor organ. Rejection of renal allografts 
can be characterised clinically as hyperacuteCwithin minutes 
or hours), acceleratedCwithin several days), acuteCwithin 
the first month), or chronicCafter the first month). The 
rejection process is a very complex phenomenon both in the 
way in which antigen is recognised and in the way the host's 
response results in graft damage. Recent evidence indicates 
that while the tissue cells themselves can act as antigenic 
stimuli, class II MHC antigen expressing bone marrow derived 
dendritic cells of donor originCpassenger leukocytes) 
represent the most potent stimulus to rejectionCMorris,
1984). In addition, recirculating macrophages and dendritic 
cells of host origin may also play a role in processing and
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presentation of donor histocompatibility antigens to host T 
cells. Although the effector arm of rejection is mediated by 
T cells, there is still controversy about the nature of this 
effector T cell. In the specific cellular response the 
cytotoxic T cell is considered the cell which mainly 
produces graft damage. In addition, recent studies in T cell 
deprived mice and rats indicate that rejection involves a 
non-specific response resulting from a delayed type 
hypersensitivity reactionCDTH) reaction mediated by cells 
with the phenotype of TChelper) and TCDTH)CLoveland et al, 
1981, Dallman et al, 1982). Nevertheless these studies have 
been criticised because cytotoxic T cell precursors may 
still be present in recostituted animals and cytotoxic T 
cell precursors may share the helper T cell phenotype. 
Furthermore, cytotoxic T lymphocytesCCTL) specific for Class 
II MHC antigens are phenotypically identical to helper T 
cellsCBiddison et al, 1982, Ball et al, 1982, UJidmer et al,
1983). Together, these studies suggest that both CTL and DTH 
may be involved in the effector limb of allograft rejection.
The role of antibody in the destruction of the graft has 
not been clearly established. The vascular lesions observed 
in hyperacute rejection are attributed to the direct action 
of complement fixing antibody , while an antibody response 
against donor HLA antigens has been implicated in 
accelerated reJectionCUJi 11 iams , 1984). Acute rejection can
be of cellular, humoral or mixed form although the use of 
immunosuppressive drugs has rendered cellular acute
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rejection unusualCDunni11, 1984). Chronic rejection of
allografts has also been associated with repetitive 
deposition of IgG on the vascular endothelium leading 
eventually to obliterative arteritis. In addition, 
lymphocytotoxic antibodies which react with donor MHC 
antigens have been found in the serum of patients who are 
rejecting or have rejected renal allograftsCMorris et al, 
I960, 19B9, Stiller & Sinclair, 1979) and antibodies have 
also been found to be deposited in rejecting kidneysCMorris,
1984).
In addition to these specific components of the immune 
system, many non-specific effector mechanisms may also be 
involved in graft rejection. Macrophages and NK cells have 
also been implicated in graft rejection, but only limited 
and partly controversial data has been published about their 
relationship to allograft rejection. Complement has been 
shown to determine the effect of antibody in hyperacute 
rejection and is required for alloantibody induced graft 
damage in ratsCFrench, 1982, Morris, 1904).
2. IMMUNOSUPPRESSIVE TREATMENT
The history of immunosuppressive treatment started when 
G-MercaptopurineCB-MP) was given to rabbits together with an 
antigen and it was observed that antibody formation was 
totally suppressedCSchwartz S Dameshek, 1959). Shortly 
afterwards B-MP and particularly its imidazolyl derivative 
azathioprine were used in animals and in patients undergoing
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kidney transplantatienCCalne, 19B0, Zukoski, 13B0, Caine et 
al, 1962). Although many powerful immunosuppressive drugs 
have been discovered since then, azathioprine is still 
considered as one of the most important drugs in clinical 
transplantation and acts by blocking the synthesis of 
inosinic acid which is manifested as a decrease in DNA 
synthesisCUJebb & Winkelstein, 1982). Azathioprine can be 
used on its own to suppress rejection but this seldom done 
since immunosuppression with azathioprine alone is not very 
effective and it is administered usually together with 
steroids.
Steroids are frequently administered in high 
concentrations as a prophylaxis against rejection or for 
treatment after it has occured. It is certain that 
administration of steroids depresses the number of T and B 
lymphocytes as well as antigen and lectin induced 
blastogenesisCCupps S Fauci, 1902). However, the precise 
mechanisms of steroid induced immunoregulation in man have 
not been elucidated and it is still not certain whether 
their effects on the immune response are responsible for 
their usefulness in preventing and treating rejection or 
their powerful anti-inflammatory action.
In the mid 1970s a powerful cyclic polypeptide received 
wide attention as a new and powerful immunosuppressant. It 
was named cyclosporine A and it was isolated from two 
strains of fungiCCylindrocarpon Lucidum Booth and 
Trichoderma Polysporum) by Sandoz in Basle. This new drug
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was not cytotoxic for lymphocytes, had no antimitotic 
activity and it appeared to inhibit helper T lymphocytes by 
preventing the production of lymphokines and especially 
IL-2. Its effects on the humoral immune responses are 
variable and although it has been shown to suppress antibody 
responses to T-dependent antigens and mitogens, it is likely 
that this inhibitory effect is due to an effect on helper T 
celIsCMorris, 1902).
In the present study, all the transplanted patients were 
treated with either azathioprine and prednisolone or 
cyclosporine A and prednisolone, and an attempt was made to 
compare the effects of these two forms of immunosuppression 
on production of immunoglobulin in vitro.
3. IMMUNOLOGIC MONITORING
The large number of mechanisms which may be involved in 
allograft rejection has been parallelled by the wide variety 
of assays which have been developed to assess the immune 
status of transplant recipients . Some of these are designed 
to assess specific anti-graft immunity, but the majority 
measure non-specific immunological parameters and each has 
its own limitations. The principal of these are that in 
vitro observations do not necessarily reflect conditions in 
vivo while studies of peripheral blood lymphocytes do not 
fully represent immune phenomena in the graft. In addition, 
many of the immune reactions in vivo are short-lived and 
frequently have no obvious clinical manifestations.
Therefore the timing, number and evaluation of immunological
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tests presents a difficult problem.
Under ideal circumstances, the most valid assays of 
immune function in graft recipients would be those which 
assess specific anti-graft immunity.The most commonly used 
donor specific tests in renal transplantation detect 
antibodies against donor HLA antigens as well as 
donor-specific cytotoxic T lymphocytes and mixed lymphocyte 
reactivity against donor cells. Nevertheless, assays of this 
type do not confirm or predict rejection episodes 
consistently, probably because the exact antigens initiating 
rejection are not known and so cannot be measured directly. 
For these reasons, non-specific assays were introduced and 
these tests have the additional advantage that host 
immunosuppression can be evaluated by the same means. Most 
of the initial studies of this nature concentrated on the 
enumeration of peripheral blood lymphocytes while later 
studies also enumerated individual T cell subpopulations.
The results From these studies have been conflicting. Thus, 
in early work using the sheep red blood cell resetting 
technique to enumerate T cells, some workers found increased 
numbers of T cells during rejection episodesCBishop et al, 
1975) but this was not confirmed by other groupsCKerman 8 
Geis, 1975, Buckingham et al, 1977). When monoclonal 
antibodies were used to enumerate T lymphocytes and their 
subsets, some groups reported an increased ratio of 
□KT4+Chelper-inducer) to OKT0+Csuppressor-cytotoxic) 
populations during rejection episodes in patients treated
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with azathioprineCCosimi et al, 1901, Ellis et al, 1982) or 
cyclosporineCKehrman et al, 1903) while others could not 
find similar changesCGuttman 8 Paulsen, 1901, Carter et al, 
1903, Von UJillebrand, 1983). Different doses of 
immunosuppressive drugs as well as differences in the 
evaluation of rejection episodes may account For the 
different results reported by different groups.
In view of the possibility that peripheral blood 
lymphocytes did not reflect events occuring in the graft 
itself, other workers studied the phenotypes of cells within 
the transplanted graft and attempted to correlate cell 
numbers with either renal allograft rejection or the 
effectiveness of immunosuppressive treatment. During 
rejection episodes in azathioprine and cyclosporin treated 
patients, a decreased 0KT4+ to DKT0+ ratio in the graft 
compared to the peripheral blood was found in frozen 
sections of conventional core needle biopsiesCCMB)CPlatt et 
al, 1902, Hancock et al, 1903, Platt et al, 1903). The 
introduction of fine needle aspirationCFNA) allowed serial 
biopsies to be performed safely at short intervals and this 
technique confirmed a significant Fall in the QKT4+ - 0KT8+ 
ratio of graft T cells in cyclosporine treated patients 
undergoing reJectionCWood et al, 1983).
Functional studies have also been used to study rejection 
and immunosuppression. The initial finding that increased 
spontaneous blastogenesis by peripheral blood lymphocytes 
was associated with rejectionCHersh et al, 1971) was
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confirmed later by other groupsCJonas & Uldall, 1974, 
Gailiunas et al, 1978) but it has been also suggested that
this is usually due to systemic infectionsCMi 11er et al, 
1978), Similarly, the initial report that an increased PHA 
response by peripheral blood lymphocytes correlated with 
rejection episodesCThomas et al, 1978) has been challenged 
on the same groundsCStenzel et al, 1978).
Many groups also enumerated immunoglobulin secreting 
cells in azathioprine treated recipients and a correlation 
was reported between increased numbers of these cells in the 
peripheral blood and rejection episodesCHorsburgh et al, 
1983, Satomi et al, 1983).
Thus, most of the studies which have been performed so 
far are complicated by the effects of secondary infection. 
Furthermore, patients have often received different 
immunosuppressive regimes and there have been no in vitro 
immunological studies which compare directly the effect of 
these two forms of immunosuppression on the responses of 
peripheral blood lymphocytes. The spontaneous plaque forming 
cell assay reflects the status of in vivo B cell 
differentiation into immunoglobulin secreting cells and it 
was considered as a relevant and useful assay to provide 
information about the immune status of transplanted 
patients. Thus,the aim of the present study was to examine 
whether renal allograft rejection can be predicted by using 
a protein A plaque assay to enumerate immunoglobulin 
secreting cells in renal transplant recipients treated with
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either cyclosporine or azathioprine. In addition, the effect 
of these agents on immunoglobulin production was examined 
and compared with the results obtained from groups of 
uraemic patients and from normal controls.
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PLAQUE ASSAYS
Although polyclonal B cell activators were First used 
during the mid ISGO's, until 197B there were no reliable 
assays to measure immunoglobulin secretion by individual 
cells and hence terminal differentiation could not be 
assessed. Proliferation assays do not give this information 
while measuring cytoplasmic immunoglobulin by 
immunofluorescenceCCooper et al, 1973, Janossy 8 Greaves, 
1975) is simple but not very accurate. In contrast those 
assays measuring immunoglobulin levels in the supernatants 
of cell cultures stimulated with B cell polyclonal 
activators were simple and reproducible but gave no 
information about the number of cells responding. Thus, 
Fauci 8 PrattC1976 ) developed a system for culture and 
measurement of single cell antibody production by human 
tonsillar or peripheral blood mononuclear cells stimulated 
either with B cell polyclonal activators or sheep red blood 
cells. The method they used to measure antibody production 
was a modification of the plaque assay described by Jerne & 
NordinC19G3).
Jerne S Nordin had observed that when a mixture of sheep 
red blood cells and lymphoid cells from a rabbit immunised 
with sheep red blood cells was plated in agar and incubated 
at 37*C with complement, distinct plaques appeared in the 
agar. These consisted of circular clear areas of haemolysis 
with a central lymphoid cell and it was suggested that this
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was due ta the release oF haemolysis by an antibody-forming 
cell at the centre of the plaque. Furthermore, the authors 
predicted correctly that by coating red cells with other 
antigenic determinants it would be possible to study other 
antigen-antibody systems at the single level. Dresser & 
WortisClSGS) subsequently showed that addition of rabbit 
anti-mouse immunoglobulin enhanced the number of plaque 
forming cells observed. They suggested that the additional 
plaques which appeared were due to the augmentation of the 
activity of a low haemolytic activity antibody, such as IgG. 
Thus, this ’’indirect” plaque assay allows measurement of 
both IgG and IgM secretion, Although these methods could 
detect cells secreting different immunoglobulin classes, 
they were limited to detecting cells secreting specific 
antibodies. In 1974, Molinaro 8 Dray introduced a plaque 
assay which detected all cells secreting immunoglobulin of a 
particular class by coating sheep red blood cells with 
antiserum specific to the various immunoglobulin classes. 
Using this technique, they were the first to make 
quantitative assessments of immunoglobulin secreting cells 
among circulating peripheral blood lymphocytesCEby et al, 
1975). This plaque assay was called the reverse haemolytic 
plaque assayCRHPA) because the antibody was coated on to 
sheep red blood cells rather than the antigen. However, this 
method had the disadvantage that if measurement of more than 
one class of immunoglobulin was required, each antibody had 
to be coupled separately to
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shaap rad blood calls and, in 137G, Gronowicz at al 
introduced a modified plaque assay which overcame these 
difficulties. Taking advantage of the ability of protein A 
from Staphylococcus Aureus to bind to the Fc portion of IgG 
molecules, sheep red blood cells were coated with protein A 
and mixed with mouse lymphocytes. The plaques were then 
developed by adding complement and an immunoglobulin class 
specific antibodyCor preferably its IgG fraction), which 
bound to the sheep red blood cells via its Fc receptor and 
to the antibody secreted by the cell via its antibody 
binding site.
It rapidly became clear that this new plaque assay would 
facilitate assessment of human B cell Function and Bird & 
BrittonC1979b) modified it for use in the assay of cultures 
of human peripheral blood lymphocytes. Since then the 
protein A plaque has been used extensively in studies not 
only of the B cell itself but also in studies of the 
different cellular and factor mediated interactions required 
for B cell differentiation. The plaque assay can not only be 
used in combination with polyclonal activators to measure 
stimulated B cell activity, but can also be used to 
enumerate cells which are secreting immunoglobulin 
spontaneously. Furthermore, the assay can be applied to B 
cells isolated from peripheral blood, spleen, tonsils and 
lymph nodes or from biopsies and extracellular fluids. Other 
workers have also modified the plaque assay to detect 
secretion products of cells other than B cells, including
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Ferritin and various complément components.
In this thesis the protein A plaque assay has been used 
in two ways. First, I have enumerated the cells which are 
secreting immunoglobulin spontaneously in the peripheral 
blood of healthy and uraemic subjects and have studied the 
effect of blood transfusion, renal transplantation, 
immunosuppression and allograft rejection on the spontaneous 
secretion of immunoglobulin by peripheral blood lymphocytes 
obtained from uraemic patients. Secondly, I have studied 
whether uraemia and blood transfusion affect the ability of 
human B cells to proliferate and differentiate into 
immunoglobulin secreting cells after being stimulated with 
different polyclonal B cell activators.
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CHAPTER II
MATERIALS AND METHODS
MONONUCLEAR CELL SEPARATION
Peripheral blood mononuclear cells were prepared From 
heparinised venous blood From patients and normal volunteers 
as described by Boyum et alClSGB). Blood was collected into 
heparinised Evans bottlesCEvans Medical Ltd, Speke, 
Liverpool, England) and two volumes of blood were layered 
over three parts of Ficol1-HypaqueCNygaarde, England) before 
centrifuging at 400g for 25 minutes. Interface cells were 
removed using a Pasteur pipette, washed twice with RPMI 
1G40CGIBC0, Paisley, Scotland) and counted in a 
haemocytometer. All lymphocyte samples From each patient or 
healthy control were cryopreserved in liquid nitrogen and 
assayed in one experiment to avoid test to test variations.
SERUM
Control lymphocytes were cultured or pre-incubated with 
serum which was obtained from normal and uraemic subjects. 
Blood from these subjects was allowed to clot on ice, and 
serum was obtained and decomplemented by heating at 5G^C for 
30min.
DETERMINATION OF UIABILITY
In studies of viability, trypan blueCGurr, Searle 
Diagnostic, Bucks, England) exclusion was used. One part 
trypan blue(0.2% in saline) was mixed with one part of a 
cell suspension containing 2 x lO^PBMC/ml. The percentage of 
peripheral blood mononuclear cells which excluded trypan 
blueCviable cells) was then counted. Viability of peripheral 
blood mononuclear cells was also examined routinely by phase 
contrast microscopy.
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WHITE BLOOD CELL AND LYMPHOCYTE COUNTS
White blood cell counts were performed using a coulter
counterCCoulter Electronics, England). Lymphocyte counts 
were performed after partially depleting peripheral blood 
mononuclear cells from plastic adherent cells by incubating 
SxlO^ PBMC/mlCin RPMI+10%ECS) for GO minutes in plastic 
culture platesCSteri1 in, Teddington, England) at 37°C.
FREEZING AND THAWING OF CELLS
The freezing technique was that of Tauris &
JorgensenC13BB).
Before freezing, each fresh cell sample was centrifuged 
at 400 X g for ten minutes and resuspended at G x 10^
cells/ml in foetal calf serumCFCS, GIBCO, Paisley, Scotland)
which had been inactivated by heating at 5G*C for 30min. An 
equal volume of a 20% dilution of dimethyIsulfoxideCDMSO, 
Koch Laboratories, England) in RPMI was added dropwise to 
the cell suspension and after mixing with a vortex mixer, 
the cells were distributed in 1ml aliquots in freezing 
tubesCSterilin, Teddington, England). The tubes were kept 
overnight at -70 * C before transferred to the vapour phase of 
a liquid nitrogen freezer.
Thawing was achieved by agitating the tubes in a 37"C 
water bath until only a small lump of ice remained. The 
cells then were transferred immediately into plastic conical 
bottom tubes containing 3 ml of RPMI 1G40 at 4*C, spun at
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400 X g For Five minutes, resuspended in 10 ml of RPÎ1Î 1B40 
and eventually washed three times in medium at 400 x g 
before being counted and used.
PLAQUE-FORMING CELL ASSAY
A. MATERIALS
Sheep Red Blood Cells
Sheep red blood cellsCSRBC, Flow Laboratories, U.K.) were 
obtained fresh each week and were stored at 4"^ C in 
Alsevier's solution. Batches of 5RBC were' always discarded 
after one week.
Normal Saline
Normal Saline was obtained from the hospital's 
pharmacy esteriflex, Boots Company PLC, Nottingham, England). 
Sterile saline prepared in the lab was not used because of 
occasional phosphate contamination.
Protein-A
Staphylococcal protein-ACPharmacia, Uppsala) was 
reconstituted to Smg/ml with normal saline and this stock 
solution was stored at 4"^ C and was used for a maximum of 
three months.
Chromic Chloride
Chromic chlorideCCrClB.BHBO, Analar, BDH Chemicals Ltd,
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Poole, England) was used For coupling protein-A to SRBCs as 
reported by Uyas et alClSGB). Fresh chromic chloride was 
prepared by diluting the reagent in normal saline while aged 
chromic chloride was prepared by dissolving lOOmg of chromic 
chloride in 100ml saline. This latter solution was stored at 
room temperature and three weeks later its pH was adjusted 
to 5.0. The stock solution was diluted 1/10 with normal 
saline before being used in the coating procedure.
Antisera To Human Immunoglobulins
In all experiments rabbit antisera specific for the heavy 
chains of human IgA, IgG and IgMCDako Immunoglobulins, 
Copenhagen, Denmark) were used. The antisera were always 
diluted in Hank's balanced salt solutionCHBS5, Gibco, 
Paisley, Scotland).
Complement
SRBC absorbed guinea-pig complementCSera-Lab, England) 
was used after being diluted in HBSS.
Agar
The agar mixture for the plaque assay was prepared by 
dissolving agarCBacto Agar, Difco Laboratories) in a 1/10 
dilution of xlO HBSS concentrate and the pH adjusted to 
7.4.DEAE-DextranCPharmecia, Uppsala, Sweden) was then added 
to the agar mixture to overcome the anti-complementary 
properties of agarCLefkovits 8 Cosenza, 1379), while 
polyethylene glycol BOOOCPEG, Sigma, St Louis, USA) was
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added ta improve detection of plaques as described by 
Trienekens et alC19B4).
B. METHODS
The protein-A plaque assay was performed as described by 
Gronowicz et alC197G) and modified by Bird 8 BrittonC1979b) . 
Several experiments were performed to standardise the 
conditions and technique for the assay. These are described 
in detail in CHAPTER III and, for simplicity only the 
outline of the method is given hereCFig.5.1).
1. COATING OF SRBC WITH PROTEIN-A
SRBC were washed six times in normal saline and were then 
coated with protein-A by incubating one volume of SRBC with 
one volume of protein-A and ten volumes of chromic chloride 
for 45min at 37“C with continuous rotation. The packed cells 
and protein-A were mixed first and the chromic chloride was 
then added dropwise while mixing with a vortex mixer. After 
incubation the protein-A coated SRBC were washed three times 
with HBSS and used in plaque assays For up to 5 days after 
preparation.
2. PLAQUE FORMING CELL ASSAY
0.025ml Protein-A-coated SRBC, 0.1ml of lymphocyte 
suspension, 0.025ml rabbit antisera specific for heavy 
chains of human IgA, IgG or IgM and 0.025ml of SRBC absorbed 
guinea pig complement all diluted in HBSS were added to 0.75 
ml of agar supplemented with DEAE-dextran and PEG 5000 kept
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in a 46*C water bath. After mixing in a vortex mixer, three 
0.2ml drops were pipetted into a plastic 90mm Petri 
dishCSterilin, Teddington, England) and a 24 mm x 32 mm 
coverslipCChance Propper Limited, UJarley, England) 
immediately placed on top of each drop. The plates were then 
incubated from 1 to IG hrs at 37*C in a humidified C02 
incubator. Potential plaque farming cells were identified by 
naked eye as microscopic holes in the agar and the presence 
of a central lymphoid cell at the centre of haemolytic spots 
was confirmed by microscopyCFig.2.2). These plaques were 
counted and the results were expressed as the mean plaque 
forming cell countCof triplicate determinations) per million 
of plated cells. True plaques were easily differentiated 
from small air bubbles by the sharp edged appearance of the 
latter. Dust particles also produced false plaques but they 
were easily detected by the naked eye.
PRE-INCUBATION WITH CYCLOHEXIMI PE
Peripheral blood mononuclear cells were suspended in RPMI 
1640 alone or RPMI 1640 with cycloheximideCSigma, Poole, 
England). They were then incubated at 10^ PBMC/ml at 37*C 
for 30min, washed three times in cold HBSS and assayed as 
above.
LYMPHOCYTE CULTURES
Lymphocytes were cultured For the measurement of both 
proliferative and immunoglobulin responses. Once again many
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experiments were required to standardise the culture systems 
and these are described in detail in CHAPTER lU. The outline 
of the assays is given below.
Proliferative Responses to Mitooens
Peripheral blood mononuclear cells were resuspended in 
RPMI 1B40 supplemented with 10% heat-inactivated PCS, 
penici11in/streptomycinClOOunits/ml), fungizone(250mcg/ml) 
and L-glutamineCEmmol)CGibco, Paisley, Scotland). Peripheral 
blood mononuclear cells were cultured in 0.1ml volumes in 
conical bottomed microtiter platesCTitertek, Flow
6
Laboratories) at cell concentrations of 0.05 to 5 x 10 
PBMC/ml. Various concentrations of purified 
phytohaemagglutininCPHA, Wellcome, England) and pokeweed 
mitogenCPWM, Gibco, Paisley, Scotland) were added before 
mixing on a plate shaker. The plates were sealed with 
non-toxic fiImCNescofiIm, Nippon Shoji Kaisha LTD, Japan) 
and incubated at 37'* C in 5% C02 in air humidified 
incubatorCFlow Laboratories, Irvine, Scotland) for 24 to 
120hrs. Four to eighteen hours before harvesting, the plates 
were pulsed with 50pl of 14C-ThymidineC Phoenix 
Pharmaceuticals, West Germany, 0.015 pCi/well) using a 
Hamilton syringeCHamilton Company, Whittier, California,
USA) and, after reculture, cell bound DMA was harvested 
using a multi-cell harvesterCTitertek Cell Harvester, 
Skatron, Norway). Cell extracts were placed in scintillation 
fluidCLKB, Scintillation Products, Loughborough, England) 
and radioactivity was measured in a scintillation
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countercPackard, United Tecnologies, USA). Cultures were 
performed in triplicate and the results are presented as the 
mean counts per minuteCcpm) per well.
Antibodu Responses to Mitogens
A. Materials
Culture Tubes
Conical bottomed plastic tubesClEx75mm, Sterilin, 
Teddington, Middlesex) were used for lymphocyte cultures.
Culture Medium
Cells were cultured in RPMI 1640 supplemented with 10% 
PCS, L-Glutamine, and antibiotics as described above.
ConcBvalin-A
Concavalin ACConA, Sigma, Poole, England) was added in 
unstimulated and PWM and SAC culuras of control lymphocytes.
Methu1-prednisolone
Methy1-prednisolone CMP, Upjohn Ltd, Sussex, England) was 
added in some unstimulated and PWM and SAC induced cultures 
of control and uraemic lymphocytes.
Indomethacin
IndomethacinCSigma, St Louis, USA), a cyclooxygenase 
inhibitor was added in unstimulated and PWM and SAC cultures 
of control and uraemic lymphocytes. Indomethacin was 
dissolved in 0.15M tris-bufferCpH=0.0). ConA, MP, and 
indomethacin were made up in RPMI 1640.
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Control and Uraemic Serum
Serum was obtained from control and uraemic subjects as 
described above.
Poluclonal B Cell Activators
Lymphocytes were cultured in the presence of PWMCGibco,
Paisley, Scotland), Staphylococcus aureus Cowan I strain
bacteriaC SAC ), or Epstein-Barr virus CEBU). SAC was 
i
prepared Eolowing the procedure described by Forsgren et 
alC197G). Staphylococcus aureus Cowan I strainCNCTC 8530) 
was cultured overnight in tryptic soy brothCDifco 
Laboratories, England) and washed in sterile saline before 
being killed by incubation in 0.5% formaldeyde for 3hr and 
heating at 0O“C for 3 min, EBU containing supernatant of the 
B95-B marmoset cell line was used as source of EBU and this 
preparation was supplied by Dr Ailsa Campbel1CDepartment of 
Biochemistry, University of Glasgow, Glasgow).
B . Method
0.05-5x10^peripheral blood mononuclear cells in one ml
of medium were cultured in plastic tubes in the presence of
PWM, SAC, or a combination of PWM and SAC. Exposure to EBU
was performed as described by Bird 8 BrittonC1979b) by
6
suspending 1 x 10 cells in 0.2 ml of virus containing 
supernatant and incubating the cell pellet for BOmin at 37°
C . The cells were then washed twice with RPMI 1B40 and 
cultured as above.
Cultures stimulated with PWM, SAC and combinations of SAC
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and PWM were incubated For 1 to 8 days, but those stimulated 
with EBU were only cultured For 5 days to avoid the 
generation of cytotoxic T lymphocytes which can occur with 
EBU-stimulated unfractionated cellsC Bird et al, 1301).
After the end of the culture period, cells were washed 
twice in RPMI 1B40 medium, counted in a haemocytometer, 
their viability assessed and then assayed for immunoglobulin 
secreting cells using the plaque farming cell assay as 
described above.In some cultures, ConA, MP, indomethacin, 
control or uraemic serum was added to study their effect on 
immunoglobulin production. When the effect of different sera 
was studied, peripheral blood mononuclear cells obtained 
from healthy subjects were either culturedC5%) or 
pre-incubated with test serum at 5% final concentration.
ANALYSIS OF T LYMPHOCYTE SUBCLASSES BY IMMUNOFLUORESCENCE 
T cell subsets were analysed by two stage 
immunofluorescence using monoclonal antibodies. One million 
peripheral blood mononuclear cellsCO.Bml) were mixed with 5 
|jg of one of the monoclonal antibodies, DKT3, 0KT4, or BKTBC 
Ortho Diagnostic Systems Ltd, High Wycombe, England) and 
were incubated on ice for 30min. The cells were then washed 
twice in phosphate buffered salineCPBS) azideC0.01%) at 4“C 
and then were resuspended in 0.1ml of culture medium plus 5% 
FCS. 0.1ml of 1/30 FITCCrabbit anti-mouse immunoglobulin) 
was added and the cells were incubated for 30min at OCC. 
After washing twice cells were resuspended in one drop of 
30% v/v glycerol in PBSCpH 7.2) and immediately placed on a
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glass slide for examination under ultra-violet light using a 
fluorescence microscope. T3, T4 and TB positive cell counts 
were expressed as a proportion of the total lymphocyte 
count.
ANALYSIS OF B LYMPHOCYTE NUMBERS BY IMMUNOFLUORESCENCE
Measurement of Sig-positive cells often gives false results 
because external Ig in serum adsorbs to Fc-receptor bearing 
lymphocytes. In order to eliminate this artefact, PBMC were incubated 
at 37^0 for 60 minutes and then washed three times in HBSS kept at 
37^0. With this procedure cytophilic Ig is released.
A pellet of 2,5x10^ PBMC/ml was resuspended in 25 yil of 
FITC-labelled (F(ab*)2 Fragment) sheep anti-human immunoglobulin 
serum(Cappel Laboratories, Dynatech, Sussex, England) diluted 
1/4 in PBS. The mixture was incubated for 30 minutes at 4"* C and 
then washed three times at 4*^ 0 with PBS containing 0.01% azide 
to prevent capping. The percentage of cells with surface immunoglobulin 
out of 200 total lymphocytes was counted in a fluorescence 
microscope.
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STATISTICAL ANALYSIS 
Statistical analysis was carried out using a variety of 
tests. Student’s t test was used when data conformed to a 
normal distribution and the unpaired t test was used to test 
two independent sets of random samples while the paired t 
test was used for sets of paired observations from two 
populations. The chi-squared test was used to compare the 
distribution of a discrete variable in a sample with the 
distribution of a discrete variable in another sample.
When the analysed data did not conform to a normal 
distribution non-parametric tests were used. The Wilcoxon 
rank sum test was used on unpaired data and the signed rank 
test on paired data.
Results were expressed as the mean+lSEM unless otherwise 
stated.
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PROTEIN-A PLAQUE ASSAY
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Fig.2.1
The outline of the protein-A plaque assay as described 
by Gronowicz et al(1976)
%
%
• t
Fio.2.2
Haemolytic plaque with an immunoglobulin secreting cell at 
the centre
CHAPTER III
CHARACTERISATION OF THE PLAQUE-FORMING CELL ASSAY
INTRODUCTION
The clinical studies performed in this thesis used the 
plaque forming cell assay to assess B cell function in vitro 
and therefore it was essential to establish the conditions 
which gave optimal results. Although most workers performing 
plaque assays use similar reagents, it is generally agreed 
that considerable problems of sensitivity and
reproducibility remain. One particular area of difficulty is 
that there are many different techniques for coating of 
sheep red blood cells with protein A in the presence of 
chromic chloride with different workers using either fresh 
or aged chromic chloride, different dilutions of chromic 
chloride and different dilutions of protein A.
The aim of the experiments in this section was to 
investigate the technical factors affecting spontaneous 
plaque formation by circulating peripheral blood mononuclear 
cells and to identify optimal conditions.
MATERIALS AND METHODS
UenoLis blood was collected from twenty five healthy 
subjectsCTable 3.1) working in the Renal Unit and the 
Department of Bacteriology and Immunology and mononuclear 
cells were prepared as described above. All the experiments 
were performed on freshly isolated cells unless otherwise 
stated and cell viability determined by phase contrast 
microscope was usually approaching 100%. Frozen cells were 
used only when viability was exceeding 80%.
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RESULTS
OPTIMAL CONDITIONS FOR COATING SHEEP RED BLOOD CELLS WITH
PROTEIN A
Age oF Chromic Chloride
In order to examine whether fresh or aged chromic 
chloride give better results in the plaque assay, 
experiments were performed using chromic chloride of 
different ages to coat sheep red blood cells. Peripheral 
blood mononuclear cells from one donor were isolated, 
cryopreserved and spontaneous plaque formation was assayed 
on four separate occasions using sheep red blood cells which 
had been coated with protein A in the presence of chromic 
chloride which was either freshly prepared, 1 week old or 1 
month old. In these experiments, only IgA-PFC were counted 
because, as discussed laterCCHAPTER IV), IgA-PFC counts are 
consistently higher than those of other isotypes in the 
spontaneous plaque forming cells assay. Fig.3.1 shows the 
numbers of IgA-PFC obtained in these four experiments and it 
can be seen that sheep red blood cells coated with fresh 
chromic chloride produce a good level of spontaneous plaque 
forming cell response which was consistent throughout the 
four experiments. In contrast, although aged chromic 
chloride occasionally produced higher plaque forming cells 
counts in individual experiments, there was also 
considerable variation between the responses obtained on 
different occasions.
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Optimal Concentration of Chromic Chloride
The next experiments were designed to establish the
optimal concentration of chromic chloride for coating sheep
red blood cells and Fig.3.2 shows the effect of using 
-4 -4
0.25x10 M to 25x10 M chromic chloride on IgA plaque
formation. If no chromic chloride was used in the coating
procedure no plaques were observed, establishing that
chromic chloride was an absolute requirement For coating.
Both 0.25x10"^ M and 2.5x10 chromic chloride allowed
plaques to develop, but 2.5x10 was more efficient and
this dilution was used in all subsequent experiments. At the
-4
highest concentrationCBSxlO M) lysis of sheep red blood 
cells occurred during the coating procedure.
Optimal Concentration of Protein A
The final variable to be studied in this section was the
effect of different dilutions of protein A on plaque
formation. Fig.3.3 shows IgA-PFC counts from three separate
experiments in which cells from the same donor were coated
with different dilutions of a 5mg/ml stock solution of
protein A. The highest number of plaques were consistently
obtained using 1:5 or 1:10 dilutions of this stock solution,
but the 1:10 dilution ujas eventually preferred because it
gave less variation between experiments.
It was concluded from these three groups of experiments
that optimal numbers of plaque forming cells were obtained
when sheep red blood cells were coated with 0.5mg/ml protein
-4
A in the presence of fresh chromic chloride at 2.5x10 M 
concentration.
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OPTIMAL CONDITIONS FDR PLAQUE ASSAY
The next series of experiments were designed to establish 
the optimal conditions for the development of plaque forming 
cells of each immunoglobulin class.
Peripheral Blood Mononuclear Cells
The effect of varying the number of peripheral blood 
mononuclear cells was examined first and Fig.3.4 shows the 
results from three separate experiments using cells from the 
same healthy subject. These studies showed that the 
concentrations of cells used in the assay had no effect in 
the number of plaque forming cells’ obtained.
Concentration of Sheep Red Blood Cells
In the next five experiments, different concentrations of 
protein A coated sheep red blood cells were used in the 
plaque assay and the results are shown in Fig.3.5. Although 
the highest number of plaque forming cells of all classes 
were obtained using 1:12 and 1:24 dilutions of packed sheep 
red blood cells, these plaques were difficult to count 
because of the low numbers of sheep red blood cells and, 
indeed, using 1:48 sheep red blood cells it was impossible 
to determine whether there was plaque formation or not. As a 
1 : G dilution of sheep red blood cells gave similar levels of 
plaque forming cell counts, this dilution was used 
subsequently because it was associated with well defined and 
easily counted plaques.
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Optimal Dilutions of Antisera and Complement
The effects of varying the concentrations of the 
developing antisera and complement were then examined in 
Five separate experimentsCFig.3.6,7). The number of plaque 
forming cells of all classes was directly related to the 
concentration of both antisera and complement, with the 
highest plaque forming cell responses being observed when 
each antiserum was diluted 1: 15-1 ;30CFig.3.B) and when 
complement was diluted 1: 2-1 ;HCFig .3.7). As anticipated, 
plaque formation was not observed in the absence of antisera 
or complement. In all subsequent experiments, antisera were 
used at 1:30 and complement at 1:4.
Use of DEAE-dextran and PEG BOOO
Next, the optimal dilution of DEAE-dextranCn=3) and the 
effect of adding PEG B000Cn=3) to the agar mixture were 
studied. In the absence of DEAE-dextran, very few plaques 
were observed, indicating that it was essential to inhibit 
the anti-complementary effect of agarCFig.3.0). These 
experiments also showed that the optimal response for all 
plaque forming cell classes was observed when DEAE-dextran 
was added at a final concentration of Emg/ml . In contrast, 
the addition of PEG GGGO did not improve the plaque forming 
cell responseCFig ,3.0). Nevertheless PEG made the plaques 
clearer and easier to count and therefore PEG BOOO was 
incorporated subsequently at a concentration of 1%.
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Effects of Agar Concentration
A further parameter which was studied in one experiment 
was the concentration of agar used in the assay. Optimal 
numbers of IgA-PFC were obtained using 0.1 or 0.5% agar and 
very few plaque forming cells were found using 1 or 2% 
agarCFig.3.10). Although both lower concentrations gave 
similar results, 0.5% agar was preferred because it was 
easier to handle in preparation. .
Effect of Varuino the Incubation Period
The effect of different incubation periods on the plaque 
forming cell response was the next parameter to be studied 
and the results are shown in Fig.3.11Cn=3). Very few plaque 
forming cells of any class appeared during the first 
l-2hours of incubation and the highest counts of plaque 
forming cells were obtained after Bhrs. Although a further 
increase was occasionally found after overnight incubation, 
the longer incubation period caused the plates to dry out.
Effect of Time and Temperature
It has been suggested that differences in handling 
effector cells before plating may account for much of the 
test to test variation which is frequently observed with 
plaque forming cells assaysCFreijd S Kunori, 1980). Thus, in 
the following experiments the effects of storing peripheral 
blood mononuclear cells for different times and at different 
temperatures after collection were examined. Fig.3.12 shows
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the results of three such experiments in which cells were 
held at room temperature For different times before an Bhr 
plaque assay was performed. It was clear that even after Ihr 
there was a reduction in the number of all classes of plaque 
forming cells and when plaque assays were performed after a 
Ghours delay virtually no plaque forming cells were 
observed. In the second series of experimentsCn=3), the 
effect of storing peripheral blood mononuclears for Ehours 
at different temperatures was examined. It can be seen from 
Fig.3.13 that a reduction in plaque forming cell numbers 
occurred when separated cells were held for Ehours at either 
room temperature or 37*C, while incubation of cells on ice 
prevented the decay in plaque farming cells activity caused 
by storage.
Effect of Cruopreservation of Cells on Plague Formation
As some of the clinical studies would involve assaying 
large numbers of serial samples, it was important to 
determine whether a storage method could be devised which 
would allow one set of samples to be tested simultaneously, 
thus eliminating errors due to interassay variation. 
Therefore, the effect of cryopreserving peripheral blood 
mononuclear cells on plaque formation was studied. On 
separate occasions, peripheral blood mononuclear cells from 
one donor were tested for plaque forming cell activity when 
freshly obtained and after cryopreservation in liquid 
nitrogen for periods of 1-12 weeks. It can be seen from 
Fig.3.14 that the ability of peripheral blood mononuclear
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cells to form plaques does not deteriorate with 
cryopreservation over these times. Recently, other workers 
have reported that plaque forming cell activity remains 
stable during cryopreservation over even longer 
periodsCTauris S Jorgensen, 1983).
Dualitu Control of the Assau
The ability to freeze Peripheral blood mononuclear cells 
without losing plaque farming cells activity allowed several 
experiments to be performed to establish a quality control 
for the assay .
In the first experiment, the variability caused by using 
different batches of protein A coated sheep red blood cells 
was examined. A large sample of peripheral blood mononuclear 
cells was frozen in liquid nitrogen as described previously. 
At weekly intervals an aliquot of cells was tested for the 
ability to form plaques using fresh batches of protein-A 
coated sheep red blood cells and in Fig.3.15 can be seen 
that the plaque forming cell counts of all classes were 
identical on twelve separate occasions. Thus, the levels of 
plaque forming cells were not affected by the batch of 
protein A coated sheep red blood cells which was used. In 
contrast, when serial plaque forming cell assays were 
performed using cells which were obtained fresh from a 
healthy volunteer at weekly intervals, there was 
considerable variation in the level of all classes of plaque 
forming celIsCFig . 3 . IB) . To investigate whether this 
variation reflected changes in lymphocyte reactivity or true
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test to test variation, part of each of these peripheral 
blood mononuclear cell samples was cryopreserved and all 
twelve samples were assayed on one single
occasionCFig.3.17). It can be seen that apart from a slight 
elevation in IgG-PFC in the 6 week sampleCalso seen in 
Fig.3.IB), there was little variation when the serial 
samples were tested simultaneously. Thus, the variation 
observed when the samples were tested fresh was due to test 
to test variation.
These results indicated the usefulness of 
cryopreservation when performing studies of large numbers of 
serial samples and also showed that the conditions of 
coating sheep red blood cells with protein A have very 
little effect on plaque formation.
Cucloheximide
The final experiment which investigated the methodology 
of the spontaneous plaque forming cell assay was designed to 
confirm that the assay detected only those B cells which 
were actively secreting immunoglobulin. Therefore, 
peripheral blood mononuclear cells were pre-incubated with 
serial dilutions of cycloheximide to examine if protein 
synthesis was a pre-requisite for plaque formation. Fig.3.IS 
shows that cycloheximide produced a dose dependent 
inhibition of IgA-PFC numbers with a complete absence of 
plaque forming cells at concentrations greater than 
200jjg/ml. Thus, plaque formation was due to active secretion 
of immunoglobulin and was not merely due to passive release 
of cytophilic or pre-formed cytoplasmic immunoglobulin.
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CONCLUSIONS
This chapter has examined several parameters which might 
affect the performance and reproducibility of the protein-A 
plaque assay. These studies established the optimal 
conditions for coating sheep red blood cells with protein A 
and for incubating peripheral blood mononuclears with sheep 
red blood cells. In addition, it was shown that the number 
of plaque forming cells was dependent on the concentrations 
of sheep red blood cells, antiserum, and complement used in 
the assay, while incorporation of PEG BOOO in the agar 
mixture was found to improve the quality of the plaques. In 
further studies, it was also shown that effector cells 
should be stored on ice for as short a time as possible 
before assaying and that the plaques should be counted after 
a standard incubation period because of the marked 
differences observed at the different times of storage. Two 
findings of considerable importance for future studies of 
serially obtained peripheral blood mononuclear cells, were 
that cells could be cryopreserved without loss of plaque 
forming cell activity and that different batches of sheep 
red blood cells could be used without introducing 
variability to the assay.
Following these studies a positive control sample like 
the one shown in Fig,3.15 was routinely assayed 
simultaneously with the test samples to provide an 
indication about the performance of the assay.
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NORMAL CONTROLS
AGE SEX
1 . D.T. 38 M
2. J.L. 25 F
3. M.W. 40 F
4. U. J. 33 F
5. T.D. 31 M
6. P.O. 32 M
7. B. J. 40 M
8 . E.F. 55 F
3 . E.G. 28 M
10. G.C. 20 M
11 . A.Y. 20 M
12. C.M. 32 M
13. T.M. 29 F
14. D.D. 27 M
15. G.P. 23 M
IB . 2.M. 35 M
17. M.F. 29 F
10. J.U. 32 M
13. C.T. 30 M
20. S.I. 20 M
21 . A.S. 21 F
22. O.K. 27 M
23. P.I. 24 M
24. S.B. 27 M
25. D .L . 25 M
Mean+SEM:30.2+1.5 M/F:lB/7
Table 3.1
Normal controls used in all the experiments described
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Influence of the age of Chromic Chloride 
on spontaneous IgA plaque formation.
Bars represent the mean of triplicate 
determinations(PFC/lO cells).
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Fig.3.2
The effect of Chromic Chloride concentration 
on spontaneous IgA plaque formation by control 
peripheral blood mononuclear cells^
Bars representthe mean+lSEM(PFC/10 cells) of 
three experiments.
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Fig.3.3
The effect of the amount of Protein-A
added to the reaction mixture on spontaneous
IgA plaque formation. 5
Bars represent the mean+lSEM(PFC/10 cells) of
three experiments.
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Fig.3.4
The effect of concentration of peripheral 
blood mononuclear cells on spontaneous IgA 
plaque formation. ^
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
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Fig.3.5
The effect of the concentration of sheep 
red blood cells on spontaneous plaque 
formation, c
Bars represent the mean+lSEM(PFC/10 cells) 
of five experiments.
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Fig,3.6
The effect of the amount of developing 
antisera on spontaneous plaque formation. 
Bars represent the mean+lSEM(PFC/10 cells) 
of five experiments.
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Fig.3.7
The effect of the amount of complement 
on spontaneous plaque formation. ^
Bars represent the maan+lSEM(PFC/10 cells) 
of five experiments.
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The effect of adding DEAE-dextran on 
spontaneous plaque formation, g
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
C/10 pone
ËlgR
IgH
Fig.3.9
The effect of adding polyethylene glycol 
6000 on spontaneous plaque formation.
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
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Fig.3.10
The effect of agar concentration on 
spontaneous plaque formation.
Bars represent the mean of triplicate 
deteminations(PFC/10 cells)
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The effect of incubation time on the 
development of spontaneous plaques.^
Bars represent the mean+lSEM(PFC/10 cells) 
of four experiments.
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Fig.3.12
The effect of storing control peripheral 
blood mononuclear cells for different times 
on spontaneous plaque formation. ^
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
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The effect of storage temperature on 
spontaneous plaque formation. Control cells 
were assayed immediately without storage 
while other cells were stored for 2hrs at 
different temperatures. ^
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
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Fig.3.14
The effect of cryopreservation on spontaneous 
plaque formation. Peripheral blood mononuclear 
cells were assayed either fresh or after storage 
in liquid nitrogen for different times.
Bars represent the mean of triplicate 
determinations(PFC/lO® cells).
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Spontaneous plaque formation by cryopreserved 
peripheral blood mononuclear cells obtained from 
the same healthy subject. One aliquot of cells was 
tested weekly using different batches of protein-A 
coated sheep red blood cells.
Graphs shown are the mean of triplicate determinations 
(PFC/10^ cells)
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Fig.3.16
Spontaneous plaque formation by peripheral blood 
mononuclear cells obtained from the same healthy 
subject at weekly intervals. Each sample was tested 
for spontaneous plaque formation using different batches 
of protein-A coated sheep red blood cells.
Graphs shown are the mean of triplicate determinations 
(PFC/IOG cells)
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Fig.3.17
Spontaneous plaque formation by cryopreserved 
peripheral blood mononuclear cells obtained at 
weekly intervals from the control subject shown 
at Fig.3.16, All twelve samples were tested on the 
same day.
Graphs shown are the mean of triplicate determinations 
(PFC/10^ cells)
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Fig.3.18
The effect of pre-incubating peripheral blood 
mononuclear cells with cyclohexiraide on spontaneous 
IgA plaque formation.
Bars represent the mean of triplicate determinations 
(PFC/10^ cells)
CHAPTER IV
PROLIFERATIVE AND PLAQUE FORMING CELL RESPONSES 
OF PERIPHERAL BLOOD MONONUCLEAR CELLS STIMULATED WITH 
MITOGENS IN VITRO
INTRODUCTION
A major aspect of this thesis was to study the ability of 
patients’s peripheral blood mononuclears cells to 
proliferate and secrete immunoglobulin in response to 
mitogens and therefore the aim of the following experiments 
was to study the factors which affected proliferation and 
immunoglobulin secretion by mitogen stimulated normal 
peripheral blood mononuclear cells. The proliferative 
responses of control peripheral blood mononuclear cells were 
studied by measuring DNA synthesis in response to the T cell 
mitogen phytohaemagglutininCPHAJ and to a mitogen which 
stimulates both T and B celIs-pokeweed mitogenCPWM), In 
addition, the polyclonal B cell activators, PUN and SAC, 
were used alone and together to establish the optimal 
conditions for immunoglobulin secretion in vitro.
MATERIALS AMD METHODS
Venous blood from healthy subjectsCTable 3.1) was 
collected, mononuclear cells were prepared and cultures of 
peripheral blood mononuclears were set up as described 
previously. Proliferation was measured after pulse-labeling . 
the cultures with 14C-thymidine and immunoglobulin secretion 
was measured using the protein-A plaque assay to enumerate 
immunoglobulin secreting cells.
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RESULTS
Measurement of Proliferative Responses to PHA and PWM
In the first experiments, the response of peripheral 
blood mononuclear cells to mitogens was examined. Cells were 
cultured in medium containing FCS selected for its low 
mitogenic activity and the effect of different 
concentrations of PHA and PWM are presented in Fig.4.1 and 
Fig.4.2 respectively. When cells were cultured in the 
presence of mitogen, a dose-dependent response in 
thymidine-uptake was noted which was maximal with 10|_tg/jjl of 
PHA and 1/500 dilution of PWM. Fig,4.3 also shows the 
response of peripheral blood mononuclear cells after l-5days 
in culture with optimal doses of PHA and PWM respectively .
It can be seen that the highest responses to both mitogens 
were observed on the third day of culture and thereafter the 
responses declined. This loss of responsiveness after three 
days was associated with falling viability in the 
culturesCdata not shown), and so three days was chosen for 
all Future experiments measuring proliferative responses to 
mitogens. PHA and PWM induced blastogenesis measured after 3 
days of culture tends to reflect T cell proliferationCCupps 
& Fauci, 1902) and since SAC is known to stimulate 
selectively B cellsCFalkoff et al, 13B2)an attempt was madë 
to establish the optimal conditions for SAC induced 
blastogenesis. Four experiments were performed and although 
a degree of thymidine uptake was obtainedCdata not shown), 
the dose and day responses were not reproducible.
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The effect of using different concentrations of
peripheral blood mononuclear cells on their response to
either PHA or PWM was examined next. Although, good
responses were obtained when cells were cultured at
5 5
concentrations between 0.5x10-50x10 cells/ml, optimal
5
proliferation was found using 5x10 cells/ml, cell crowding 
producing significant suppression of lymphocyte 
transformationCFig.4.4).
Production of Immunoglobulin in Response to Poluclonal B
Cell Activators
Having established the optimal conditions for mitogen 
induced proliferative responses, I went on to examine the 
optimal conditions for immunoglobulin secretion in response 
to PWM and SAC. Peripheral blood mononuclear cells from 
different donors were cultured with different concentrations 
of PWM and SAC and secretion of IgA, IgB, and IgM was 
measured using the plaque forming cell assay. Fig.4.5 shows 
IgA, IgG and IgM responses obtained from four experiments 
using PWM and it can be seen that the most consistent 
responses were obtained using a 1:100 final dilution of PWM. 
This applied to all isotypes and this dilution was used in 
all subsequent experiments. Next, the optimal dose for SAC 
was determined and Fig.4.6 shows plaque farming cell 
responses from four different cultures stimulated with the 
same batch of SAC. It was essential to use the same batch of 
bacteria in each group of experiments since it wias prepared 
in the laboratory on several different occasions and
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different conditions. The 1:1000 dilution of SAC gave the 
highest plaque forming cell response and, despite some 
variation between batches of SAC, this dilution consistently 
gave the optimal response.
Suneraistic Effects of PWM and SAC on Immunoglobulin
Production
In the next series of experiments, peripheral blood 
mononuclear cells were cultured with both SAC and PWM to 
study the ability of a combination of these two activators 
to produce more efficient B cell activation than either 
aloneCSaiki & Ralph, 1981b). As before, all classes of 
plaque forming cell response to PWM and SAC alone were 
optimal using 1:100 and 1:1000 dilutions respectivelyCTable 
4.1). For each concentration of PWM, addition of all 
concentrations of SAC produced more plaque forming cells 
than seen with PWM alone, and, using lower concentrations of 
mitogens, the response of mixed cultures was greater than 
would be expected if the responses to either alone were 
added. This synergistic effect was most pronounced using 
1:10000 SAC plus 1:1000 PWM and these concentrations were 
used in all subsequent experiments.
Time Course of Plague Forming Cell Development
In view of the different proliferative responses observed 
at different times of culture it was important also to 
examine the time course of plaque formation by cultured
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cells in response to polyclonal B cell activators.
In the previous series of experiments IgG-PFC counts were 
consistently shown to be the highest and it was this class 
which was subsequently studied in order to establish the 
optimal conditions of mitogen-induced immunoglobulin 
production. Thus, peripheral blood mononuclear cells were 
cultured with PWM, SAC, PWM+5AC and assayed for IgG 
secretion one to eight days laterCFig.4,7) . Very few plaque 
forming cells were found in cultures before day 4 and in 
each case the optimal response was usually obtained on the 
sixth day, with a similar response also frequently being 
found on the seventh day. On the eigth day a sharp drop in 
plaque forming cell counts was observed and this was 
associated with marked loss of viability within the 
cultures, which was normally >90% until this time.
Effect of Cell Concentration on Immunoglobulin Production
The effect of cell concentration on PWM or SAC induced
IgG-PFC was also studied and the results are shown in
Fig.4.8, Peripheral blood mononuclear cells were cultured in
5
concentrations ranging from O.S to 50x10 PBMC/ml and, as 
with the proliferative responses, most cell concentrations 
responded well in the plaque forming cell assay, but the 
highest plaque forming cell responses were consistently
5
obtained when cells were cultured at either 5 or 10 x 10 
PBMC/ml . The lower of these concentrations was used in 
subsequent experiments to minimise cell use in patients with 
low white blood cell count.
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Rearoducibilitu of Mitogen Stimulated Immunoglobulin 
Production
Reproducibility is a major concern when measuring 
mitogen-stimulated immunoglobulin productionCBurns & Pike, 
1981). Therefore, similar experiments to those performed to 
study the reproducibility of spontaneous plaque formation 
were performed. When peripheral blood mononuclears from one 
donor were cryopreserved for 1-12 weeks and assayed in 
individual experiments for PWM-induced plaque farming cell 
activity, the levels of all plaque forming cell classes 
remained stable throughout the periodCFig.4.9), When 
peripheral blood mononuclears were taken on 12 separate 
occasions from a single donor and cultured fresh with PWM, 
considerable variations were observed in the level of plaque 
forming cells over that periodCFig.4.10), As with the 
spontaneous plaque forming cell assay, these variations were 
due to test to test variability in the plaque assay itself, 
rather than in lymphocyte reactivity, as these differences 
were minimised when each blood sample was cryopreserved and 
assayed on the same occasionCFig.4.11). However, it should 
be noted that there was generally more variability in the 
plaque forming cell responses after culture than with the 
spontaneous plaque forming cell assay, presumably reflecting 
the greater complexity of the culture system.
Other Factors Affecting reoroducibilitu
It was also observed that other factors like different
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materials, reagents and equipment used could affect 
significantly plaque forming cell activity. Thus, culture 
tubes of different shape, PWM or FCS from different sources 
and different CDS incubators were all found to affect plaque 
FormationCData not shown)
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CONCLUSIONS
This chapter examined the optimal conditions For both
.proliferation and immunoglobulin production in response to
mitogenic stimulation.
Three parameters which may affect the proliferative
response were studied and the optimal response was obtained
5
when cells were cultured at a final concentration of 5x10
PBMC/ml in the presence of either 10|jg/^l PHA or 1/500 PWM
for three days. In parallel studies of immunoglobulin
production in vitro the optimal plaque forming cell response
5
was obtained when 5x10 PBMC/ml were cultured in the presence 
of 1/100 PWM, or 1/1000 SAC or 1/1000 PWM plus 1/10000 SAC 
For G days.
In addition my studies confirmed the synergistic effect 
of PWM and SAC on immunoglobulin production and established 
the optimal conditions for this synergy. Studies using 
cryopreserved peripheral blood mononuclear cells confirmed 
their suitability■for use in mitogen-stimulated cultures and 
indicated that the reproducibility of the PWM and SAC 
culture systems was satisfactory. Thus, the experiments 
described here and in CHAPTER III have established the 
optimal conditions for studying B cell responses using 
normal peripheral blood mononuclear cells and these methods 
will now be applied to the study of B cell activation and 
immunoregulation in uraemic subjects.
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Proliferative responses of control peripheral 
blood mononuclear cells to PHA,
Bars represent the mean^^ c Thymidine uptake on 
the third day of culture +1SEM in 4 experiments
iFig.4.2
Proliferative responses of control peripheral 
blood mononuclear cells to PWM.
Bars represent the mean  ^ C Thymidine uptake on 
the third day of culture +1SEM in 4 experiments.
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Proliferative responses of control peripheral 
blood mononuclear cells cultured for different times 
with PHA or PWM,
Bars represent the mean 
in 4 experiments.
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The effect of cell concentration on the 3 day 
proliferative responses of control peripheral blood 
mononuclear cells to PHA and, PWM,
Bars represent the mean ^ C Thymidine uptake +1SEM 
in 4 experiments.
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Fig.4.5
The effect of different dilutions of
PWM on immunoglobulin production by control
peripheral blood mononuclear cells.^
Bars represent the mean+lSEM(PFC/10 cells) 
of four experiments.
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Fig.4.6
The effect of different dilutions of SAC 
on immunoglobulin production by control 
peripheral blood mononuclear cells.^
Bars represent the raean+lSEM(PFC/10 cells) 
of four experiments.
DILUTION OF SAC
DILUTION OF PWM 0 1 ; 100 1:1000 1 : 10000 1:100000
1 . loA - PFC
0 14792 10416 11233 2674
1: 100 32316 45760 53239 67203 54766
1 ; 1000 24754 36390 69092 00404 72238
1 : 10000 6532 0934 12153 11290 5766
1 : 100000 1277 1390 2214 3574 2473
2 . 106 - PFC
0 — 13732 23576 12137 1906
1 : 100 425BB 50632 69754 62630 49574
1:1000 32730 45033 62900 97766 47532
1:10000 121G5 32796 44560 52832 0574
1 : 100000 3267 12133 33654 36743 3476
3. loM - PFC
0 — 11206 14506 0573 547
1:100 16732 20032 31517 29413 10217
1:1000 12416 10413 28507 46756 21014
1:10000 8571 17561 22032 30664 4772
1:100000 1016 14436 21677 10116 2273
Table 4.1
Synergistic effect of SAC and PWM on production of immunoglobulin. 
Control peripheral blood mononuclear cells were cultured in the 
presence of PWM, SAC or p combination of the two. Results are 
expressed as mean PFC/10 cells of triplicate determinations.
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Time course of plaque forming cell response to optimal 
concentrations of PWM, SAC, PWM+SAC.
Graphs shown are the mean+lSEM of three experiments.
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Fig.4 .8
The effect of cell concentration on the 6 day 
immunoglobulin responses of control peripheral 
blood mononuclear cells to PWM and SAC,
Bars represent the mean+lSEM(PFC/10 cells) 
of three experiments.
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Fig.4.9
PWM induced plaque formation by cryopreserved 
peripheral blood mononuclear cells obtained from 
the same healthy subject. One aliquot of cells was 
tested weekly using different batches of protein-A 
coated sheep red blood cells.
Graphs shown are the mean of triplicate determinations 
(PFC/1Q3 cells)
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Fig.4.10
PWM induced plaque formation by peripheral blood 
mononuclear cells obtained from the same healthy 
subjects at weekly intervals. Each sample was tested 
using different batches of protein-A coated sheep red 
blood cells.
Graphs ^hown are the mean of triplicate determinations 
(PFC/10 cells)
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. Fig.4.11
PWM induced plaque formation by cryopreserved 
peripheral blood mononuclear cells obtained at weekly 
intervals from the control subject shown at Fig,4,10. 
All twelve samples were tested on the same day.
Graphs shown are the mean of triplicate determinations 
(PFC/103 cells).
CHAPTER U
PRODUCTION OF I MnurjPGLDBUL IN IN VITRO BY HEALTHY SUBJECTS
INTRODUCTION
The results of the previous chapters established the 
optimal conditions For measuring immunoglobulin production 
by the plaque Forming cell assay using Freshly isolated 
peripheral blood mononuclear cells and also determined the 
culture conditions which Favoured optimal proliFeration and 
immunoglobulin synthesis in response to mitogens. The aim oF 
the studies in this chapter was to use the protein A plaque 
Forming cell assay to establish a normal range For 
production oF immunoglobulins both spontaneously and in 
response to polyclonal B cell activators, and to investigate 
the regulation of immunoglobulin production in response to 
différent activators.
Thus, peripheral blood mononuclear cells From normal 
volunteers ujere stimulated ujith the T dependent mitogens PWM 
and SAC as well as the T independent EBU. In addition, I 
investigated the role of suppressor T cells and monocytes in 
regulating immunoglobulin production. Making use of the 
Finding that only PWM responses are sensitive to the action 
oF suppressor T cellsCPryjma et al, 1980;, ConA was added as 
a possible stimulator of suppressor T cell activity, wihile 
methyl-prednisolone was used to selectively inhibit 
suppressor T cell activity1 Cupps 8 Fauci, 1982).
Furthermore, I examined the possibility that monocytes can 
suppress immunoglobulin production in vitrofKnapp & 
Baumgartner, 1978, Gmelig-Mey1ing & Waldmann, 1901) via 
cycloDxygenase pathway products of arachidonic acid 
metabolism, such as prostaglandin EECGoodwin & Webb, 1980). 
Thus, indomethacin, a cyclooxygenase inhibitor, was used to 
study the role of prostaglandins in the differentiation of B
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cells into immunoglobulin secreting cells in response to PWM 
or SAC.
MATERIALS AND METHODS
Venous blood was obtained From the same normal adult 
volunteersCTab!e 3.1) and mononuclear cells were prepared 
and tested For immunoglobulin production as described above 
In the ConA, methy1-prednisolone and indomethacin 
experiments only IgG-PFC were measured because preliminary 
experiments showed that IgG-PFC response was consistently 
higher.
RESULTS
Spontaneous Production oF Immunoglobulin
Spontaneous IgA-, IgG-, and IgM-PFC counts of peripheral 
blood mononuclear cells From these twenty Five normal adult 
volunteers are shown in Fig . 5 .1CIgA-PFC: 1380+253,
IgG-PFC: 1137 + 171, IgM-PFC: 342+73). Although IgA-PFC counts 
were higher than IgG-PFC counts in 10 of the 25 subjects, 
there was no significant difference between these values. 
However, both IgA and IgG production was significantly 
higher than that of IgMCp<0.001). These Findings therefore 
confirm those of CHAPTER III.
Production of Immunoolobulin in Response to Poluclonal B
Cell Activators
When peripheral blood mononuclear cells were cultured
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unstimulated Far six days the plaque Farming cell réponse 
was minimaleIgA-PFC:414+23, IgG-PFC:G3G+2B, IgM-PFC:445+37). 
In contrast, when peripheral blood mononuclear cells From 
the same healthy volunteers were cultured in the presence oF 
PWM, SAC or PWM plus SAC, the production of all 
immunoglobulin classes showed a marked increase over the 
spontaneous plaque forming cell responsesCFig . 5 . 2) . IgG 
responses were significantly higher than those of IgA and 
IgMCp<0.001) which were identical, while significantly 
higher IgA- and IgG-PFC responses were Found in response to 
PWM than to SACCp<0.001) . The highest plaque forming cell 
responses were observed when PWM and SAC were used together 
to induce immunoglobulin productionCp<0.001 For all 
classes). A synergistic effect was arbitrary defined when 
the PFC counts exceeded by 25% the PFC counts induced by SAC 
and PWM alone. This synergistic eFFect was demostrated For 
all immunoglobulin classes and occurred in 72% of healthy 
subjects.
Although the amounts of EBU available prevented formal 
testing of the dose dependency and time course, studies with 
additional subjects were performed to compare EBU with PWM 
and SAC For its ability to induce immunoglobulin synthesis. 
The culture conditions for the EBU were as described by Bird 
et aie 1379), Fig.5,3 summarises the results of seven such 
experiments and it can be seen that EBU stimulated higher 
IgM responses which were higher than those Found with 
SACCn.s) and similar to those with PWM. IgG responses to EBU 
were much smaller than with PWMCp<0.01, Wilcoxon rank sum 
test) and similar to those with SAC. The IgA responses were 
similar in all three systems.
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EFFect of ConA on Immunoglobulin Production 
The ability of 20pg/ml ConA to modify IgG-PFC responses 
to PWM or SAC was studied in six volunteers and the results 
are shown in Table 5.1. When cells were cultured only in the 
presence of ConA, no plaque forming cell response was 
observed(Data not shown). In all cases, the response to PWM 
was substantially depressed by addition of
ConACrange :25-6G%) with a mean suppression of 51+5.B%Cp=0.05 
vs controls, signed rank test). In contrast, although ConA 
suppressed SAC responses in 5/6 subjects this was markedly 
less than that seen with PWMCmean ; 25.G + 4 .S%, range:5-33%) 
and was not found to be significant. When the sensitivity of 
the two culture systems to ConA was compared, there was 
significantly greater suppression of PWM responses than SAC 
responsesCp<0.05, Wilcoxon rank sum test).
Effect of Methul-prednisolone on 
Immunoglobulin Production
The eFFect of different doses of methy1-prednisolone on 
PWM and SAC induced IgG-PFC responses was examined in eight 
control subjects and the results are presented in Fig.5.4. 
When cells were cultured For six days only in the presence 
of 0,01 or O.l^g/ml methy1-prednisolone, the plaque Forming 
cell réponse was minimal and not significantly higher than 
the background plaque forming cell responseC1057+77 and 
1220+112PFC/10^celIs, respectively, vs 750+37PFC/10^ e 1Is, 
background). The response to PWM was enhanced by addition of 
0.01, 0.1, and l^ jg/ml methy 1-prednisolone with an optimal
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response at 0 . l^ ig/ml f. p< 0 .01, signed rank test). At higher 
concentrations, the plaque Forming cell response showed 
lesser increases above control levels. The eFFect oF 
methy1-prednisolone was most evident in the response to PWM, 
although a similar, IF lesser eFFect, was observed in the 
SAC system, where only G.l|jg/ml of methy 1-prednisolone 
produced statistically significant increaseCp<0.05, signed 
rank test). At this optimal concentration,
methy1-prednisolone produced a mean increase in PWM response 
of 232+23% compared with 51+13% enhancement of the SAC 
respanseCp<0.01, Wilcoxon rank sum test).
Effect of Indomethacin on Immunoglobulin production
The effect of indomethacinCIpg/ml) on IgG-PFC responses 
to PWM and SAC was studied in six control subJectsCTable 
5.2). Indomethacin had no significant effect on the response 
to PWMCPWM:24B44+2S77, PWM+Indo:25205+3458) but in 5/5 cases 
addition of indomethacin increased the response to 
SACCSAC:15383+1255, SAC+1ndo: 18334 + 1840) . In the other case, 
indomethacin suppressed the response. When peripheral blood 
mononuclear cells were cultured For six days only with 
indomethacin, as in the Cona study, no plaque formation was 
observedCData not shown) .
94
CONCLUSIONS
Using the protein A plaque Forming cell assay to measure 
spontaneous secretion of immunoglobulin, this study showed 
that the counts oF IgA-PFC exceeded those oF IgG-PFC in most 
casesC18/25) whereas IgG-PFC counts were usually highest 
after stimulation by polyclonal B cell activators. Studies 
with polyclonal B cell activators showed PWM to be the most 
effective, although EBU induced similar IgM-PFC counts as 
PWM. SAC was the least efficient inducer of IgG and IgM 
synthesis.
Normal peripheral blood mononuclear cells were also 
cultured in the presence of ConA and methy1-prednisolone in 
order to study the role of suppressor T cells in the 
production of immunoglobulin in response to different 
polyclonal B cell activators. Co-stimulation of cells with 
polyclonal B cell activators+ConA showed that while both the 
PWM and SAC culture systems were suppressed by ConA 
activity, PWM induced responses were much more sensitive to 
this effect and SAC responses showed little suppression. PWM 
stimulated production of immunoglobulin was also more 
readily enhanced by addition of methy1-prednisolone and 
together, these Findings support the view that stimulation 
of B cells by PWM is much more susceptible to regulation by 
suppressor T cells than SAC responses. In contrast, 
preliminary studies using indomethacin to inhibit 
prostaglandin synthesis showed that SAC induced 
immunoglobulin production was affected considerably more by 
the addition of indomethacin, and this indicates indirectly 
that SAC induced immunoglobulin production maybe regulated 
by monocytes rather than suppressor T cells.
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Results shown are the mean+lSEM(PFC/10 cells) 
for 7 healthy subjects.
1 .pun 2.SAC
PWM PUM+ConA % / SAC SAC+ConA %
EXP 1 1B733 12554 -25% / 15732 11257 -28%
EXP 2 27820 9573 -88% / 14853 9857 -33%
EXP 3 23572 11214 -53% / 15744 11408 -28%
EXP 4 31785 14818 -53% / 13912 15785 + 13%
EXP 5 18000 7530 -58% / 13324 12684 -5%
EXP B 20505 9358 -51% / 12348 8135 -34%
MEAN 23085 11137 14285 12898
SEM 2178 1130 553 980
Table 5.1
The effect of co-stimulating peripheral blood mononuclear cells with 
20ug/ml ConA on their P^C response to PWM and SAC. The results shown 
are the mean IgG-PFC/10 celIs of triplicate determinations from 0 
normal controls. The percentage values represent the proportion of 
decrease after adding ConA,
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Fla.5.4
The effect of methyl-prednisolone on PFC responses 
to PWM and SAC by control peripheral blood 
mononuclear cells. 6
Bars represent the mean+1SEM(PFC/10 cells) of 
8 experiments.
1 .PWM 2.SAC
PWM PWM+INDO % / SAC SAC+INDO %
EXP 1 31735 32134 + 1.2% / 15614 10732 +20%
EXP 2 21051 22211 +5,5% / 12670 17330 +3B.7%
EXP 3 1B7BB 1B857 ~3.B% / 14935 12201 -19%
EXP 4 15705 14802 "5.B% / 21337 2BB81 +2B%
EXP 5 33151 35B92 +7.7% / 13494 1B435 +22%
EXP 6 28581 29345 +2.7% / 14313 18B25 +30%
MEAN 24844 2520B / 15393 10334
SEM 29B4 3454 / 1261 1932
Table 5.2
The effect of indcmethacinCl|jg/ml) on PWM and SAC cultures of 
peripheral blood mononuclear cells. The results shown are the mean 
IgG-PFC/10 cells of triplicate determinations from B normal controls. 
The percentage values represent the proportion of change after adding 
indomethacin.
CHAPTER VI 
IMMUNE DEFECTS IN CHRONIC RENAL FAILURE
INTRODUCTION
The aim of this study was to use the plaque assay to 
examine the effect of uraemia on immunoglobulin production 
in vitro and to correlate this with other assays of 
lymphocyte number and function.
In addition to counts of total white blood cells and 
lymphocytes, B lymphocyte numbers were assessed by the 
presence of surface immunoglobulin while monoclonal 
antibodies to T3, T4, and T8 were used to detect T cells and 
their subsets. The proliferative responses of uraemic 
lymphocytes to PWM and PHA were studied and the effect of 
steroids on these responses was also studied to determine 
whether uraemic lymphocytes are more sensitive to steroids 
than control lymphocytes, as has been suggested by Langhoff 
& LadefogedC19B4).
In parallel, extensive studies of immunoglobulin 
production by uraemic peripheral blood mononuclear cells 
were performed by measuring secretion of immunoglobulin both 
spontaneously and after stimulation by either PWM, SAC, PWM 
plus SAC, or EBU, In addition, the possibility that uraemia 
altered the kinetics of immunoglobulin production was 
examined by investigating the response to PWM on
different days and comparing this with the responses by 
healthy subjects. The role of active suppression of 
immunoglobulin production by uraemic peripheral blood 
mononuclear cells was examined by adding methyl-prednisolone 
and indomethacin to PWM and SAC stimulated cultures of
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uraemic peripheral blood mononuclear cells. Finally, the 
eFFect of uraemic serum on immunoglobulin production was 
studied by pre-incubating normal peripheral blood 
mononuclear cells with uraemic serum.
MATERIALS AND METHODS
Thirty seven patientsCTable B.l) undergoing regular 
haemodialysisC4hr, thrice weekly) and ten patients on CAPD 
were studied, ranging in age From IB to B3
yearsCmean: 40.05+1.9 years). The mean duration on dialysis 
prior to the study was 2.4 months with a range From 1 to 13. 
Chronic renal Failure was ascribed to chronic 
glomerulonephritisC17 patients), chronic pyelonephritisC15 
patients), polycystic kidney diseaseC5 patients), essential 
hypertension C4 patients), diabetesC4 patients), and unknown 
aetiologyC2 patients). The mean serum creatinine prior to 
the study was 737 jjmol/1 with a range From 523 to 
1134CNormal Range : B2“120|jmol/1 ) . None of the patients were 
receiving corticosteroids or other immunosuppressive drugs 
and none of them had evidence of systemic lupus 
erythematosus or other identifiable systemic immunological 
disease. Finally, none of the patients had ever received a 
blood transfusion. Control blood samples were those shown in 
Table 3.1 and to enable direct comparison with results in 
uraemic subjects, some of the results presented in CHAPTER U 
are also presented here. In some experiments, only the IgG 
plaque forming cell response, is presented, because initial
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experiments showed thaffe this was consistently higher than 
the other immunoglobulin classes. All the cell cultures and 
assays were performed as described previously and results 
are expressed as mean+SEti unless otherwise stated.
RESULTS
White Blood Cell and Lumphocute Counts
The mean total white blood cell count in the uraemic 
grcupCn=lB) was lower than the control groupCn=lE, 
4;55B+B47/cmm vs 579B+4B7/cmm) as were the total lymphocyte 
countsCl151+91 vs 1430+130). However, these differences were 
not statistically significant. The results From B and T 
lymphocyte studies performed in ten patients with uraemia 
and twenty normal controls were expressed as percentages of 
the total lymphocyte number and are presented in Fig.B.l. 
Patients with uraemia had a normal proportion of T cells as 
measured by the monoclonal antibody 0KT3 and the percentages 
of 0KT8+ and 0KT4+ cells were also not significantly 
different from those found in normal controls. Uraemic 
patients also had a normal proportion of B cells, as 
measured by the presence of surface 
immunoglobulinCk,DCFig.G.l) .
Proliferative Responses of Lumphocutes
Peripheral blood mononuclear cells From Fifteen normal 
controls and seventeen uraemic patients were stimulated with 
PHA and PWM and their proliferative responses assessed on 
day 3. It can be seen that the response to both PHA and PWM
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were significantly lower in uraemic patients compared with 
controls C Fig . B , 2-, p<0.001).
Addition of O.Ol-lOpg/ml methyl-prednisolone to 
PHACFig.G.3) and PbJMC Fig . G . 4 ) stimulated cultures led to a 
dose dependent depression of proliferation which was similar 
in normal and uraemic patients. Thus, the maximally 
effective dose of methy 1-prednisolone ( 10|^ ig/ml !) produced 
Gl+9% suppression of uraemic PHA responses and BG+G% 
suppression of their PWM responses compared with 5B+4% and 
48+5% suppression of control responses to PHA and PWM 
respectively. However, these differences were not 
statistically significant and thus, the findings of Langhoff 
S LadefogedC19B4) were not confirmed.
Spontaneous Production of Immunoglobulin in Uraemia
The spontaneous secretion of IgA, IgG, and IgM by uraemic 
and control cells was investigated using the spontaneous 
plaque forming cell assay. As shown in Fig.B.B, uraemic 
patients had very low levels of all immunoglobulin classes, 
with IgA- and IgG-PFC numbers around 25%-30% of levels 
previously found in controlsCp<0.001). IgM-PFC were also 
suppressedC40% of control levels), although this was not as 
marked as with IgA and IgGCp<0.05). Interestingly, the 
counts of IgG secreting cells in the uraemic group were 
consistently higher than the counts of IgA secreting cells 
whereas the opposite pattern was observed in the control 
group. However, the difference between IgA- and IgG-PFC 
counts in the uraemic group failed to reach statistical 
signif icance.
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Production of Immunoglobulin in Response to Poluclonal B
Cell Activators
The ability of uraemic peripheral blood mononuclear cells 
to produce immunoglobulin in response to polyclonal B cell 
activators was studied by enumerating immunoglobulin 
secreting cells in cultures stimulated with PWM,'SAC, PWM 
plus SAC, or EBU.
The results of the PWM induced cultures are presented in 
Fig.B.B. and it can be seen that IgA, IgG, and IgM-PFC 
counts were not significantly different from those obtained 
previously in normal controls, with both groups having 
higher IgG responses than either IgM or IgA. In addition, 
uraemic subjects showed the same dose response pattern to 
PWM as controls, with optimal doses at 1 ; 100CFig.B .7) and 
had normal responses from 3-7 days of culture, with the peak 
response also being found on day BCFig.B.8). Furthermore the 
viability of B day cultures was the same using uraemic or 
control peripheral blood mononuclear cellsCB7+4% vs 92+5%). 
The PWM induced plaque forming cell responses of CAPD and 
haemodialysis patients were compared but not significant 
differences were foundCdata not shown).
In contrast to PWM, uraemic patients had a significantly 
lower response of IgA, IgG and IgM classes to SAC compared 
with the control group valuesCp<0.02, p<0.001, p<O.OGl, 
respectively). This was most pronounced for IgG and IgM 
responses and, unlike control responses, the IgG responses 
of uraemics to SAC was not higher than IgA and IgM, with 
identical plaque forming cell numbers being found for all 
classes(Fig.G.9).
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As shown ear 1ierCCHAPTER IU and V), the combination of 
PWM+SAC induced IgA, IgG, and IgM responses by control cells 
which were significantly higher than would be expected by 
addition of the responses to either. Synergy was not 
observed for any immunoglobulin class in uraemic 
SLibJectsCPig. E . 10) and indeed, the response to PWM+SAC in 
these patients was substantially less than that found i.uith 
PWM alone and similar to that luith SAC alone, This 
synergistic effect ujas observed in 13/19 healthy subjects 
but only in 2/27 uraemic patientsCTable G.2, p<0.001).
When the responses of control and uraemic peripheral 
blood mononuclear cells to EBU were studied, equivalent 
plaque forming cell responses ujere found in the two groups, 
with only IgM-PFC response being slightly but not 
significantly lower in uraemic sutajectsCFig . G . 11) .
Effect of Uraemic Serum on Immunoo1obulin Production
In view of the suppressed response of uraemic peripheral 
blood mononuclear cells to SAC and pre\;ious evidence of 
inhibitory factors in uraemic serumf'Sengar et al, 1375, 
Holdsworth et al, 1979) , I in\'estigated the effect of serum 
from uraemic patients on immunoglobulin production by 
control peripheral blood mononuclear cells.
Peripheral blood m.ononuclear cells uiere pre-incubated for 
2hrs with either uraemic or normal heterologous serum before 
culture uiith PWM, The 2haurs incubation period
was chosen as more convenient, since no differences were 
found luhen control cells were pre-incubated between 1-Ghours 
with uraemic serumCData not shown). The mean IgG response
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was lower after treatment with uraemic serum than with 
control serumCFig.6 .12), but this difference failed to reach 
statistical significance. Interestingly, in comparison with 
control plaques, the plaques produced by peripheral blood 
mononuclear cells which had been pre-incubated in uraemic 
serum were always less clear and less well-defined than 
plaques produced by peripheral blood mononuclear cells 
pre-incubated with normal heterologous serum, and 
microscopic examination revealed incomplete lysis of sheep 
red blood cells near the central lymphocyte. To investigate 
further the effect of uraemic serum, control lymphocytes 
were also cultured with PWM for six days in the presence of 
uraemic or control serum. In five out of seven experiments, 
no plaque forming cells were detected after six days in 
culture in the presence of either normal or uraemic serum, 
despite normal blastogenesis measured after 72hours and 
normal viability after the end of the cultureCData not 
shown). The continuous presence of either uraemic or control 
serum interfered with PWM induced B cell differentiation and 
thus, no definitive results were obtained.
Effect of Methul-prednisolone on Production of 
Immunoglobulin in vitro bu Uraemic Peripheral Blood 
I I Mononuclear Cells
As described in CHAPTER V , addition of certain doses of 
methyl-prednisolone led to higher IgG responses by control 
subjects, presumably due to selective depletion of 
suppressor T cells, I therefore investigated the effects of
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methy 1-preclnisolone on immunoglobulin production by uraemic 
peripheral blood mononuclear cells in an attempt to 
determine a possible role For suppressor T cells in the 
defective immune responsiveness in these patients.
As discussed earlier, addition of methy1-prednisolone to 
PUM stimulated cultures of control cells produced a 
significant increase in IgG-PFC counts which was maximal 
when O.lpg/ml of methy1-prednisolone was used. Uraemic cells 
showed a normal response to PWM alone but although there was 
a small increase after adding methy1-prednisolone to uraemic 
cultures, this was minimal in comparison to those observed 
in control culturesCMaximal Enhancement : Controls :E43+2B, 
Uraemic Patients:4G+G) and failed to reach statistical 
significance at any dilution of
methy 1-prednisoloneCFig . G . 13!) . However, control cells were 
significantly more sensitive than uraemic cells to the 
addition of methy l-prednisolonef!p<0 . 05 , UJilcoxon rank sum 
test).
Similar results were obtained in cultures stimulated with 
SAC where the responses of control peripheral blood 
mononuclear cells were significantly enhanced by the 
addition of O.lpg/ml methyl-prednisoloneCp<0.05) while the 
very low responses of uraemic peripheral blood mononuclear 
cells were not improved by methy1-prednisolonerFig.G .14).
Effect of Indomethacin on Production of Immunoglobulin in 
vitro bu Uraemic Peripheral Blood Mononuc1 ear Cells 
The role of prostaglandins in regulating production of 
immunoglobulin by uraemic peripheral blood mononuclear cells
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was studied by adding indomethacin to cultures stimulated 
with PWM or SACCTable E.3).
Variable results were obtained when indomethacin was 
added to PWM cultures with 7/11 uraemic patients showing an 
increased IgG-PFC response ranging From 20 to 69% increase, 
while in four cases a decrease was noted. However, none of 
these changes were statistically significant. These results 
are therefore comparable to those obtained with PWM 
stimulated control cellsCTable 5.2, CHAPTER V) where it was 
found that indomethacin had no overall effect on PWM induced 
production of immunoglobulin. Interestingly, when 
indomethacin was added to cultures stimulated with SAC, an 
increased IgG response was observed in 8/11 patients and 
this was frequently very largeCup to 219% enhancement). A 
decreased IgG response was observed in three cases. Although 
the overall effect of indomethacin failed to reach 
statistical significance, when the effect of indomethacin on 
the SAC response of uraemic peripheral blood mononuclear 
cells was compared with that obtained with control 
subjectsCTable 5.2), it appeared that the response of 
uraemic patients was more sensitive to enhancement than that 
of normal controls.
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CONCLUSIONS
These studies showed that while uraemia had not 
significant effect on the number or proportion of lymphocyte 
populations, the proliferative responses of uraemic 
peripheral blood mononuclear cells to PHA and PWM were 
reduced.
Studies employing the plaque assay demonstrated that EBU 
and PWM induced production of immunoglobulin were normal in 
uraemic patients. In contrast, both spontaneous and SAC 
induced immunoglobulin production were reduced by uraemia 
and a combination of PWM and SAC did not produce the 
synergistic effect found in control cultures.
In an attempt to identify the factors responsible for the 
abnormal spontaneous and SAC induced immunoglobulin 
responses, the effects on plaque forming cell production of 
uraemic serum, methy1-prednisolone, and indomethacin were 
investigated. Pre-incubation of control peripheral blood 
mononuclear cells with uraemic serum had both quantitative 
and qualitative effect on PWM-induced IgG plaque forming 
cell whereas addition of methy1-prednisolone to PWM and SAC 
stimulated cultures of uraemic peripheral blood mononuclear 
cells did not produce the increased immunoglobulin 
production found in controlsCCHAFTER V). In contrast, the 
IgG response of uraemic peripheral blood mononuclear cells 
to SAC seemed to benefit more by the addition of 
indomethacin than the corresponding response of control 
peripheral blood mononuclear cells.
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URAEMIC PATIENTS
AGE SEX
1. S.W 23 f1
s . M.S,. * 43 F
3. I .M 40 F
4. J.B . * 35 F
5 . C.M 34 F
6 , A.K . * 27 M
7. T.Y 59 M
8. J.H 56 M
9. W.B 57 M
10. D.H 20 M
11 . C.B IB F
12. J .M 63 n
13. M.H 36 F
14. J.M . ** 39 F
15 . B. J 27 M
IB. J.P 53 M
17. W.Y 42 M
IB. J.B 52 M
19. c.s 33 M
20. M.n 30 M
21 . UI.H .* 31 M
22. J.L 33 M
23. p.F 49 M
24. T.C 53 M
25. K.M 53 F
26. P.M 24 F
27. W.B 57 M
20 . T.S 49 M
29. UI.B 22 M
30. R.H 27 M
31 . R.F 27 M
32. R.B 53 M
33. L.. A 59 F
34 . L.M . ^ 55 F
35. J.G .* 20 M
36. D.M . 52 M
37. A.U , 50 F
30. R.F , 47 M
39. T. J , 50 M
40. J.H 52 M
41 . H.M . 42 M
42. S.L 10 F
43. E.S 55 M
44 . J.H 35 n
45. A .H 30 F
46. H.H 59 M
47. R.M ■ 19 M
nean+SEM:4O.05+E 
Table 6.1
M/F;33/14
Uraemic patients used to examine B cell function.
*These patients were also studied as part of the blood transfusion 
trial, described in CHAPTER UII>
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T and B lymphocyte populations in normal controls(n=20) 
and uraemic patients(n=ic>) assessed by immunofluorescence, 
B cells and T cells were expressed as a percentage of 
the lymphocyte count
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Fig.6.2
Proliferative responses to PHA and PWM of 
peripheral blood mononuclear cells from normal 
controls(n=îl5 ) and uraemic patients(n=17 ).
Bars represent the mean Thymidine uptake
on the third day of culture +1SEM,
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Fig.6 .3
The effect of methy1-prednisolone on the 
proliferative responses to PHA by control 
and uraemic peripheral blood mononuclear cells.
Bars represent the mean Thymidine uptake
on the third day of culture +1SEM in 4 experiments.
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Fig.6 .4
The effect of methy1-prednisolone on the 
proliferative responses to PWM by control 
and uraemic peripheral bigod mononuclear cells.
Bars represent the mean C Thymidine, uptake 
on the third day of culture +1SEM in 4 experiments.
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Fig,6 .5
Spontaneous plaque formation by peripheral 
blood mononuclear cells from normal 
controls(n=25) and uraemic patients(IgAin=21, 
IgG:n=39, IgM:n=16), ^
Bars represent the mean+lSEM(PFC/10 cells)
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Fier. 6. 6
PWM induced plaque formation by peripheral 
blood mononuclear cells from normal controls{n=25) 
and uraemic patients(IqA:n=15, IgG*n=38, IgM%n=15) 
Bars represent the mean+lSEM(PFC/10^ cells)
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Fig.6 .7
The IgG response to different dilutions of PWM 
of control(n=4) and uraemic(n=4) peripheral 
blood mononuclear cells, ^
Bars represent the mean+lSEM(PFC/10 cells)
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Fig,6.8
Time course of IgG production by control(n=4) 
and uraemic(n=4) peripheral blood mononuclear 
cells in response to PWM. g
Bars represent the mean+lSEM(PFC/10 cells)
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Flq.6.9
SAC induced plaque formation by peripheral 
blood mononuclear cells from normal controls(n=25) 
and uraemic patients(IgA:n=15, IgGin=39, IgMin=15), 
Bars represent the mean+lSEM(PFC/10^ cells)
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Fig.6.10
Plaque formation induced by an optimal 
combination of PWM and SAC in normal 
controls(n=18) and uraemic patients(IgA:n=15, 
IgG:n=27, IgM:n=15). ^
Bars represent the mean+lSEM(PFC/10 cells)
Synergistic efFect--No synergistic effect
Normal Controls 13
Uraemic Patients 25
Table G.2
Synergistic effect between SAC and PWM in Normal Controls(n=lB)and 
Uraemic PatientsCn=27), A synergistic effect was defined when IgG-PFC 
counts induced ‘by PWM+SAC were more than the sum of IgG-PFC counts 
induced by SAC and PWM alone plus 25%. 2
The chi-squared test was used to analyse the resultsCx = 23.40, 
p<0.001)
c/l PfiiC
lESlS
IgR IgG IgH
Fig.6 .11
EBV induced plaque formation by peripheral 
blood mononuclear cells from normal controls(n=7) 
and uraemic patients(n=7). ^
Bars represent the mean+lSEM(PFC/10 cells)
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Fig.6 .12
PWM induced IgG-PFC response of control peripheral blood 
mononuclear cells pre-incubated with either control or 
uraemic serum.
Results shown are the mean of triplicate determinations.
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Fig.6.13
The effect of methyl-prednisolone on PWM 
induced plaque formation by control(n=8 ) and 
uraemic(n=8 ) peripheral blood mononuclear cells. 
Bars represent the mean+lSEM(IgG-PFC/10® cells)
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The effect of methy1-prednisolone on SAC 
induced plaque formation by control(n=8 ) and 
uraemic(n-8 ) peripheral blood mononuclear cells. 
Bars represent the mean+lSEM(IgG-PFC/lO cells)
1 .PWM 2.SAC
PWM PWM+INDO % / SAC SAC+ÎNDO %
EXP 1 4775 5995 4-25.5% / 21506 10500 -14%
EXP 2 925 1406 +60% / 1000 1660 +52%
EXP 3 1B95B 3557 -79% / 1156 3303 + 105%
EXP 4 41B2 2569 -39% / 9250 12950 +40%
EXP 5 4000 6001 +69% / 1790 4162 + 131%
EXP B 1541 1982 +20% / 1632 2522 +54%
EXP 7 14230 12331 -13% / 1206 1360 +0%
EXP B 22460 13056 -42% / 12065 6727 -44%
EXP 9 10551 12662 + 20% / 5008 4201 -17.5%
EXP 10 40031 52505 +29% / 3016 " 0174 + 114%
EXP 11 30649 19355 -35% / 2520 0055 +219%
MEAN 13735 12001 / 5556 6510
SEM 3946 4202 / 1941 1596
Tab1e B .3
The effect of indomethacinClug/ml1 on PWM and SAC cultures of uraemi* 
peripheral blood mononuclear cells. The results shown are the mean 
IgG-PPC/10 cells of triplicate determinations from 11 uraemic 
patients. The percentage values represent the proportion of change 
after adding indomethacin.
CHAPTER VII
EFFECT OF PRE-TRANSPLANT BLOOD TRANSFUSION ON IN VITRO
IMMUNOGLOBULIN SECRETION
INTRODUCTION
The most effective treatment of uraemia is allogeneic 
renal transplantation, but its success is limited by the 
occurence of graft rejection. Recently, it has been shown 
that rejection of renal allografts may be prevented by 
pre-transplant blood transfusions and it is believed that 
this reflects altered immune responsiveness by the 
hostCWatson et al, 1979, Fisher et al, 1980). As antibody 
production may be important in some forms of renal allograft 
rejection, the aim of this part of the study was to assess 
the effect of third party blood transfusion on 
immunoglobulin production by uraemic patients on dialysis 
awaiting renal transplantation. This was achieved by 
measuring immunoglobulin secretion by peripheral blood 
mononuclear cells both spontaneously and after stimulation 
with the polyclonal B cell activators PWM or SAC. In 
addition, as these activators differ in their sensitivity to 
regulation by T cells, the results should help elucidate the 
mechanisms by which blood transfusion alters the immune 
response.
MATERIALS AND METHODS
The study group consisted of 27 patients with chronic 
renal Failure undergoing routine dialysis who had not 
previously been transfusedCTable 7.1). All patients received
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□ne unit of packed red cells From random third party donors 
every 14 days. 13 patients received 5 units of blood in 
total, while 13 received 5 additional units. Peripheral 
blood mononuclear cells were obtained before the First blood 
transfusion and at 14 day intervals throughout the blood 
transfusion programme. Samples were tested For their 
spontaneous secretion of IgG and For their ability to 
differentiate into immunoglobulin secreting cells in 
response to optimal concentrations of PWM and SAC, using the 
protein-A plaque forming cell assay. Ten normal 
subJectsCTable 7.2) and seventeen age and sex-matched 
non-transfused dialysis patientsCTable 7.3) were also 
studied sequentially as control groups. All samples of 
peripheral blood mononuclear cells were cryopreserved 
immediately after separation and each sample from the same 
subject was assayed on the same day to avoid test to test 
variarion. In this study, only IgG production was assessed 
because IgG-PFC counts were consistently higher and because 
it was technically difficult to measure all three isotypes 
simultaneously. Significant changes in the IgG-PFC count 
after blood transfusion were defined as a variation of more 
than ESD From the mean response found in uraemic controls.
RESULTS
Spontaneous Production of Immunoglobulin
Tables 7.4, 7.5, 7.G show the spontaneous IgG-PFC 
responses in transfused patients and in both groups of
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controls, before, and at the conclusion of the blood
transfusion programme. When the mean spontaneous IgG-PFC
responses of the three groups are compared it can be seen
that, at the beginning of the study, the response of both
uraemic groups was significantly depressed compared with
that of the healthy subJectsCp<0.001). The numbers of
spontaneous plaque forming cells in healthy subjects and
non-transfused uraemics remained constant throughout the 
study(Tab,7.5,7,6). Although there was no significant overall change 
in the spontaneous response after blood transfusion, it appeared that 
some patients reacted differently. Thus, in 12/27 transfused patients 
an increase in the spontaneous response was observed and in six of them 
the post-BT to pre-BT ratio ranged from 2 to 7.21 and there was a clear 
bimodal distribution. In eleven patients there was no change while a 
decrease was observed in four.
The five additional units of blood received by thirteen patients 
were not shown to produce a significant effeet(pre-BT:537+120, 
post-5BT:568+73, post-lOBT: 675+90).
Production of Immunoglobulin In Response to PWM 
When PWM was used to activate peripheral blood 
mononuclear cells from the three groups of subjects at the 
beginning of the study no differences were observed between 
the IgG responses of the three groups, confirming that PWM 
induced production of immunoglobulin is normal in uraemic 
patientsCTable 7.4, 7.5, 7.G). The only difference between 
healthy subjects and uraemic patients was the greater 
intersubject variation observed in the two uraemic groups
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which is reflected in the higher SEM values. As shown in 
Table 7.5, 7.B, the PWM induced IgG response remained 
constant throughout the study in both healthy subjects and 
non-transfused uraemic patients while in the transfused 
group a significant decrease in response to PWM was found 
after blood transfusionCTable 7.4, p<0.05). It can be seen
in Fig.7.2 that this decrease occurred in eighteen of the 
twenty six CGS%) transfused patients, compared to a decrease 
in the SAC induced IgG-PFC response in only five of the 
twenty six patientsC19%, p<0.001). In three patientsC12%), 
the PWM induced plaque forming cell response was unchanged 
while fiveC19%) transfused patients had increased plaque 
farming cell responses to PWM after the last blood 
transfusion. In these five patients the increase appeared 
after the second or third blood transfusion, and in three 
patients the increase in PWM induced plaque forming cell 
response was accompanied by a simultaneous increase in 
spontaneous and SAC induced plaque forming cell 
countsCFig.7.1, 7.4). In the eighteen patients who showed a 
decrease of the PWM induced plaque forming cell 
response-compared to the pre-blood transfusion sample-the 
suppression of the response became significantCp<0.05) after 
the second blood transfusion and was progressive 
thereafterCFig,7.3). In the 13 patients who received five 
additional blood transfusion^ the plaque forming cell counts 
remained unchanged overall between the fifth and tenth blood 
transfusionCPre-BT;23879+6200, Post-5BT;19347+4996,
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Post-IOBT:21155+9007). In B of these patients a decrease in 
plaque Forming cells had been observed after 5 blood 
transfusions and in these patients the 5 additional units of 
blood produced a further decrease of the plaque forming cell 
response which was statistically
significantCPre-BT:27B37+B746, *Post-5BT:13142+3902, 
*Post-10BT:8592+2728, *p<0.05, Signed Rank Test).
Production of Immunoglobulin in Response to SAC
When peripheral blood mononuclear cells were stimulated 
with SAC at the beginning of the study, the IgG response of 
healthy subjects was significantly better than both 
transfused and nan-transfused uraemic patientsCTable 7.4, 
7.5, 7.B, p<0.001). In the two control groups the counts of
IgG-PFC were stable over the 12 week perioriCTable 7.5, 7.B) 
and this was also observed in all of the transfused group 
except for three patients whose plaque farming cell response 
increased and for five patients whose plaque forming cell 
response decreasedCFig.7.4) . The five additional blood 
transfusions given to 13 patients did not change the overall 
values of SAC induced IgG-PFCCPre-BT; 4161 + 1273,
Post-5BT:4377+1225, Post-IOBT: 5015+1710) .
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CONCLUSIONS
These studies confirmed that spontaneous and SAC induced 
plaque forming cell responses are reduced in uraemic 
patients and showed that blood transfusion had no effect 
on SAG responses whereas it enhanced the spontaneous response 
in some patients. In contrast, the response to PWM 
was confirmed as being normal in uPaemic patients and it was 
reduced by the programme of blood transfusions. Therefore, 
as PWM driven B cel1 differentiation is regulated by 
suppressor T cells, in contrast to the response to SAC which 
is not greatly affected by suppressor T cell activity, these 
results indicate that blood transfusion exerts its 
immunosuppressive effect through suppressor T cells.
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AGE SEX BT
1. S.W. 23 M 10
2 . M.S. 43 F 10
3. P.M. 24 F 5
4 . J.B. 35 F 5
5 . M.M. 38 M 10
B . A.K. 27 M 10
7 . T . Y . 59 M 5
8 . P.M. 27 M 5
9. M.H. 36 F 10
10 . J.M. 39 F 10
11 . B. J. 27 M 10
12 . J.P. 53 M 10
13 , J.B. 52 M 10
14 . C.S. 33 M 10
15 . W.H. 31 M 10
16. J.L. 33 M 10
17. P.P. 49 M 10
18 . I.e. 53 M 5
19 . K.M. 53 F 5
20 . T.S. 49 M 5
21 . W.G. 22 M 5
22 . P.P. 27 M 5
23 . R.B. 53 M 5
24 . L . A , 59 F 5
25. L.M. 55 F 5
26 . J .G . 20 M 5
27 . J.H. 52 M 5
Mean+SEM: 39.7+2.5 M/F:18/9
Table 7.1
Uraemic patients who received 5-10 blood transfusions and were studied 
in the blood transfusion trial. Additional information is presented 
in Appendix 1.
AGE SEX
1. D .T . 38 M
2 . J.L. 25 F
3 . M.W. 40 F
4 . V.J. 33 F
5 . I .D . 31 M
B . P.O. 32 M
7. B. J. 40 M
B . E.F . 55 F
9. E.G. 28 M
10. D.D. 27 M
Mean+SEM:35+2.0 M/F:G/4
Table 7.2
Normal controls used in the blood transfusion study
AGE SEX
1 . S.W. 23 M
2. M.S. 43 F
3. I.M. 48 F
4 . J.B. 35 F
5 . C.M. 34 F
G . A.K. 27 M
7 . T.Y. 58 M
8. J.H. 5G M
3 . W.B. 57 M
10 . D.H . 28 M
11 . B.B. 18 F
12 . J.M. B3 M
13. M.H. 3B F
14 . B.M. 52 M
15 . A.V. 50 F
IB . R.F. 47 M
17 . T.J. 50 M
Mean+SEM:42.7+3.3 M/F:10/7
Table 7.3
Uraemic patients who did not receive blood transfusions and were 
used as uraemic controls in the blood transfusion study
Transf used 
uraemic patients 
n=27
pre-BT post-BT
Spont 422+57 555+73
SAC 457E+102G 401B+B9S
PWM *21237+4455 *14723+4488
Table 7.4
IgG-PFC counts(mean+SEM) in uraemic patients before and after
5-10 blood transfusions, PWM responses showed a significant
decrease post*BT(*p<0,05, signed rank test), SAC responses were
unaffected while spontaneous responses were increased due to the
high titres observed post-BT in some patients. However, the difference
between pre- and post-BT spontaneous responses was not statistically
significant.
Spontaneous PLUM-induced SAC-induced
Day 0 12 weeks Day 0 12 weeks Day 0 12 weeks
1 . 418 535 38755 32554 13405 14758
2 . 1354 14G3 21203 19507 13573 12586
3 . 580 575 30785 28503 14457 12875
4 . 417 452 22585 18750 12006 10842
5. 2740 3525 25555 25785 11832 13072
G . 3554 4532 11498 13573 12787 13300
7. 335 054 25738 23935 13788 12533
0. 710 1140 15407 19000 12504 11740
9 . 350 1005 31755 35547 17055 15438
10 . 1103 1257 32207 20455 22594 25485
MEAN 1285 1545 25853 24789 14429 14391
5EM 335 434 2541 2183 1020 1308
TABLE 7.5
Variation in IgG production by healthy peripheral blood mononuclear 
cells over a period of 12 weeks. Results shown are the mean IgG-PFC/1 
cells of triplicate determinations from 10 normal controls. No 
significant variation in IgG production was noted.
Spontaneous PUIN” induced SAC-induced
Day 0 12 weeks Day 0 12 weeks Day 0 12 weeks
1. 215 1G3 44733 43600 10432 16350
2. 235 242 27335 20304 1353 1206
3. 210 211 20175 21053 1423 1030
4. 202 134 3015B 40525 1354 2205
5. 138 134 15454 16400 1253 1454
B. 204 316 B2734 67272 2574 2600
7. 92 110 72500 67502 1734 2332
B. 331 38B 23173 21513 1354 1107
9. 153 177 14525 15704 1312 1297
10. 04 95 11197 12061 1385 1339
11 . 205 175 32037 37570 1321 1387
12. 353 317 9750 12410 1120 956
13. 1905 24BB — - - -
14. 553 704 6600 6440 1734 1653
15. 315 3BB 5045 5310 1585 2140
IB. 347 432 4624 4312 1530 1042
17. 010 707 50142 53706 6246 6050
MEAN 301 425 27090 20420 2313 2967
3EM 104 134 5260 5107 1047 365
. .....
Table 7.G
Changes in IgG-PFC counts in uraemic controls. Results shown are the 
nean IgG-PFC/10 cells of triplicate determinations from 17 uraemic 
□atients,
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Fiq.7.1
Ratio of post-BT to pre-BT spontaneous PFC in 27 transfused 
patients. Numbers within circles indicate the number of each 
individual patient as presented in Tab.7.1, 7.3. Shaded area 
represents the mean±2SD change in the 17 uraemic controls 
studied sequentially over a period of 12 weeks. Significant 
changes were defined as variation of more than 2SD from the 
mean response found in controls and a clear bimodal distribution 
of results is evident.
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Fig.7.2
Ratio of post-BT to pre-BT PWM induced PFC in 26 transfused 
patients. Numbers within circles indicate the number of 
the pa tient(Table 7,1, 7,3), Shaded area represents the 
mean+2SD change in the 16 uraemic controls studied sequentially 
over a period of 12 weeks. Significant changes were defined 
as variation of more than 2SD from the mean response found 
in controls
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Fig.7.3
The effect of blood transfusion on PWM 
induced IgG production in eighteen responders. 
Bars represent the mean-HSEM(IgG-PFC/10^ cells)
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Fiq.7.4
Ratio of post-BT to pre-BT SAC induced PFC in 26 transfused 
patients. Numbers within circles indicate the number of 
patient (Table 7.1, 7.3). Shaded area represents the mean+2SD 
change in the 16 uraemic controls studied sequentially over a 
period of 12 weeks. Significant changes were defined as variation 
of more than 2SD from the mean response found in controls.
CHAPTER u n i
STUDIES OF SPONTANEOUS PLAQUE FORMATION IN RENAL 
ALLOGRAFT RECIPIENTS TREATED WITH CYCLOSPCRIME 
OR AZATHIDPRINE
INTRODUCTION
Acute rejection of renal allografts may involve an 
anti-donor antibody response and it would be useful to have 
a reliable immunological assay to establish the onset of 
rejection at an early stage. Thus, the principal aim of this 
study was to determine whether there was an association 
between acute rejection episodes and counts of spontaneous 
plaque Forming cells. In addition, I examined the effects of 
immunosuppression with either azathioprine or cyclosporins 
on spontaneous immunoglobulin production by renal transplant 
patients within the first six weeks post transplant.
MATERIALS AND METHODS
Eleven patients treated with azathioprine and 
prednisolone and fourteen patients treated with cyclosporins 
and prednisolone were studied and the two groups were 
matched for age, sex, number of blood transfusions, and 
number of HLA-A, -B and -DR mismatches between donor and 
recipientCTable 8.1, 8.2). Azathioprine was administered 
orally at a dose of 2mg/kg/day and it was reduced 
accordingly when white blood cell counts were falling below 
4000/cmm , The dose of cyclosporins was 17.5mg/kg/day for 
the first week tailing to 15mg/kg/day on the second, 
10/mg/kg/day on the third, and then 4-lOmg/kg/day for the 
first two months depending on the levels of cyclosporins in 
blood. Finally, prednisolone was administered orally at a 
dose of 20mg/day .
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Spontaneous production of immunoglobulin was assessed on 
crgopreserved samples of peripheral blood mononuclear cells 
obtained 4, 7, 14, 21, 20, and 35 days after 
transplantation.
Rejection episodes were diagnosed clinically and were 
confirmed using a combination of serum creatinine levels, 
renal biopsy, and ultrasound. The type of rejection which 
occurs most frequently within the two months post-transplant 
is the acute form and the clinical criteria which were taken 
as evidence of acute rejection were fever, tenderness in the 
region of the transplant, reduced renal blood flow as shown 
by ultrasound scan, leukocytosis, reduced output of urine, 
gain in body weight, a rise in serum creatinineOO. 2mg/dL) 
and proreinuria. The diagnosis of rejection was confirmed if 
one or more of the following features were found on 
histological examination:
1 . Tubulo-interstitial nephritis with oedema and cortical 
infiltration by lymphocytes, lymphoblasts, plasma cells and 
eosinophils
2. Endothelial swelling of peritubular and glomerular 
capillaries and arterioles
3. Fibrinoid necrosis of small arteries and arterioles
4. Platelet aggregates and thrombi in glomerular and 
peritubular capillaries
5. Foci of tubular necrosis with infiltration of the tubular 
wall with a cellular infiltrate.
Of these features, numbers 2-5 were considered to be a 
direct consequence of rejection due to humoral immune 
response.
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When rejection was suspected, patients were treated by 
either a ten-day course of high-doseCEOOmg) oral 
prednisolone or infusions of 500mg methy1-prednisolone on . 
two to four consecutive days.
In this study, post-transplant values of spontaneous 
production of immunoglobulin were also compared with plaque 
forming cell values of healthy controls and dialysis 
patients which were presented in Fig.6.5,
RESULTS
Effects of Immunosuppression on Immunoglobulin Production
To examine the effects of the two forms of 
immunosuppression on production of immunoglobulin, samples 
were tal<en from 1-B weeks post-transplant and their plaque 
forming cell activity was compared. In addition, this was . 
compared with the plaque forming cell response obtained in 
patients undergoing dialysis and in healthy subjects. The 
results from all individual samples were pooled and are 
shown in Table 8.3.
The mean IgA-, IgG- and IgM-PFC counts of dialysis 
patients were extremely low compared with those in healthy 
controlsCp<0.001, p<0.001, p<0.05, respectively) as decribed 
in CHAPTER UI. When transplanted patients were examined, 
both azathioprineCIgG) and cyclosporineCIgG,IgA,Igh) treated 
groups had significantly lower plaque forming cell responses
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than healthy controls. In the case of cyclosporins treated 
patients, the plaque forming cell counts were not 
significantly different to the very low levels found in 
dialysis patients but azathioprine treated patients had 
significantly increased plaque forming cell numbersCIgG and 
IgA) compared with dialysis patientsCp<0.001). In addition, 
their production of IgG- and IgA-PFC was significantly 
higher than that found in cyclosporine treated patients. As 
will be discussed, these differences are likely to reflect 
the lower number of rejection episodes observed in 
cyclosporine treated patients.
A similar pattern emerged when the sequential changes in 
IgG-, IgA-, and IgM-PFC over the six week period were 
examined and the results are shown in Figs.0.1, 8.2, and B.3 
respectively. Cyclosporine treated patients showed a very 
stable level of IgG-PFC throughout the post-transplant 
period, whereas patients receiving azathioprine had 
increased numbers of IgG-PFC from 2-4 weeks. After an 
initially high level during the first week, patients on 
cyclosporine had a low and stable level of IgA-PFC which was 
significantly lower than that Found in patients receiving 
azathioprineCFig.0.2) . IgM-PFC were generally low in all 
patients but azathioprine treated patients had consistently 
higher IgM-PFC levels after the first week, although this 
Failed to reach statistical significance at any 
timeCF ig.8.3) .
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Effects oF Re lection on Immunoglobulin Production
The incidence oF rejection episodes in these two groups 
of transplant patients was assessed in parallel with 
measurement oF plaque forming cell activity in order to 
examine the relation between immunoglobulin production and 
rejection. In the azathioprine group 10/11 patients had at 
least one episode of rejactionCpatient No 11 was the only 
one who did not have a rejection episode), and as a whole, 
this group had a total of eighteen rejection episodes during 
the six weeks following transplantation. In 7/10 of these 
patients biopsies were performed to confirm the diagnosis 
and in 5/7 a large vascular component, suggesting humoral 
rejection, was reported.
In contrast, only three of the fourteen patientsC5,10,13) 
in the cyclosporine group showed evidence of rejection, with 
a total of four episodes over the same periodCp<0.001). In 
two of the rejecting patients biopsies were performed and 
one biopsy revealed vascular featuresC13) while the 
other CIO) showed interstitial changes more typical of 
cellular rejection. This relationship is demonstrated in the 
results shown in Fig.8.4 which present serial changes of 
plaque forming cells in one patient treated with 
azathioprineCG) and in one patient treated with 
cyclosporineC13) both of whom experienced rejection 
episodes. In the azathioprine treated patient, rejection was
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diagnosed clinically and severe vascular rejection was 
confirmed histopathologically on the 10th day. This episode 
correlated very well with a rise in the levels of both IgG- 
and IgA-PFC counts at the. beginning of the 2nd week. The 
serial plaque forming cell counts of the cyclosporine 
treated patient showed a similar pattern and increased 
IgG-PFC levels were observed during rejection episodes on 
the seventh day and on the twenty-eighth day. Analysis of 
all twenty-two rejection episodes showed that IgG-PFC were' 
increasedC>25%) in 20/22 rejection episodes and in several 
cases this was accompanied by a rise in IgA production. In 
contrast, rejection episodes were not consistently 
associated with changes in IgM-PFC production.
In four patientsCazathioprine group : No 11, cyclosporine 
group ; No 3,4,9), increased plaque forming cell responses 
were observed in the absence of rejection and in 3/4 
casesC11,3,4), this was associated with systemic infection. 
It is important to note that these cases were the only ones 
in which increased IgG- and IgA-PFC counts were also 
accompanied by an increased IgM-PFC response. Plaque forming 
cell results from a representative case of this typeCNo 11) 
are shown in Fig.8.5. Elevated plaque forming cells of all 
classes occured from 7-21 days post-transplant and this was 
associated with a diagnosis of basal pneumonia on day 10.
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CONCLUSIONS
These results emphasised once again that spontaneous 
immunoglobulin production is suppressed in dialysis 
patients. In addition, this study showed that 
immunosuppression with cyclosporine was associated with 
lower numbers of cells spontaneously secreting 
immunoglobulin compared with the response obtained in 
azathioprine treated patients. This difference correlated 
very well with a reduced number of rejection episodes in the 
former group. An association was also found between 
rejection episodes and elevation of IgG-PFC and this finding 
is in agreement with previous reports by other workers that 
an increase in the number of IgG-PFC in the first weeks 
post-transplant signifies rejection. Systemic infection was 
also Found to cause a rise of IgA- and IgG-PFC and in 
contrast to elevation due to rejection, these were 
accompanied by an increase in the IgM-PFC.
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HL.A MISMATCHES
AGE SEX BT A B DR
1 . T.G. 49 M 5 2 0 0
2. S.W. 40 M 5 2 2 0
3 . E .0 . 58 F G 2 2 0
4, A.D. 42 F 5 1 2 1
5 . J .0 . 51 F 7 1 1 1
G. J.M. 35 M 9 2 1 2
7 . U.K. 37 M 5 2 1 1
8 . J.T. 32 M 5 2 1 1
9 . T.K . 48 M 5 0 1 1
10 . A .B . 31 M 5 1 1 1
11 . S.W. 23 M 10 1 0 1
M/F;0/3
Mean+SEM: 40+3 G .1+0.5 1.5+0.21 1 .1+0.2 0.8 + 0
Table 6.1
Renal transplant patients treated with azathioprine who were used 
in this study
HLA MISMATCHES
AGE SEX BT A B DR
1. T .S. 49 M 5 1 1 0
2. J ,. A . 41 M 5 1 0 1
3 . T .C . 53 M 5 2 1 1
4 . W ,.H. 31 M 10 1 1 2
5 . W ,G . 22 M 5 2 2 1
B . c ,S . 33 M 10 2 1 0
7 . p .M. 24 F 5 1 1 1
8. M , 55 F B 1 1 0
8. A .M . 53 M 5 1 0 0
10. J .,P . 48 M G 1 2 0
11 . H ,H . 51 F 5 0 1 -
12 , M,,S. 43 F 10 2 0 2
13 . J .M . 39 F 10 1 2 1
14 . J,.G . 20 M 5 2 1 1
Mean+SEM: 40 + 12
M/F:9/5
G ,5+0.5 1.3+0.2 1.0+0.2 O.B+C
Table 8.2
Renal transplant patients treated with cyclosporine who were used 
in this study
Group
Number of 
Patients IgG-PFC IgA-PFC IgM-PFC
Az-treated
transplants 11 B68+134 910+214 234+69
CsA-treated
transplants 14 328+71 '367+157 133+30
Dialysis
patients -
(n=38)
386+53
(n=21)
341+40
Cn=16)
143+14
Healthy
subjects 25 1137+171 1380+253 342+73
Table 8.3
Spontaneous immunoglobulin productionCMean+lSEM PFC/10 cells) by 
renal transplant patients treated with either azathioprine or 
cyclosporine in comparison with response in untransplanted uraemic 
patients and healthy subjects.
Results shown for healthy subjects and uraemic patients are the same 
with those presented in CHAPTER UI.
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Fig.8.1
Spontaneous production of IgG during the 
first six weeks after renal transplantation 
in patients treated with azathioprine or 
cyclosporine, ^
Bars represent the mean+lSEM(IgG-PFC/10 cells) 
and figures within bars indicate the number of 
rejection episodes at each time.
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Fig.8 .2
Spontaneous production of IgA during the first 
six weeks after renal transplantation in patients 
treated with azathioprine or cyclosporine.
Bars represent the mean+lSEM(IgA-PFC/10^ cells) 
and figures within bars indicate the number of 
rejection episodes at each time.
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Fig.8.3
Spontaneous production of IgM during the first 
six weeks after renal transplantation in patients 
treated with azathioprine or cyclosporine.
Bars represent the mean+lSEM(IgM-PFC/lO^ cells) 
and figures within bars indicate the number of 
rejection episodes at each time.
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Fig.8.4
Serial changes of PFC activity in representative patients 
treated with azathioprine and cyclosporine.
PFC counts represent the mean of triplicate 
determinations(PFC/10^ cells).
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Fig.8.5
Serial changes of PFC activity in one patient with 
systemic infection after renal transplantation.
PFC counts shown are the mean of triplicate 
determinations(PFC/lO^ cells)
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GENERAL DISCUSSION
It has become clear over the recent years that the 
mechanism of regulation of immunologic reactivity is the 
balance between positive and negative influences in the form 
of monocytes, helper T and suppressor T cells, and in the 
humans T and B cell function is modulated by a complex 
interaction by mononuclear cell populationsCStobo, 1982).
The role of B cell indicator systems has also been 
established and B cell assays have been utilised frequently 
to investigate the function of monocytes, helper T, 
suppressor T and B cells.
The work in this thesis dealt predominantly with the 
haemolytic plaque forming cell assay and several culture 
systems have been employed both for the enumeration of 
immunoglobulin secreting cells and For the measurement of 
mitogen induced blastogenesis in healthy and uraemic 
subjects.
PLAQUE ASSAYS
A protein A plaque Forming cell assay was used in this 
study to enumerate, spontaneous or mitogen stimulated 
immunoglobulin secreting cells. Several experiments were 
performed using control cells to study the performance and 
reproducibility of the assay.
In these experiments, it was demonstrated that different 
handling of effector cells before plating as well as 
differences in the plating procedure probably account for 
the difficulties many workers had experiencedCTruffa~Bachi &
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Bardenave, 1980, Burns & Pike, 1981). The sources and 
optimal dilutions oF the reagents I used were comparable to 
those used by most workers and slight modifications in 
dilutions and concentrations were not found to affect 
significantly plaque forming cell counts. It was shown that 
optimal reproducibility required that effector cells had to 
be stored on ice for as short a time as possible before 
plating and that the assay had to be performed as soon as 
possible after cell separation. In addition, the plaques had 
to be counted after a standard incubation period because of 
the differences observed in plaque forming cell counts 
obtained over different times. When two or more samples from 
the same individual were studied, I found that the cells had 
to be frozen down and the plaque assays performed on the 
same day in order to avoid significant test to test 
variation. This work also indicated the need for a positive 
control which could be used as a quality control for the 
assay and the one presented in CHAPTER III(Pig.3.15) proved 
to be reliable and simple. Alternatively other workers have 
used as control cells human spleen cells which were firstly 
cultured for a few days with PWM before being 
frozenCHorsburgh, unpublished data).
When all these conditions were met, the plaque assay was 
a very versatile and useful method. Although other workers 
have suggested various major or minor modifications in order 
to improve reproducibility, such as storage of large batches
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of protein A coated SRBC to avoid batch to batch 
variationCAgger et al, 1983), I found no significant 
variation on routine testing of each new batch of coated 
SRBC with its predecessor. Others have also suggested the 
use of IgG depleted complement to reduce variation due to 
different batches of complementCUan Oudenaren et al, 1981), 
This procedure was time consuming and, in my study, it was 
unnecessary, because only five different batches of 
complement were used, which gave similar responses when 
compared with each other. Trienekens et alClGBH) suggested 
that addition of PEG 8000 in the agar mixture improves 
reproducibility and reliability of the assay by improving 
stability of immune complexes. In the present experiments, 
the use of PEG BOOO was also associated with the development 
of better defined haemolytic zones but did not produce a 
significant increase in the number of plaque Forming cells.
My results showed clearly that the most important 
technical factor affecting the detection and measurement of 
immunoglobulin secretion by peripheral blood mononuclear 
cells was the handling of the cells particularly before 
plating. Although the amounts and sources of reagents were 
also important these factors were not difficult to 
standardise.
Spontaneous Plague Formation
When spontaneous plaque formation was examined in normal 
controls, the counts of IgA-PFC usually exceeded those of
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IgG-PFC in agreement with previous reports of spontaneous 
immunoglobulin productionCFreiJd & Kunori, 1980) and 
presence of intracellular immunoglobulin. These findings are 
interesting in view of the predominant role of IgA as a 
mucosal immunoglobulin and contrast with the low serum 
concentration of IgA compared to that of IgG. It has been 
suggested that this discrepancy may be explained partly by 
the short half-life of IgA in serum and by the hypothesis 
that the recirculation of IgA secreting cells is very 
shortCFreijd & Kunori, 1980). The same authors also 
suggested that these IgA secreting cells are IgA lymphocyte 
precursors in Payer’s patches, which after being primed by 
antigen, leave the gut by the lymphatics and recirculate 
until settling in the lamina propria of mucous membranes of 
secretory glands.
Production of Immunoglobulin in Response to Poluclonal B
Cell Activators
The protein A plaque assay was also used to enumerate 
plaque forming cells in polyclonal B cell activator induced 
cultures of peripheral blood mononuclear cells. Several 
experiments were performed to find the optimal conditions 
for B cell differentiation and several technical factors 
were examined including the time course, dose response, and 
cell concentration. In addition, it was found important in 
these studies to use the same reagents, materials and
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equipment throughout, because even small changes in one or 
more of these parameters, had significant effects on the 
final result.
The IgA-, IgG-, and IgM-PFC counts obtained from PWM,
SAC, PWM plus SAC, and EBV cultures were in agreement with 
previous studiesCFauci et al, 1900, Bird & Britton, 1379, 
Tauris, 1983a,b, Saiki S Ralph, 1901a). IgG-PFC counts were 
higher in most cases and this is the reason why only IgG-PFC 
were measured in the studies of various parameters such as 
co-stimulation with ConA etc. Other workers have reported a 
larger number of IgM-PFC than IgG-PFC after PWM or SAC 
stimulationCHammarstrom et al, 1379). The apparent 
difference between these studies and my study may have 
resulted from the chance selection of donors or from 
different laboratory conditions, eg. Hammarstrom et al 
cultured human cells in RPMI 1640 supplemented with human AB 
serum instead of PCS. However, other workers also reported a 
predominance of IgG production in the PWM system and also 
found that EBV gave rise to a proportional dominance of IgM 
secretionCTauris, 1983a,b. Bird & Britton, 1979b). In my 
study a small number of control samples were studied with 
EBV and it was found that IgM response was the highest and 
and at the same level as PWM induced IgM-PFC. The IgG-PFC 
response was comparable to the response induced by SAC and 
significantly lower than the PWM response.
When all technical parameters were standardised, these
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initial studies confirmed the potential usefulness of the 
plaque assay as a means of assessing humoral immunity in 
serial samples from large groups of patients. In addition, 
although not studied here, the assay could be modified to 
investigate functions of purified lymphoid cell 
subpopulations and, using appropriate antisera, could also 
be used to enumerate cells which are secreting mediators 
other than immunoglobulin, including interleukins, growth 
and differentiation factors, and other immunoregulatory 
substances.
STUDIES OF LYMPHOCYTE SUBPOPULATIONS AND LYMPHOCYTE
FUNCTION IN URAEMIA
Previous studies have shown that both cellular defects 
and immunosuppressive factors in uraemic serum contribute to 
the reduced immune responsiveness of uraemic subjects. In 
the present study of a number of immunological parameters, 
an emphasis was given to the investigation of immunoglobulin 
production in vitro. In addition, total white cell, 
lymphocyte and lymphocyte subpopulation counts were 
performed together with assays of proliferative responses of 
uraemic lymphocytes .
There was no difference in white cell and lymphocyte 
counts between normal controls and uraemic patients. 
Lymphopenia is not a universally accepted feature of uraemia 
and while my results support the report by Kauffman et 
alC1975), they contradict other reports which showed that
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uraemic patients were lymphopénieCJensscn et al, 1958,
Wilson et al, 1965, Boulton-Jones et al, 1973). It is 
possible that these discrepancies reflect the study of 
patients with different degrees of renal failure as well as 
differences in the use of cytotoxic drugs, blood 
transfusions, and time on dialysis.
My results also showed that lymphocyte subpopulations 
were not significantly abnormal in uraemic patients, a 
finding which contrasts with other recent reports that the 
helper T cell subpopulation is reduced in uraemiaCLortan et 
al, 1982, Raska et al, 1983). All the patients examined in 
the present study had never received a blood transfusion, 
and this may account for the differences between my results 
and those of other workers. In a recent study, Bender et 
alC19B4) tried to determine the effects of blood transfusion 
on lymphocyte subsets of uraemic patients and showed that 
changes in peripheral blood lymphocyte subpopulations 
occured almost exclusively in the group who received 
erythrocyte transfusions. The other workers who examined 
white cell and lymphocyte counts in uraemics did not 
separate their patients in transfused and non-transfused 
groups.
My results indicate strongly that immunosuppression in 
uraemia is not merely due to reduced numbers of T and B 
lymphocytes but reflects a true functional abnormality.
This hypothesis is supported by the Finding that 
proliferative responses of peripheral blood mononuclear
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cells to both PHA and PWM were reduced in uraemic patients. 
This confirms a number of previous reports of depressed 
proliferative responses to T-cell mitogens and confirms that 
T lymphocyte function is impairedCHuber et al, 1969,
Kauffman et al, 1975, Holdsworth et al, 1970, Kunori et al, 
1900, Alevy & Slavin, 1981). Furthermore, I did not find 
that uraemic lymphocytes were more sensitive than control 
cells to the suppressive effects of steroids in vitro and, 
thus, my results are in contrast to a recent reportCLanghofF 
& Ladefoged, 1984) and do not support the idea that immune 
responsiveness in uraemia is inherently normal and that 
immune suppression is observed merely because uraemia 
potentiates the activity of drugs known to suppress the 
immune responseCNelson et al, 1980).
The spontaneous production of immunoglobulin by uraemic 
peripheral blood mononuclear cells was examined, using the 
protein A plaque assay, and it was clearly demonstrated that 
spontaneous plaque formation was impaired in uraemic 
subjects. This impairment was more pronounced for the IgA 
and IgG classes although IgM was also significantly lower 
than normal. These differences have not been reported 
before, and contradict two previous reports which could not 
detect any abnormalities in immunoglobulin production by 
unstimulated peripheral blood mononuclearsCHorsburgh et al, 
1903, Satomi et al, 1983). Studies of serum concentrations 
of immunoglobulins in uraemia have shown that IgA and IgM
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did not differ significantly from normal values, while serum 
IgG had a wide scatter of valuesCCascianni et al, 1378). 
Nevertheless, serum immunoglobulin levels are not a reliable 
method of studying humoral immunity in these patients 
because of the possibility of abnormal renal excretion of 
immunoglobulins.
This result is a reliable indicator of depressed humoral 
immunity in uraemic patients and, since B cell numbers were 
normal in these patients, the present study suggests that 
the defective humoral immune response is due to 
abnormalities in B cell differentiation associated with the 
uraemic state.
When the PWM induced plaque forming cell responses were 
examined, it was found that PWM stimulated uraemic 
peripheral blood mononuclear cells differentiated normally 
into immunoglobulin secreting cells, in contrast to the 
defective proliferative responses to both PWM and PHA. In 
addition, no significant differences were found in the 
kinetics of PWM stimulated cultures of peripheral blood 
mononuclear, cells obtained from healthy subjects and uraemic 
patients, and in both groups the peak plaque forming cell 
responses were observed on the Bth day using the optimal PWM 
dilution. These results indicate that there is a defect in 
the proliferative potential of uraemic T cells and also 
suggest that the PWM stimulated uraemic helper T cell can 
provide the necessary help for terminal B cell
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differentiation. This apparent discrepancy is not surprising 
in view of the fact that T cells do not need to divide to 
exhibit helper activityCKeightley et al, 1976). Furthermore, 
these findings suggest that the overall reduction in 
proliferative response to PWM mainly reflects a defect on 
the T cell populationCCupps’& Fauci, 1902) and that B cell 
Function is relatively normal. As PWM stimulated 
immunoglobulin production was normal in uraemia, it is also 
apparent that T-B cell cooperation remains intact in uraemic 
patients.
EBV induced B lymphocyte activation and differentiation 
is independent from T cell help and it is unaffected by the 
presence of autologous ConA induced suppressor cellsCBird & 
Britton, 1979, Bird et al, 1901). These properties of EBV 
are advantageous in the study of human B cell function and 
accordingly, I studied the plaque farming cell responses of 
uraemic peripheral blood mononuclear cells to EBV in order 
to examine whether T-cell independent B cell differentiation 
was affected. Peripheral blood mononuclear cells were 
exposed to EBV and then cultured for a short period in order 
to avoid secondary in vitro activation of cytotoxic 
virus-specific T lymphocytes resulting in limitation of B 
cell growthCBird et al, 1981). The EBV responses were found 
to be normal in uraemic patients and this finding in 
association with all my previous findings further support 
the hypothesis that reduced immunoglobulin production in
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uraemia is due to a T cell rather than B cell defect.
In contrast to the results with PWM, the plaque farming 
cell response of uraemic cells to SAC was shown to be 
impaired. This confirms and extends an earlier report by 
Kunori et alClSBO), and provides further information on the 
nature of the immune defect in uraemics. SAC stimulates B 
cells via an interaction between its cell wall protein and 
immunoglobulin on the B cell surface, and while the 
resulting proliferative response is T cell independent, full 
differentiation of the B cell is dependent on T cell 
helpCFalkoff et al, 1982). Interestingly, SAC itself does 
not appear to stimulate T cellsCFalkoff et al, 1982), and so 
the B cell differentiation factors which must be present to 
permit B cell differentiation are probably supplied by 
helper I cells which are either activated in culture by FCS 
or which are already preactivated in vivo. As I have shown, 
both spontaneous and SAC induced immunoglobulin production 
were depressed in uraemic patients whereas PWM induced 
immunoglobulin production was normal, As both defective 
responses rely on preactivated helper T cells, it is 
tempting to speculate that the defective immunoglobulin 
response in uraemic patients is due to abnormal activation 
of helper T cell in vivo or alternatively due to low 
background stimulation in culture. In contrast, when these 
cells were stimulated with PWM after removal from the 
uraemic environment, normal immunoglobulin production was 
demostrated, because PWM is known to activate T
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cellsCGreaves S Janossy, 1972), This helper T cell defect 
must be functional since helper T cell counts were found to 
be within the normal range.
One further difference in the production of 
immunoglobulin in response to PWM or SAC was that while the 
depressed response to SAC was considerably improved by 
indomethacin, this had no effect on the response to PWM. 
These results indicate that prostaglandin production by 
uraemic cells may contribute to suppressed SAC response.
Such a dissociation between PWM and SAC responses of B cells 
was also observed by Thompson et alC1994) when they studied 
the regulation of human B cell proliferation by 
prostaglandin E2CPGE2) . They were able to show that PGE2 
inhibits B cell proliferation in response to SAC but not in 
response to PWM and also presented data from preliminary . 
studies suggesting that PGE2 exerts selective regulatory 
effects on human B cell responses such as inhibition of 
production of B cell differentiation factorCBCDF) but no 
effect on the production of B cell growth factorCBCGF). In 
this study, SAC cultures of uraemic cells responded better 
than control cells to the addition of indomethacin and these 
Findings are consistent with the idea that the suppressed 
activation of helper T cells in uraemic patients, discussed 
above, could be due to excessive production of PGE2. A 
substantial body of evidence implicates prostaglandins as 
potent regulators of the immune response and recently it was
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reported that prostaglandins suppress IL-E production by 
human lymphocytesCRappaport S Dodge, 1382) while very recent 
studies showed that IL-E receptors are expressed on SAC 
activated B cellsCMuraguchi et al, 1985). Thus, the low 
spontaneous and SAC responses in this study can be either 
due to inhibition of IL-E or BCDF production by 
prostaglandins or due to PGE2 induced suppressor T 
lymphocytesCChouaib et al, 1984). The second hypothesis was 
not supported in this study because SAC is not greatly 
influenced by suppressor T cell function and, as will be 
discussed later, when steroids were added to inhibit 
selectively the suppressor T cell subset, the SAC induced 
plaque forming cell responses of the uraemic patients 
remained relatively unchanged. Prostaglandin inhibition of 
IL-2 production by T cells explains the low spontaneous and 
SAC plaque forming cell responses in uraemia, since IL-E can 
have both a direct and an indirect effect on B cell 
differentiation. Initially, IL-E was considered to have a 
central role in immunity by its capacity to sustain division 
of helper and cytotoxic T lymphocytes, but recently, normal 
B cells were found to express functional IL-2 receptors and 
IL-E was found to induce significant enhancement of 
proliferation in SAC activated B cellsCMingari et al, 1984). 
Interestingly, addition of IL-E to PHA cultures of uraemic 
lymphocytes has been recently shown to normalise the 
proliferative responses to this T cell mitogenCLanghoff et
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al, 1985). îly hypothesis is that uraemic helper T cells 
secrete a normal or reduced amount of IL-E or other 
differentiation factors the production of which is inhibited 
by a physiological or abnormally increased secretion of 
PGES. This happens when T cells are preactivated either in 
vivo or in vitro but it doesn't happen when the cells are 
activated with PWM which activates both T and B cells. It 
would therefore be interesting to examine the effects of 
prostaglandins and IL-E on spontaneous and SAC induced 
plaque formation by uraemic peripheral blood mononuclear 
cells. In previous studies, macrophages present in the 
spleen, the peritoneum and the lung of uraemic rats, have 
been shown to suppress mitogen reactivity of spleen 
cellsCAlevy et al, 1983 & Alevy et al, 1982). The same 
authors in another study showed that the suppression of PHA 
response in uraemic rats is mediated by an adherent and 
la-negative suppressor cellCAlevy et al, 1981). When these 
cells were pretreated with indomethacin which inhibits 
prostaglandin synthesis, they were shown to be 
indomethacin-insensitive, and although these findings could 
reflect a role for preformed PGEE in this model of uraemia, 
it would be of interest to examine directly the function of 
adherent cells on in vitro immunoglobulin production by 
uraemic peripheral blood mononuclear cells.
One further explanation for the differential effects of 
uraemia on PWM and SAC induced immunoglobulin responses is 
that this may reflect functional abnormalities in separate B
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cell subsets. This is supported by evidence that B cells 
which respond to SAC carry receptors For mouse red blood 
cellsCflRBC-*-) , whereas PWM responsive B cells do notCIto & 
Lawton, 1384). Thus, it would be important to determine the 
numbers of these B cells in uraemic patients. IF such an 
abnormality exists, the low SAC responses in uraemia could 
be due to low numbers of MRBC+ B cells, but this finding 
would not explain the low spontaneous plaque forming cell 
responses.
One further point of interest from my study was that, in 
contrast to control cells, uraemic patients did not show a 
synergistic plaque forming cell response to PWM+SAC in 
combination. Indeed, the response■to the two activators was 
less than that with PWM alone and correlated with the low 
response to SAC. In conjunction with the normal response to 
PWM this indicates that the defective ability to respond to 
SAC is alone responsible for the lack of synergy. Very 
little is known about the B and T signal synergy in human 
immunoglobulin secretion. The B cells induced by PWM may be 
already activated in the blood, e.g., recently stimulated or 
memory cells, and easily activated by T cell factorsCMacy & 
Stevens, 1880). SAC activates the remaining B cells, and a 
possible role of the PWM in the synergistic effect is to 
provide the B cell differentiation factors secreted by T 
cells. In this study, uraemic B cells did not respond 
normally to SAC, and thus were unable to differentiate into
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immunoglobulin secreting cells in response to 
differentiation factors provided by PWM induced T cells. 
Therefore, the B cells which finally differentiated were 
those which were already activated in the peripheral blood.
The effect of corticosteroids on immunoglobulin 
production was examined with the aim of exploiting the 
selective effect of corticosteroids on suppressor T cells 
and to elucidate further the mechanisms of depressed 
immunoglobulin synthesis in uraemia.
In the present study, the immunoglobulin response to PWM 
was increased by addition of methyl-prednisolone, but this 
was more pronounced in controls than in uraemic patients. In 
addition, immunoglobulin responses to SAC were also 
increased in normal controls while they were unaffected in 
uraemic patients and as discussed earlier this finding 
supports further the hypothesis that abnormal immunoglobulin 
production is due to a Functional helper T cell defect.
It is well known that corticosteroids suppress in vitro 
mitogen induced blastogenesis although some mitogen systems 
are more sensitive than othersCHeilman, 1972, Heilman et al, 
1973, Blomgren & Andersson, 1973). More specifically, these 
authors reported that corticosteroids suppress the 
proliferative responses induced by PHA and ConA whereas the 
responses to PWM were only slightly inhibited. In this 
study, PHA and PWM responses were shown to be inhibited by
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methyl-prednisolone, and as discussed above, in contrast to 
a recent report no difference was found in this inhibition 
between control and uraemic lymphocytesCLanghoff &
Ladefoged, 1384). It is also known that immunoglobulin 
production in cultures of human peripheral blood mononuclear 
cells is markedly increased by in vitro
corticQsteroidsCSmith et al, 1972 & Grayson et al, 1901) and 
this increase was more clearly demonstrated in the PWM 
systemCCooper et al, 1379). Interestingly, Grayson et 
alC1901) showed that corticosteroids enhanced immunoglobulin 
production in vitro in the absence of any other stimulating 
factor but in this study, when control and uraemic 
peripheral blood mononuclear cells were cultured only in the 
presence of methyl-prednisolone, the plaque forming cell 
response was at background levels. The role of 
corticosteroids in production of immunoglobulin in vitro is 
investigated in detail in a very recent report where it is 
suggested that corticosteroids produce their enhancing 
effect on the PWM system by'selectively inhibiting at 
pharmacological concentrations the suppressor T cell 
subsetCPaavonen, 1385). Nevertheless, the finding of these 
authors that SAC induced immunoglobulin production is 
insensitive to the action of corticosteroids was not 
confirmed in this study.
In view of the normal PWM induced plaque forming cell 
responses in uraemic patients one would not expect to see
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such a différence in lymphocyte sensitivity to
methyl-prednisolone between uraemic and control subjects.
The enhancement observed in the uraemic cultures failed to 
reach statistical significance at any dilution of 
methyl-prednisolone but nevertheless a dose dependent 
pattern was observedCFig,B.13) . This indicates that 
methyl-prednisolone inhibited at least one proportion of 
uraemic suppressor T cells but further studies are needed to 
investigate whether methyl-prednisolone left unaffected one 
proportion of uraemic suppressor T cells and whether it also 
impaired the function of other immunoregulatory cells or of 
the B cell itself.
MethyIprednisolone also enhanced the immunoglobulin 
response of control cultures to SAC although the increase 
was significantly lower than that observed with PWM. This 
accords with the findings of Falkoff et alClBBB) who used 
irradiation to eliminate suppressor T cells and together 
these results indicate that suppressor T cells normally 
regulate SAC-induced immunoglobulin production, although not 
to the same degree as PWM-induced responses.
MethyIprednisolone had no effect at all on the SAC response 
of uraemic cells, suggesting that the low SAC responses in 
uraemia are not due to increased suppressor T cell activity 
and supporting the view that the reduced SAC responses are 
due to defective levels of T helper activity. In addition, 
the finding that there is no difference in steroid
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sensitivity between control and uraemic proliferative 
responses indicates that the differences in the SAC-plaque 
forming cell responses are probably not due to differences 
in sensitivity to methyl-prednisolone between control and 
uraemic suppressor T cells.
Many groups have investigated the role of uraemic serum 
in mediating the immunosuppression of uraemic patientsCSilk, 
1967, Newberry & Sanford, 1971, Raskova & Raska, 1901, 
Langhoff & Ladefoged, 1904) and my own results showed that 
pre-incubation of control peripheral blood mononuclear cells 
with uraemic sera suppressed slightly the PWM induced 
immunoglobulin production of normal peripheral blood 
mononuclear cells although this failed to reach statistical 
significance. In addition, I found that uraemic serum also 
affected the quality of the plaques as determined by 
microscopic examination.
These findings are in agreement with previous reports 
that uraemic serum can suppress both mitogen responses as 
well as antibody production in vitroCMezzano et al, 1984). 
One methodological difference between my own and previous 
work is that in earlier studies, lymphocytes were cultured 
in the presence of uraemic serum, whereas I was unable to 
establish a reproducible system for culturing peripheral 
blood mononuclear cells in the presence of uraemic serum, 
and cells were only pre-incubated with serum before culture. 
However, it has been shown in the ratsCRaskova et al, 1981)
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that continuous presence of uraemic serum is not essential 
to demonstrate inhibited PHA responses and that the later 
stages of the response are unaffected by uraemic serum. In 
the only previous study investigating the effect of uraemic 
serum on antibody production in vitro, Mezzano et alC1904) 
showed that uraemic serum suppressed the antibody responses 
of rat spleen cells to bovine serun albumin but not to sheep 
red blood cells. The same authors also found that the 
response of lymphocytes from uraemic rats could be restored 
to virtually normal levels by culture in medium supplemented 
with normal rat serum, emphasising the importance of serum 
factors in determining the response of uraemic cells. It is 
possible that such serum factors affect the spontaneous and 
SAC-induced plaque forming cell responses of the uraemic 
lymphocytes as well as the plaque forming cell responses of 
control cells pre-incubated with uraemic serum,
The nature of the factorCs) responsible for this 
inhibitory effect has not been elucidated and the 
immunosuppressive effect of the uraemic serum does not 
correlate with the levels of urea, creatinine, calcium, and 
phosphorusCModai et al, 1905). One uraemic blood constituent 
which has received much recent attention is a very low 
density lipoproteinCULDL) which was first identified in the 
serum of rats with chronic renal insufficiency. This ULDL 
completely inhibits the response of lymphocytes to
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allogeneic cells or phytohaemagglutinin ACRaska et al, 1300, 
Raskova & Raska, 1901), and has also been shown to induce 
suppressor cell activityCRaskova & Raska, 1983). In humans, 
uraemia is associated with hyperlipidaemiaCNorbeck &
Carlson, 1901) and serum lipoproteins of different types 
have been shown to inhibit spontaneous plaque forming cell 
activityCAntonaci et al, 1904). In addition, lipoproteins 
contain phospholipids which can bind and activate human T0+ 
lymphocytes to generate suppressor T cell activityCUiadee & 
Rabson, 1903). Although a Factor like ULDL may be 
responsible for the observed suppressive effect of uraemic 
serum on PWM induced immunoglobulin production by control 
cells, and for the low spontaneous and SAC-induced plaque 
forming ceil responses of uraemic cells, it is very unlikely 
that ULDL induced suppressor T cell activity was the causing 
mechanism, because in this study no evidence was found for 
increased suppressor T cell activity among uraemic 
peripheral blood mononuclear cells. Thus, it is possible 
that ULDL exerts its immunoinhibitory effect on 
immunoglobulin production by affecting the function of 
helper T cells or monocytes, and although a direct effect on 
B cell function cannot be excluded, it is not likely since 
the EBU-induced plaque forming cell responses were found to 
be normal in uraemic patients.
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EFFECT OF BLOOD TRANSFUSION ON IMMUNOGLOBULIN SECRETION
One oF the Factors which could possibly account For the 
immunosuppression oF uraemia is blood transfusion, as it is 
well known that pre-transplant blood transFusion suppresses 
cell mediated immunity in prospective kidney-graFt 
recipients. The exact cellular mechanisms oF this 
immunosuppression are unclear and, in the present study, the 
eFFects oF blood transFusion and the role oF T and B cells 
in determining the abnormal immune responsiveness were 
examined. This was achieved by examining the eFFect oF blood 
transFusion on production oF immunoglobulin both 
spontaneously and in response to polyclonal B cell 
activators which diFFer in their dependence on T cells.
The results showed that spontaneous production oF 
immunoglobulin was not aFFected signiFicantly by blood 
transFusion, with any variations which did occur being 
independent oF blood transFusion. Although one might have 
expected that the spontaneous plaque Forming cell response 
would Follow alterations in the immune status described 
below, this did not occur in the present study, probably 
because the spontaneous plaque Forming cell counts in 
uraemic patients beFore blood transFusion were already very 
low compared with control values.
This problem oF inherently low plaque Forming cell 
responses was overcome by examining immunoglobulin 
production aFter stimulating peripheral blood mononuclear
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cells with PWM or SAC. In these studies of polyclonal B cell 
activation, PWM induced immunoglobulin production by 
peripheral blood mononuclear cells was depressed by blood 
transFusion in 10/BB patients, and this required at least 2 
blood transFusions. In eight oF these patients pre-BT, 
post-SBT and post-lOBT values were compared and it was shown 
that the Five additional blood transFusions Further 
suppressed the PWM response. Other workers have reported 
increased suppressor cell activity aFter the First or second 
blood transFusionCKlatzmann et al, 1983, Smith et al, 1983). 
Others Found a correlation between PHA and MLR activity and 
the amount oF blood givenCFehrman et al, 1981) as well as a 
progressive reduction in patient’s proliFerative responses 
to suboptimal doses oF ConA with increasing numbers oF 
transFusionsCTait et al, 1984).
In contrast to PWM, SAC induced immunoglobulin production 
was not aFFected by blood transFusion even aFter 5 or 10 
blood transFusions, indicating that blood transFusion did 
not aFFect the ability oF the B cell to diFFerentiate into 
immunoglobulin secreting cells in response to SAC. SAC 
induced B cell proliFeration is T cell independent while SAC 
induced B cell diFFerentiation strictly depends on helper T 
cells and thus, my results indicate that blood transFusion 
does not aFFect helper T or B cell Function. Further studies 
using EBU will not only provide inFormation about the 
involvement oF the B cell itselF but also in parallel with 
PWM and/or SAC studies will be a useFul control since the
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EBU system does not depend on helper T cells and is not 
aFFected by suppressor T cellsCin short term cultures).
As PWM induced diFFerentiation oF B cells into 
immunoglobulin secreting cells is a process known to be 
inFluenced by suppressor T cell activityCPryJma et al, 1900) 
these results indicate that the suppression oF PWM induced 
immunoglobulin secretion is due to an eFFect oF blood 
transFusion on T cells, The position with SAC induced B cell 
activation is more complex. Although it has been reported 
that SAC induced immunoglobulin production is not aFFected 
by ConA generated suppressor T cell activityCPryjma et al, 
1900), othersCFalkoFF et al, 1982) irradiated T cells to 
eliminate suppressor T cells and Found that this enhanced 
the SAC induced plaque Forming cell response in some 
individuals indicating that the SAC induced B cell 
diFFerentiation was also inFluenced by suppressor T cell 
activity. This is in agreement with my own resultsCCHAPTER 
U) which showed that SAC induced production oF 
immunoglobulin was moderately decreased by costimulation 
with ConA and slightly enhanced aFter addition oF 
methy1-prednisolone. However, my study indicated that the 
response to SAC was less aFFected than the response to PWM 
by suppressor activity and it does appear that these 
polyclonal B cell activators diFFer in their susceptibility 
to regulation by suppressor T cells. Thus, the results oF 
the present study suggest that the diFFerential inhibitory
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eFFects oF blood transFusion on B cell diFFerentiation into 
immunoglobulin secreting cells is due to an increase in 
suppressor T cell activity.
My results are in accord with those oF these 
investigators who have shown an increase in non-antigen 
speciFic suppressor cell activity aFter blood transFusion 
but Further studies are needed to identity the ceilCs) 
responsible For this eFFect. Both monocytes and suppressor T 
cells have been shown to act as suppressor cells in the 
immediate and late post-transFusion period,
respectivelyCLenhard et al, 1982b), and both these cells are 
known to inhibit PWM induced immunoglobulin productionCFauci 
et al, 1980, Rosenkoetter et al, 1984). Recognition, 
characterisation and isolation oF these immunoregulatory 
cells has been achieved in large part by a variety oF 
monoclonal antibodies and the availability oF these reagents 
can Facilitate the identiFication oF the cellCs) responsible 
For the observed eFFect oF blood transFusion on PWM 
responses.
This is the First study to use the plaque Forming cell 
assay to assess the eFFects oF pre-transplant blood 
transFusion on immune responsiveness and my proposal that 
random blood transFusion acts by suppressing T cell 
dependent polyclonal B cell activation is supported by a 
recent experimental study oF donor speciFic blood 
transFusion in experimental ratsCLenhard et al, 1985a).
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These workers showed that transFusion oF Lew rats with BN 
blood produced a decreased antibody response to a subsequent 
BN kidney graFt and this eFFect could be transFerred by 
spleen cells From multi-transFused recipients. These spleen 
cells were nylon-wool non-adherent and carried markers For 
the suppressor/cytotoxic T cell subsetCOXB) but not oF the 
helper T cell classCUl3/E5) and it was concluded that the 
suppression oF antibody responses in this experimental model 
oF blood transFusion was mediated by suppressor T cells. It 
would be oF interest to use the plaque Forming cell assay 
and diFFerent polyclonal B cell activators to examine the 
eFFect oF blood transFusion on Fractionated lymphocyte 
subpopulations.
Although it has not be proven that suppressed humoral 
immunity accounts For some oF the beneFicial eFFects oF 
blood transFusion in renal transplant recipients, there is 
some evidence to support this view. Thus, transFusion oF 
strongly MHC-incompatible BN and LEW rats with 15 
transFusions oF BN blood suppressed both the speciFic 
anti-BM response and the reactivity to third party blood and 
this correlated very well with prolongation oF skin graFts 
From BN or CBNxLEW)Fl . Interestingly, there was also some 
improvement in the survival oF third party graFtsCLenhard et 
al, 1985b).
Further support For the role oF suppressed antibody 
production in preventing graFt rejection comes From clinical
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studies which showed that patients who did not develop donor 
speciFic lymphocytotoxic antibodies during blood transFusion 
had a better graFt survival aFter renal transplantation. In 
detailed studies oF this phenomenon, Opelz et alC1973b)
Found that halF oF a group oF patients receiving random 
blood transFusions did not develop cytotoxic antibodies even 
aFter thirty blood transFusions and in some instances 
complete loss oF antibody activity occurred. Similarly, 
Ferrara et alC1974) showed that in some volunteers given 
repeated injections oF small aliquots oF blood, cytotoxic 
anti-HLA antibody responses declined progressively until 
complete unresponsiveness occurred and they suggested that 
blood transFusion may induce a state oF humoral 
unresponsiveness to HLA antigens. Finally, Barsoum et 
alClSBO) reported one case oF a pre-sensitised uraemic 
patient who was initially considered unsuitable For 
transplantation due to the presence oF cytotoxic antibodies 
but who was subsequently accepted when these disappeared 
Following prospective multiple transFusion therapy.
For these reasons, serial assessment oF PWM induced 
plaque Forming cells could be a useFul means oF determining 
whether individual pretransplant patients are beneFiting 
From a course oF blood transFusion and will have a good 
outcome aFter renal transplantation. My study was to small 
to establish statistically that there may be a relationship 
between blood transFusion associated suppression oF PWM
145
induced plaque Farming cell response and kidney transplant 
outcome.
MONITORING OF PFC ACTIVITY IN RENAL TRANSPLANT PATIENTS
The changes in spontaneous plaque Formation by peripheral 
blood mononuclear cells From renal transplant recipients on 
immunosuppression were not unexpected in view of the known 
eFFects oF both allograFt rejection and immunosuppressive 
therapy on lymphocyte reactivity. The First part oF this 
study examined the relatioship between immunoglobulin 
production and rejection episodes in patients receiving 
renal allograFts. IgG-PFC were increased in 20 oF 22 
rejection episodes and, in most cases this was accompanied 
by an increase in the IgA-PFC, In addition, a greater number 
oF azathioprine treated patients had increased plaque 
Forming cell activity compared with cyclosporins treated 
patients arid this correlated with the number oF rejection 
episodes in the two groups. These results are conFirmed by 
other recent reports oF an association between increased 
immunoglobulin production and rejection episodes.
Garovoy et alC130Ea,b) were the First to report that 
increased numbers oF immunoglobulin secreting cells was a 
useFul indicator oF rejection activity and that these Fell 
in response to treatment. Although these Findings suggest 
that IgG-PFC numbers might be a reliable indicator oF the 
humoral Form oF rejection, it is not clear whether this is 
due to graFt speciFic antibody production or to polyclonal
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activation oF host B cellsCHorsburgh et al, 1983). In a 
detailed report, Satomi et alC19B3) also showed that the 
increased plaque Forming cell response associated with 
rejection episodes rather than B cell numbers, 
pre-transplant blood transFusions or HLA diFFerences and 
suggested that this was due to polyclonal activation oF B 
cells. Although they did not present direct evidence For 
this idea, polyclonal production oF all classes oF 
immunoglobulin occurs in human mixed lymphocyte cultures 
which may be an in vitro correlate oF graFt rejectionCKunori 
& Ringden, 1979,1980). However, it has been suggested that 
the increased immunoglobulin production during rejection 
episodes reFlects production oF a range oF alloantibodies 
and autoantibodies rather than true polyclonal activation oF 
B cells CGoulillou et al, 1981) and it would be oF interest 
to examine directly the speciFicity oF antibodies during 
rejection episodes. It is also not known whether the 
increase in spontaneous production oF immunoglobulin during 
rejection episodes is due to an increase in the absolute 
number oF B cells but a recent study has suggested that an 
increased number oF B cells in the First three weeks aFter 
renal transplantation correlates very well with rejection 
episodes, especially IF there is also an increased 
proportion oF T4+ cellsCGreen et al, 1905). A Further 
important Finding From my study was that although there was 
no increase in IgM-PFC during rejection episodes Four 
patients without clinical signs oF rejection had an increase
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in both IgG-PFC and IgM-PFC which coincided with a systemic 
infection. The 20% incidence of increased IgG-PFC in the 
absence of clinical or histopathological evidence of 
rejection which I found confirms another recent 
reportCMcNaughton & White, 1905). Interestingly, these 
authors suggested that the plaque forming cell assay was of 
limited diagnostic value because elevated plaque Forming 
cell responses occurred during infections but also suggested 
that it might be possible to distinguish rejection and 
infection by the class of immunoglobulin which was induced. 
My results confirm this possibility by indicating that in 
the presence of infection, an increase in IgG production 
does not suggest rejection if the IgM response is also 
increased and I would suggest that in further studies, 
IgM-PFC can be used to discriminate between rejection and 
systemic infection in renal transplant patients.
The second part oF this study used the plaque forming 
cell assay to assess the immune status of transplant 
recipients who were immunosuppressed with either 
azathioprine or cyclosporins. Not unexpectedly, the results 
indicated that immunoglobuin production was depressed by 
both immunosuppressive drugs although not to the same 
degree. As noted above, cyclosporins treated patients had 
lower IgG-PFC responses than azathioprine treated patients 
and this correlated with a lower incidence of rejection 
episodes in cyclosporins treated patients. Although it is 
possible that this reFlects stimulation of immunoglobulin'
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production secondary to graft rejection, as discussed 
earlier, it is also possible that the lower incidence of 
acute rejection in cyclosporine treated patients reflects a 
more potent immunosuppressive effect of cyclosporine on 
humoral immunity. In addition to its profound effect on T 
cell mediated immunity , there is also evidence that 
cyclosporine can also affect antibody production. Thus, T4+ 
cells from cyclosporine treated patients exhibit an impaired 
ability to help anti-SRBC antibody production in vitro while 
the same was not observed in azathioprine treated 
patientsCUan Buren et al, 1982). In addition, several 
workers have reported that cyclosporine inhibits T dependent 
B cell proliferation and differentiation in vitroCPaavonen & 
Hayry, 1980, Berger et al, 1303). The question of whether 
cyclosporine also has a direct effect on B cell function is 
more controversial. Although it has been suggested that 
cyclosporine inhibits both T dependent and T independent 
immunoglobulin synthesisCPaavonen & Hayry, 1900), this work 
used SAC as a T independent mitogen and it is now known that 
SAC requires T cell help for the Final differentiation of 
the B cell into an immunoglobulin secreting cell. In 
addition it has been shown that while T cell independent B 
cell proliferation induced by anti-IgM antibodies and by SAC 
is sensitive to cyclosporineCBerger et al, 1903), activation 
of human B cells by EBU is insensitive to the action of 
cyclosporine. Thus, it was suggested that certain B cell 
activation mechanisms are sensitive to cyclosporine while
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others remain unaffected. These Findings indicate that the 
inhibition of plaque forming cell response I observed in 
cyclosporine treated patients could be due to both a direct 
action of cyclosporine on B cells or through inhibition of 
helper T cells. It would be of interest to examine this by 
looking at PWM, SAC and EBU responses in cyclosporine 
treated patients.
In the present study, azathioprine treatment proved less 
successful than cyclosporine both in suppressing spontaneous 
immunoglobulin production and in preventing acute rejection 
episodes. The mechanism of azathioprine induced 
immunosuppression is mainly by decreasing DNA synthesis 
although there is evidence of other modes of action. Thus, 
depressed K cell activity has been found in long term 
azathioprine tre ated patients and it has also been 
suggested that it may interact specifically with T 
cellsCWebb & Winkelstein, 1982). In addition, animal studies 
have shown that azathioprine does not interfere with the 
generation of antibody molecules controlling an anti-SRBC 
plaque forming cell responseCMedzihradsky et al, 1982). It 
is tempting to speculate that the less potent anti-rejection 
activity of azathioprine reflects the fact that this agent 
only inhibits B cell differentiation secondary to its 
effects on other cells. In view of the significance of this 
hypothesis it would be interesting to set up in vitro 
correlates to compare azathioprine and cyclosporine in 
T-dependent and T-independent culture systems for production
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of immunoglobulin.
The results presented here show that studies of B cell 
function in renal transplant patients can contribute 
considerably to understanding the mechanisms of 
immunosuppression as well as the acute phase of allograft 
rejection. In the last few years cyclosporine therapy has 
reduced dramatically the incidence of rejection within the 
first after transplantation and chronic rejection now 
constitutes the major threat for the transplant patient. As 
antibody mediated mechanisms are also important in this 
procBssCWilliams, 1984, Soulillou et al, 1881), it would 
have been interesting to extend my study to investigate 
plaque forming cell responses in patients with chronic graft 
rejection. This idea is supported by a recent report that 
PWM induced immunoglobulin secretion is increased in 
patients undergoing chronic rejection of renal 
allograftsCLandsberg et al, 1885). In addition, studies of 
this nature could also provide useful information about the 
involvement of B cells in chronic rejection and about the 
efficiency of the anti-rejection treatment under these 
circumstances.
151
CONCLUSIONS
In this thesis, a sensitive reverse plaque assay system 
was used in combination with various polyclonal B cell 
activators to investigate human lymphocyte behaviour in 
uraemia.
These B cell indicator systems have been used before to 
investigate health and disease states and have been proven 
very important analytical tools in studies of monocyte, T 
and B cell function, However, they have never been 
employed-at least at the extent used in this thesis-in 
investigations of endogenous immunosuppression in uraemia 
and in studies of the effect of third party blood 
transfusion on the immune response of uraemic patients.
The results obtained from these studies are suggesting 
that these systems can provide a new investigative approach 
to the studies of the immunosuppression associated with 
uraemia and blood transfusion, particularly in association 
with the techniques using monoclonal antibodies to obtain 
purified mononuclear cell subpopulations, Thus, these B cell 
systems will be most appropriate in studies for the 
identification and functional characterisation of the blood 
transfusion induced suppressor cell or for confirming my 
hypothesis that helper T cell function is defective in 
uraemic patients.
The large number of publications about the 
reproducibility of these assay systems and the technical 
difficulties encountered by many workers has discouraged 
investigators of the immune status in uraemia from using
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them in their studies, I have shown that although these 
systems are indeed technically demanding, they are very 
versatile, sensitive and reproducible for in vitro studies 
of immune reactivity and can be significantly more 
informative compared with more conventional functional 
assays such as mitogen transformation.
Finally, I must emphasise that throughout this thesis a 
rather broad approach has been taken and I strongly feel 
that all areas described should be looked into more in depth 
that can be done by one person for all the problems which I 
have presented.
153
REFERENCES
Agger, R ., Petersen, J. & Andersen, U, C19B3) Storage of protein 
A-conjugated sheep erythrocytes for use in plaque farming 
cell assays.
Journal of Immunological Methods. BO, 197-172.
Ala-Houhala, I., Uotila, A., Pasternack, A. 8 Krohn, K. (1979)
Cellular immunity in renal diseases.
Acta Medica Scandinavica. 205, 5B3-58G.
Alevy, Y.G., Slavin, R.G. 8 Hutcheson, P. (1901) Immune
Response in Experimentally Induced Uremia. I. Suppression 
of Mitogen Responses by Adherent Cells in Chronic Uremia. 
Clinical Immunoloau and Immunopatholoau. 19, 8-18.
Alevy, Y.G. 8 Slavin, R.G. (1901) Immune Response in
Experimentally Induced Uremia, II. Suppression of PHA 
Responses In Uremia is Mediated by an Adherent,la-Negative 
and Indomethacin-Insensitive Suppressor cell.
Journal of Immunoloau. 125, 2007-2009.
Alevy, Y.G., Mueller, K.R. 8 Slavin, R.G. (1902) Immune response 
in experimentally induced uraemia. IU. Characterization of 
suppressor peritoneal macrophages in the uraemic rat. 
Journal of Laboratoru and Clinical Medicine. 100, 735-744.
Alevy, Y.G., Mueller, K.R., Hutheson, P. 8 Slavin, R.G, (1903) 
Immune response in experimentally induced uremia.
V . Description of a model of chronic uremia in the rat 
that produces ,a long-term suppressive effect on T cell 
responses to mitogens.
Journal of Laboratoru and Clinical Investigation. 101, 
717-725 .
Alevy, Y.G., Mueller, K .L . 8 Slavin, R.G, (1984) Suppression of 
Mixed Lymphocyte Culture by Uremic Adherent Spleen Cells 
and Peritoneal Macrophages Is Dependent on a 
Cyclophosphamide-Sensitive Cell.
International Archives of Allerau and Applied Immunoloau. 
74, 97-103.
Antonaci, S., Jirillo, E ., Ventura, M.T., Capurso, A., Garofalo, 
A.R. 8 Bonomo, L. (1904) In vitro effects of human 
lipoproteins on the immune system in healthy donors; 
inhibition of plaque forming cell generation and decreased 
frequency of NK cells.
Clinical Experimental Immunoloau. 55, G77-GB2.
Balch, H.H. (1955) The effect of severe battle injury and of
post-traumatic renal failure on resistance to infection. 
Annals of Suraeru. 142, 145-1G3.
154
Ball, E.J. S Stastny, P, (1982) Cell mediated cytotoxicity
against HLA-D region products expressed in monocytes and B 
lymphocytes. IV, Characterization of effector cells using 
monoclonal antibodies against human T-cell subsets. 
Immunoaenetlcs. IB, 157-189.
Barsoum, P.S., Kamel, M ., El-Khachab, Hassabala,
M . 8 Safwat, M . (1980) Succesful renal transplantation in
a presensitised recipient after multiple blood 
transfusions.
Clinical Nephroloou. 14, 45-48.
Bender, E.S., Curtis, J.L., Nagel, J.E., Chrest, F.J., Kraus, 
E.S., Briefel, G.R. 8 Adler, W.H. (1984) Analysis of 
immune status of hemodialysed adults: Association with 
prior transfusions.
Kidneu International. 25, 435-443.
Berger, R ., Meingassner, J.G. 8 Knapp, W.'(1983) In vitro effects 
of cyclosporin A on human B cell responses.
Scandinavian lournal of Immunoloau. 17, 241-249.
Biddison, W .E ., Rao, P.E., Tails, N.A., Goldstein, G. 8 5haw, S.
(1982) Possible involvement of the ÜKT4 molecule in T cell 
recognition of class II HLA antigens: Evidence from 
studies of cytotoxic T lymphocytes specific for SB 
antigens.
Journal of Experimental Medicine. 155, 1055-1075.
Bird, A.G. 8 Britton, 5. (1979a) A live B cell activator
operatingin isolation of other cellular influences. 
Scandinavian Journal of Immunolopu. 9, 507-510,
Bird, A.G. 8 Britton, S. (1979b) A new approach to the study of
human B lymphocyte function using an indirect plaque assay 
and a direct B cell activator.
Immunological Reviews. 45, 41-57.
Bird, A.G., Britton, S., Ernberg, I. 8 Nilsson, K . (1901)
Characteristics of Epstein-Barr virus activation of human 
B lymphocytes.
Journal of Experimental Medicine. 154, 832-039.
Bishop, G . , Cosimi , A.B., Uoy now , N . K . , bJhelchel , J.D. 8 Wortis, 
H.H. (1975) Effect of immunosuppressive therapy for renal 
allografts on the number of circulating sheep red blood 
cell resetting cells.
Transplantation. 20, 123-129.
Blarney, R .W ., Knapp, M.S., Burden, P.P. 8 Salisbury, M.
(1970) Blood transfusion and renal allograft survival. 
British Medical Journal, 1(5105), 138-140.
155
Blomgren, H. 8 Anderson, B. C197B) Steroid sensitivity oF the PHA 
and PWM responses of Fractionated human lymphocytes in 
vitro.
Experimental Cell Research. 77, 233-240.
BorleFFs, J.C.C., Neuhaus, P., Marquet, R.L. 8 Balner, H. C19B3) 
Blood transfusions and changes in humoral and cellular 
immune reactivity in Rhesus monkeys.
Transplantation. 35, 150-155,
Boulton-Jones, J.M., Vic);, R . , Cameron, J.S. 8 Black, P.J.
(1973) Immune responses in uremia.
Clinical Nephroloou. 1, 351-350.
Boyum, A. (1950) Isolation of mononuclear cells and granulocytes 
from human blood.
Journal of Laboratoru and Clinical Invest iaat ion(SlippI ) . 
21, 77-09.
Briggs, J.D., Cannavan, J.S., Dick, H.M., Hamilton, D.N.H., Kyle, 
K.F., MacPherson, 5.G., Paton, A.M. 8 Titterington, D.M.
(1970) Influence of HLA matching and blood transfusion on 
renal allograft survival.
Transplantation. 25, 00-05.
Britton, J. 8 Palacios, R. (1902) Cyclosporin A-Usefulness, Risks 
and Mechanism of Action.
Immunological Reviews. 55, 5-22.
Buckingham, J.M., Ritts, R.E., Woods, J.E. 8 Ilstrup, D.M. (1977) 
An assessment of cell-mediated immunity in acute allograft 
rejection in man.
Mauo Clinic Proceedings. 52, 101-105.
Burns, G.F. 8 Pike, B.L. (1901) Spontaneous reverse haemolytic 
plaque formation. I. Technical aspects of the protein A 
assay .
Journal of Immunological Methods. 41, 259-277.
Butler, W.T. 8 Rossen, R.D. (1973) Effects of corticosteroids in 
immunity in man. I, Decreased serum IgG concentration 
caused by 3 or 5 days of high doses of 
methy1-prednisolone.
Journal of Clinical Investigation, 52, 2529-2540.
Byron, P.R., Mallick, N.P. 8 Taylor, G. (1975) Immune potential
in human uremia. 1. Relation of glomerular filtration rate 
to depression of immune potential.
Journal of Clinical Patholoou, 29, 755-759.
156
Caine, R.Y. (13G0) The rejection of renal homografts: Inhibition
in dogs by G-Mercaptopurine.
Lancet. i, 417-41B.
Caine, R .Y ., Alexandre, G.P.J, 8 Murray, J.E. C19G2) A study of 
the effects of drugs in prolonging survival of homologous 
renal transplants in dogs.
Annals of the New York Academu of Science. 93, 743-7G1.
Carter, N.P., Cullen, P.R. 8 Thompson, J.F., Bewick, A.L.T.,
Wood, R.F.M. 8 Morris, P.J. (1983) Monitoring lymphocyte 
subpopulations in renal allograft recipients. 
Transplantation Proceedings, 15, 1157-1159,
Cascianni, C.U., De Simone, C ., Bonini, S., Galluci, M.T.,
Matteuci, G ., Ualesini, G ., Meli, D. 8 Masala, C .
(1978) Immunological aspects of chronic uremia.
Kidneu International. 13, S49-S54.
Chessin, L.N., Borjesson, J., Welsh, P., Douglas, 5.D. 8 Cooper,
H.L. (1957) Studies on human peripheral blood lymphocytes 
in vitro. II. Morphological and biochemical studies on the 
transformation of lymphocytes by pokeweed.
Journal of Experimental Medicine. 124, 873-884.
Chouaib, J., Chatenoud, L ., Klatzmann, D, 8 Fradelizi, D. (1984) 
The mechanisms of inhibition of IL-2 production. II, PGE2 
induction of suppressor T lymphocytes.
Journal of Immunoloau. 132, 1851-1857.
Cochrum, K.C., Hanes, D ,, Potter, D ., Uincenti, P., Amend, W ., 
Fedaska, M., Perkins, A. 8 Salvatierra, 0. (1979) Donor 
specific blood transfusions in HLA-D-Disparate 
one-haplotype-related allografts.
Transplantation Proceedings. 11, 1903-1907.
Cooper, M.D., Keightley, R.G., Wy, L.Y.F. 8 Lawton, A.R. (1973) 
Developmental of T and B cell lines in humans. 
Transplantation Reviews. 15, 51-84.’
Cooper, D.A., Duckett, M ., Petts, V . 8 Penny, R. (1979)
Corticosteroid enhancement of immunoglobulin synthesis 
by PWM stimulated human lymphocytes.
Clinical Experimental Immunolaou, 37, 145-151.
Cosimi, A.B., Colvin, R.B., Burton, R.C., Rubin, R.H., Goldstein, 
G., Kung, P.C., Hansen, W.P., Delmonico, F.L. 8 Russel,
P.S. (1981) Use of monoclonal antibodies to T cell subsets
157
Far immunologic monitoring and treatment in recipients oF 
renal allograFts.
New England Journal oF Medicine. 305, 300-314.
Coutinho, A . S Mol1er, G. (1375) Thymus independent B cell 
induction and paralysis.
Advances in Immunoloau. SI, 113-235.
Cupps, T.R. 8 Fauci, A.5. (1302) Corticosteroid mediated
immunoregulation in man.
Immunological Reviews. 55, 133-155.
Daliman, M.J., Mason, D .W . 8 Webb, M . (1902) The role of host and
donor cells in the rejection of skin allograFts by T-cell 
deprived rats injected with syngeneic T cells.
European Journal oF Immunoloou. 12, 511-510.
Damnin, G.J., Couch, N.P. 8 Murray, J.E. (1957) Prolonged 
survival of skin allografts in uremic patients.
Annals of the New York Academu of Science. 64, 967-975.
Daniels, J.C., Sakai, H ,, Remmers, A.R.Jr., Sarles, H.E., Fish, 
J.C., Cobb, E.K., Levin, W.C. 8 Ritzmann, S.E. (1971) In 
vitro reactivity of human lymphocytes in chronic uraemia: 
Analysis and interpretation.
Clinical Experimental Immunoloau. 0, 213-227.
De Sousa, M . (1903) Blood transfusions and allograft survival: 
Iron related immunosuppression?
Lancet. 2, 501.
Douglas, S.D., Hoffman, P.P., Borjeson, J. 8 Chessin, L.N. (1957) 
Studies on human peripheral blood lymphocytes in vitro. 
III. Fine structural features of lymphocyte transformation 
by pokeweed mitogen.
Journal of Immunoloou, 90, 17-30.
Dresser, D.W, 8 Wortis, H.H. (1955) Use of an antiglobulin serum 
to detect cells producing antibody with low haemolytic 
eff iciency.
Nature. 5013, 859-851.
Dunnill, M.S. (1904) Histopathology of rejection in 1dney 
transplantation.
Kidneu Transplantation. 2nd Edition, 355-301.
Dupont, E ., Uereerstraeten, P., Espinosa, □., Tielemans, C .,
Dhaene, M. 8 Wybran, J. (1983) Multiple transfusions and T 
cell subsets: A role for ferritin?
Transplantation. 35, 500-510.
150
Eby, W.C., Chong, C.A., Dray, S. S Molinaro, G.A. (1375) 
Enumerating immunoglobulin-secreting cells among 
peripheral human lymphocytes. A hemolytic plaque assay For 
a B cell Function.
Journal of Immunoloau. 115, 1700-1703.
Einhorn, L. S Ernberg, I, (1978) Induction oF EBNA precedes 
stimulation of DNA synthesis in EBU infected human 
lymphocytes.
International Journal of Cancer. 21, 157-lBO.
Ellis, T.N., Berry, C.R., Mendez-Picon, 6., Goldman, M.H., Lower, 
R.R., Lee, H .M . 8 Mohanakumar, T . (1982) Immunological 
monitoring of renal allograft recipients using monoclonal 
antibodies to human T lymphocyte subpopulations. 
Transplantation. 33, 317-313.
Falkoff, R.J.M., 2hu, L.P. 8 Fauci, A.S. (1982) Separate signals 
for human B cell proliferation and differentiation in 
response to Staphylococcus Aureus: Evidence for a
two-signal model of B cell activation.
Journal of Immunoloau. 129, 97-102.
Fauci, A.S. 8 Pratt, K.R. (1975) Activation of human
lymphocytes. I. Direct plaque forming cell assay for the 
measurement of polyclonal activation and antigenic 
stimulation of human B lymphocytes.
Journal of Experimental Medici ne. 144, 574-584.
Fauci, A.S., Pratt, K.R. 8 Whalen, G. (1975) Activation of 
human B lymphocytes.il Cellular interactions in the 
PPG response of human tonsillar and peripheral 
blood B lymphocytes to polyclonal activation by 
pokeweed mitogen.
Journal of Immunoloau. 117, 2100-2104.
Fauci, A.S., Pratt, K.R. 8 Whalen, G . (1977) Activation of human 
B lymphocytes. IU. Regulating effects of corticosteroids 
on the triggering signal in the plaque forming response of 
human peripheral blood lymphocytes to polyclonal 
activation.
Journal of Immunoloau. 119, 598-503.
Fauci, A.S., Whalen, G . 8 Burgh, C . (1980) XUÎ . Cellular
requirements, interactions, and immunoregulation of 
pokeweed mitogen induced total-immunoglobulin producing 
plaque forming cells in peripheral blood.
Cellular Immunoloau. 54, 230-240.
159
Fehrman, I., Ringden, 0., Mol1er, E ., Lundgren, G. 8 Groth, C .-6
(1981) Is Cell Mediated Immunity in the Uraemic Patient 
AFFected by Blood TransFusion?
Transplantation Proceedings. 18, 184-188.
Fehrman, I., Ringden, □. 8 Moller, E . (1983) Blood transfusions
as pretreatment for kidney transplantation; Immunisation 
rate and effect on cellular immune response in vitro. 
Transplantation. 35, 333-343.
Ferrara, G.B., Tosi, P.M., Azzolina, G ., Carminati, G. 8 Congo,
A. (1374) HL-A unresponsiveness induced by weekly 
transfusions of small aliquots of whole blood. 
Transplantation. 17, 134-200.
Fisher, E ., Lenhard, V ., Seifert, P., Kluge, A. 8 Johannsen, R.
(1980) Blood transfusion-induced suppression of cellular 
immunity in man.
Human Immunoloau. 1, 187-194.
Forsgren, A., Svedjelund, A. 8 Wigzell, H . (197G) Lymphocyte
stimulation by protein A of Staphylococcus Aureus. 
European Journal of Immunoloau. 8, 207-213.
Freijd, A. 8 Kunori, T . (1980) Spontaneous plaque forming human
lymphocytes detected with protein A plaque assay, 
Scandinavian Journal of Immunoloau. 11, 283-289.
French, M.E. (1972) The early effects of alloantibody and 
complement on rat kidney allografts.
Transplantation■ 13, 447-451.
Gailiounas, P., Suthanthiran, M., Person, A., Strom, T.B.,
Carpenter, C.B. 8 Garovoy, M.R. (1978) Posttransplant 
immunological monitoring of the renal allograft 
recipient.
Transplantation Proceedings. 10, 809-811.
Garovoy, M.R., Reddish, M.A., Carpenter, B.J. 8 Tilney, N.A.
(1982a) Measurement of immunoglobulin secreting cells:an 
indicator of rejection activity and response to therapy . 
Kidneu International. 21, 298.
Garovoy, M.R., Reddish, M.A., Bush, G.J. 8 Tilney, N.A. (1982b) 
Immunoglobulin secreting cells recovered from rejected 
human renal allografts.
Transplantation. 33, 109-111.
Gmelig-Meyling, F. 8 Waldmann, T.A. (1981) Human B cell
activation in vitro: augmentation and suppression by
160
monocytes of the immunoglobulin production induced by 
various B cell stimulants.
Journal of Immunoloau. 12G, 523-537.
Goodwin, J.S., Bankhurst, A .D . 8 Messner, R.P. (1377) Suppression 
of human T cell mitogenesis by prostaglandin.
Journal of Experimental Medicine. 145, 1713-1734.
Goodwin, J.S. 8 Webb, D.R. (ISBO) Regulation of the immune 
response by prostaglandins.
Clinical Immunoloau Immunopatholoau. 15, lOG-122.
Gordon, D. 8 Nouri, A.M.E. (1981) Comparison of the inhibition by
glucocorticDsteroids and cyclosporin A of mitogen 
stimulated human lymphocyte proliferation.
Clinical Experimental Immunoloau. 44, 287-234.
Gowland, G . 8 Smiddy, F.G. (13G2) The effect of acute
experimental uremia on the immunological responses of the
rabbit to bovine serum albumin.
British Journal of Uroloau. 34, 274-273.
Grayson, J., Dooley, N.J., Koski, I.R. 8 Blaese, P.M. (1981) 
Immunoglobulin production in vitro by glucocorticoid 
hormones. T cell dependent stimulation of immunoglobulin 
production without B cell proliferation in cultures of 
human peripheral blood.
Journal of Clinical Investigation. GB, 1533-1547.
Greaves, M.F. 8 Janossy, G . (1972) Elicitation of selective T and 
B lymphocyte responses by cell surface binding ligands. 
Transplantation Reviews. 11, 87-130.
Greaves, M.F., Browm, G. 8 Rickinson, A, (1975) Epstein-Barr
virus binding sites on lymphocyte subpopulations and the 
origin of lymphoblasts in cultured lymphoid cell lines and 
in the blood of patients with infectious mononucleosis. 
Clinical Immunoloau and Immunopatholoau. 3, 514-524.
Green, W.F., Niblack, J.D., MacDonnell, R.C., Johnson, H.K. 8 
Richie, R.G. (1985) Altered B lymphocyte levels in the 
peripheral blood of renal allograft recipients undergoing 
rejection.
Transplantation Proceedings. 17, G35-G37.
Gronowicz, E ., Coutinho, A. 8 Melchers, F. (1376) A plaque assay 
for all cells secreting Ig of a given type or class. 
European Journal of Immunoloau, G , 588-530.
Guttman, R.D. 8 Paulsen, R.S. (1981) Altered immunoregulatory 
function in long-term renal allograft recipients. 
Proceedings of European Dialusis Transplant Association.
IB, 357-3B1.
I6l
Hallgren, R., Fjellstram, K.-E S Ddlind B. C1902) Total serum IgE 
in uremia and after Renal Transplantation.
Scandinavian Journal of Uroloau and Nephroloau. 17,
3B5 —3B0 .
Hamilton, □. (1984) Kidney Transplantation: A History
Kidneu Transplantation. 2nd edition, 1-13.
Hammarstrom, L., Bird, A.G., Britton, S. 8 Smith, C.I.E. (1979)
Pokeweed mitogen induced differentiation of human B cells: 
Evaluation by a protein A plaque assay .
1mmunoloau. 38, 181-189.
Hancock, W .W ., Thompson, N.M. 8 Atkins, R.G. (1983) Composition 
of interstitial cellular infiltrate identified by 
monoclonal antibodies in renal biopsies of rejecting human 
renal allografts.
Transplantation. 35, 458-453.
Haynes, B.F. 8 Fauci, A.S. (1979) Mechanisms of corticosteroid 
action on lymphocyte subpopulation. IV. Effects of in 
vitro hydrocortisone on naturally occuring and 
mitogen-induced suppressor cells in man.
Cellular Immunoloau, 44, 157-158.
Heilman, D.H. (1972) Failure of hydrocortisone to inhibit
blastogenesis by pokeweed mitogen in human leukocyte 
cultures.
Clinical Experimental Immunoloau. 11, 393-403.
Heilman, D.H., Gambrill, M. 8 Leichner, J.P. (1973) The effect of 
hydrocortisone on the incorporation of tritiated thymidine 
by human blood lymphocytes cultured with 
phytohaemagglutinin and pokeweed mitogen.
Clinical Experimental Immunoloau. 15, 203-212.
Hersh, E.M., Butler, UI.T., Rossen, R.D., Morgan, R.G. 8 Suki, W .
(1971) In vitro studies of the human response to organ 
allografts: Appearance and detection of circulating 
activation lymphocytes.
Journal of Immunoloau. 107, 571-578.
Holdsworth, S.R., Fitzgerald, M.G., Hosking, C.5. 8 Atkins, R.C. 
(1978) The effect of maintenance dialysis on lymphocyte 
function. I, Haemodialysis.
Clinical Experimental Immunoloau, 33, 95-101.
Horsburgh, T., Hall, H. 8 Wood, R.F.M. (1983) Spontaneous 
plaque-forming cells in renal transplant patients:
Possible correlation with antibody mediated rejection. 
Transplantation. 35, 511-513.
162
Huber, H., Pastner, D., Dittrich, P. 8 Braunsteiner, H. C19G3) In 
vitro reactivity of human lymphocytes - A comparison with 
the impairment of delayed hypersensitivity.
Clinical Experimental Immunoloou. 5, 75-82.
Hume, D.M., Merrill, J.P., Miller, B.F. 8 Thorn, G.U. (1955)
Experiences with renal homotransplantation in the human*, 
report of nine cases.
Journal of Clinical Investigation. 34, 327-382.
Ilfield, D.N., Krakauer, R.S. 8 Blaese, M. (1977) Suppression of 
the human autologous mixed leukocyte reaction by 
physiologic concentrations of hydrocortisone.
Journal of Immunoloau. 119, 428-434.
I to, S. 8 Lawton, A.R. (1984) Response of human B cells to
staphylococcus aureus Cowan I: T-independent proliferation 
and T-dependent differentiation to immunoglobulin 
secretion involve subsets separable by resetting with 
mouse erythrocytes.
Journal of Immunoloau. 133, 1831-1895.
Jaboulay, M. (190G) Greff de reins au pli du coude par soudures 
artérielles et veineuses.
Luon Medicine, 107, 575-577.
Janossy, G. 8 Greaves, M. (1975) Functional analysis of murine 
and human B lymphocyte subsets.
Transplantation Reviews. 24, 177-235.
Jensson, 0. (1958) Observations on the leukocyte blood picture in
acute uremia .
British Journal of Haematoloau. 4, 422-427.
Jerne, N.K. 8 Nordin, A.A. (19G3) Plaque formation in agar by 
single antibody producing cells.
Science. 140, 405.
Jonas, A.L. 8 Üldhall, P.R. (1974) DMA synthesis in peripheral 
blood leukocytes following renal transplantation.
Kidneu International. 5, 378-385.
Kahan, B.D., Uan Buren, C.T., Lin, S.N., Gno, V, Agostino, G .,
LeGrue, S.J., Boileau, M., Payne, W .D . 8 Kerman, R.H.
(1982) Immunopharmacological monitoring of cyclosporin A 
treated recipients of cadaver kidney allografts. 
Transplantation. 34, 3G-45 .
Kasakura, S. 8 Lowenstein, L. (19B7) The effect of uremic blood
on mixed lymphocyte reactions and on cultures of
leukocytes with phytohemagglutinin.
Transplantation. 5, 283-283.
163
Kauffman, C .A ., Manzler, A.D. & Phair, J.P. (1975) Cell-mediated 
immunity in patients on long-term haemodialysis.
Clinical Experimental Immunoloau. 22, 54-Gl.
Keightley, R.G., Cooper, M.D. & Lawton, A.R. C197G) The I cell 
dependence of B cell differentiation induced by pokeweed 
mitogen.
Journal of Immunoloau. 117, 1538-1544.
Keown, P. A. & Bescamps, B. (1979) Improved renal allograft 
survival after blood transfusion: A non-specific, 
erythrocyte mediated immunoregulatory process?
Lancet. 1, 20-22.
Kerman, R.H. & Geis, W .P , C197G) Total and active T cell dynamics
in renal allograft recipients.
Surgery. 79, 390-407,
Kerman, R.H., Flechner, S., Van Buren, C ., T., Payne, W . & Kahan,
B.D. (1903) Immunologic monitoring of renal allograft 
recipient treated with cyclosporins.
Transplantation Proceedings. 15, 2302-2305.
Kirkpatrick, C.H., Wilson, W.E.C. & Talmage, D.W. C19G4)
Immunologic studies in human organ transplantation.
I . Observation and characterization of suppressed 
cutaneous reactivity in uremia.
Journal of Experimental Medicine, 119, 727-742.
Klatzmann, D., Gluckman, J.C., Foucault, C., Bensussan, A.,
Assobga, U. & Duboust, A. (1903) Suppression of lymphocyte 
reactivity by blood transfusions in uremic patients, I. 
Proliferative responses.
Transplantation, 35, 332-330.
Knapp, U!. & Baumgartner, G . (1978) Monocyte mediated suppression 
of human B cell differentiation in vitro.
Journal of Immunology. 121, 1177-1183.
Kunori, T. 8. Ringden, 0. (1979) Polyclonal antibody secretion 
induced in mixed lymphocyte cultures.
Scandinavian Journal of Immunoloau, 10, 409-493.
Kunori, T. 5 Ringden, D. (1900) Polyclonal antibody secretion in 
human mixed lymphocyte cultures. II. No direct activation 
of B-celIs.
Tissue Antigens. 15, 403-491.
Kunori, T., Fehrman, I., Ringden, 0. & Mailer, E. (1900) In vitro 
Characterization of Immunological Responsiveness of Uremic 
Patients.
Nephron. EG, 234-239.
1.64
Kuss, R . , Legrain, M., Mathe, G., Mecley, R. & Carney, M . C19G2)
Homologous human kidney transplantation.
Postgraduate Medical Journal. 38, 528-531.
Landsberg, D.N., Bush, L.E. 5 Cardella, C.J. C18B5) In vitro
immunoglobulin production in long-term renal transplant 
recipients .
Transplantation. 35, 389-332.
LanghoFF, E. 8 LadeFoged, J. (1984) Cellular Immunity in Renal
Failure:Depression of Lymphocyte Transformation by Uraemia 
and MethyIprednisolone .
Intra-Individual Consistency of Lymphocyte Responses to 
the in vitro Suppressive Effect of Steroid.
International Archives of Allerou and Applied Immunoloau. 
74, 241-245.
Langhoff, E ., Ladefoged, J ., Glgaard, K. 8 Madsen, 5. (1985)
Restoration of uraemic lymphocyte responses in vitro by 
interleukin-2 .
Proceedings of the EDTA-ERA, 22, 932-935.
Lefkovits, I. 8 Cosenza, H . (1979) Assay for plaque forming 
cells.
Immunological Methods, 1st Edition, 275-285.
Lenhard, V ., Seifert, P., Maassen, G ,, Grosse-UiIde, H .,
Johannsen, R ., Geisen, H.P. 8 Kluge, A. (1982a) Blood 
transfusion-induced suppression of cellular immunity in 
prospective kidney-graft recipients.
Transplantation Proceedings. 14, 150-153.
Lenhard, V ., Massen, G ., Seifert, P., Johannsen, P. 8 
Grosse-Wilde, H. (1982b) Characterization of 
transfusion-induced suppressor cells in prospective kidney 
allograft recipients.
Transplantation Proceedings, 14, 329-332.
Lenhard, V ., Wonigeit, K . 8 Opelz, G. (1905a) Regulation of
antibody response by T suppressor cells in multi transfused 
rats .
Proceedings of the second ESOT congress. Abstract 42.
Lenhard, U ., Renner, D ., Hansen, B. 8 Opelz, G , (1985b)
Suppression of antibody response and prolongation of skin 
graft survival by multiple blood transfusions in the rat. 
Transplantation, 39, 424-429.
Loveland, B.E., Hogarth, P.M., Ceredig, R.L. 8 McKenzie, I.P.O. 
(1901) Cells mediating graft rejection in the mouse.
I. Lyt-1 cells mediate skin graft rejection.
Journal of Experimental Medicine. 153, 1044-1057.
165
Lortan, J.E., Kiepiela, P., Caovadia, H.M. 8 Seedat, Y.K. (1982) 
Suppressor cells assayed by numerical and Functional tests 
in chronic renal failure.
Kidneu International. 22, 192-197.
tiacy, E. 8 Stevens, R.H. (1900) A restricted component of T cell 
help in pokeweed mitogen stimulated human peripheral blood 
cell cultures.
Journal of Immunoloau. 124, 752-759.
Mannick, J.A., Powers, J.H, Mithoefer, J . 8 Ferrebee, J .W . (1980) 
Renal transplantation in azotemic dogs.
Suroeru. 47, 340-345.
Matas, A.J., Simmons, R.L., Kjellstrand, C.M., Buselmeier, T.J. 8 
Najarian, J.S. (1975) Increased incidence of malignancy 
during chronic renal failure.
Lancet. 1, 883-885.
Matzner, Y ., Hershiko, C . 8 Pollisch, A. (1979) Suppressive 
effect of ferritin on in vitro lymphocyte function.
British Journal of Haematoloau, 42, 345-353.
McLeod, A.M., Mason, R.J., Stewart, K.N., Power, D.A., Shewan, 
W.G., Edward, N . 8 Gatto, G.R.D. (1903) 
Fc-Receptor-blocking antibodies develop after blood 
transfusions and correlate with good graft outcome. 
Transplantation Proceedings. 15, 1019-1021.
McNaughton, B.C. 8 White, D.J.G. (1985) Measurement of immune 
activity in transplant patients.
Transplantation Proceedings. 17, 559.
Medzihradsky, J.L., klein, G . 8 Elion, G.B. (1982) Differential 
interference by azathioprine and B-mercaptopurine with 
antibody mediated immunoregulation: Synergism of 
azathioprine and antibody in the control of an immune 
response.
Journal of Immunoloau. 129, 145-149.
Merrill, J.P, (1958) The immunologic capability of uraemic 
patients.
Cancer research. 28, 1449-1451.
Mezzano, S., Pesce, A.J., Poliak, U.E., Reed, R. 8 Michael,
J.G. (1982) Antibody production and antigenic specific 
suppression to bovine serum albumin in uremic rats. 
Clinical Experimental Immunoloau. 48, 111-117.
Mezzano, S., Pesce, A.J., Poliak, V.E. 8 Michael, J.G. (1984)
Analysis of Humoral and Cellular Factors that Contribute 
to Impaired Immune Responsiveness in Experimental Uremia. 
Nephron. 35, 15-19,
I66
Miller, J., Lifton, J. 8 Wilcox, C . C1978) The use oF second
generation assays in pre- and post-transplant monitoring: 
The primed or second-degree MLC,
Transplantation Proceedings. 10, 573-578.
Mingari, M.C., Gerosa, P., Carra, G., Accolla, R.S., Moretta, S., 
Zubler, R.H., Waldmann, T.A. & Moretta, L. (1984) Human 
interleukin-2 promotes proliferation of activated B cells 
via surface receptors similar to those of activated T 
cells.
Nature. 312, B41-G43.
Modai, D., Hadi, Y ., Weissgarten, J.,Relier, 5. 8 Kaufman, 9.
(1385) The effect of several uremic parameters on uremic 
serum inhibition of lymphocyte blastogenesis.
Immunologu Letters. 9, 275-278.
Molinaro, G.A. & Dray, S. (1974) Antibody coated erythrocytes as 
a manifold probe for antigens.
Nature. 248, 515-517.
Morris, P.J., Williams, G.M., Hume, D.M., Mickey, M.R. &
Terasaki, P.I. (1950) Serotyping for homotransplantation. 
XII. Occurence of cytotoxic antibodies following kidney 
transplantation in man.
Transplantation. 5, 392-399.
Morris, P.J., Mickey, M.R., Singal, D.P. 8 Terasaki, P.I. (1959) 
Serotyping for homotransplantation. XXII. Specificity of 
cytotoxic antibodies developing after renal 
transplantation.
British Medical Journal. 1, 758-759.
Morris, P.J. (1984). The immunology of rejection.
Kidneu Transplantation. 2nd Edition, 15-32.
Muraguchi, A., Kehrl, J.H., Longa, D.L., Uolkman, D.J., Smith,
K.A. 8 Fauci, A.9. (1985) Interleukin-2 receptors on human
B cells:Implications for the role of interleukin-2 in 
human B cell function.
Journal of Experimental Medicine. 151, 181-197.
Murray, J.E., Merrill, J.P., Harrison, J.H., Wilson, R.E. 8
Damnin, G.J. (1953) Prolonged survival of human kidney 
homografts by immunosuppressive drug therapy .
New England Journal of Medicine. 258, 1315-1323.
Murray, S., Dewar, P.J., Uldall, P.R., Wilkinson, R ., Kerr,
D.N.S. 8 Taylor, R.M.R.(1974) Some important factors in 
cadaver-donor kidney transplantation.
Tissue Antigens. 4, 548-557.
167
Nakhla, L.S. 8 Goggin, M.J. (1973) Lymphocyte Transformation in 
Chronic Renal Failure.
Immunoloou. E4, 229-235.
Nelson, J, Drmrod, D.J., Wilson, D. & Miller, T.E. (19B0) Host
immune status in uremia. III. Humoral response to selected 
antigens in the rat.
Clinical Experimental Immunoloau. 42, 234-240.
Newberry, W.M. 8 Sanford, J.P. (1971) Defective Cellular Immunity 
in Renal Failure: Depression of Reactivity of Lymphocytes 
to Phytohemagglutinin by Renal Failure Serum.
Journal of Clinical Investigation. 50, 1252-1271.
Norbeck, N.E. 8 Carlson, L .A . (1981) The uraemic .
dysiipoproteinemia: its characteristics and relations to
clinical factors.
Acta Medica Scandinavica. 209, 489-503.
Nube, M.J., Persijn, G.G., Van Es, A., Kalff, M.W., de Graeff, J . 
8 Van Rood, J.J, (1983) Beneficial effect of HLA-A and B 
matched pretransplant blood transfusions on primary 
cadaveric kidney graft survival.
Transplantation. 35, 555-551,
Gnsrud, M . 8 Thorsby, E. (1981) Influence of in vivo 
hydrocortisone on some human blood lymphocyte 
subpopulations. I. Effect on natural killer cell activity. 
Scandinavian Journal of Immunologu. 13, 573-579.
Opelz, G ., Sengar, D.P.S., Mickey, M.R. 8 Terasaki, P.I. (1973a) 
Effect of blood transfusions on subsequent kidney 
transplants.
Transplantation Proceedings. 5, 253-259.
Opelz, G ., Mickey, M.R. 8 Terasaki, P.I. (1973b) Blood 
transfusions and unresponsiveness to HL-A.
Transplantation. 15, 549-555.
Opelz, G . 8 Terasaki, P. I, (1974) Poor kidney-transplant survival 
with frozen-blood transfusions or no transfusions.
Lancet, 2, 535—599.
Opelz, G . 8 Terasaki, P.I, (1975) Prolongation effect of blood 
transfusions on kidney graft survival.
Transplantation, 22, 380-383.
Opelz, 6. 8 Van Rood, J.J. (1983) Mechanisms responsible for the 
blood transfusion effect.
Transplantation Proceedings, 15, 1520-1521.
Paavonen,T . 8 Hayry (1980) Effect of cyclosporin A on T-dependent 
and T-independent immunoglobulin synthesis in vitro. 
Nature, 287, 542-544.
168
Paavonen, T. C1985) Glucocorticoids enhance the in vitro Ig
synthesis of pokeweed mitogen stimulated human B cells by 
inhibiting the suppressive effect of T8+ T cells. 
Scandinavian Journal of Immunologu. El, G3-71.
Parrillo, J.E. 8 Fauci, A.S. (1978b) Comparison of the 
effector cells in human spontaneous cellular 
cytotoxicity: Differential sensitivity of effector
cells to in vivo and in vitro corticosteroids.
Scandinavian Journal of Immunologu. B, 99-107.
Persijn, G.G., Van Hooff, J.P., Kalff, M .W ., Lansbergen, D. 8 Van 
Rood, J.J. (1977) Effect of blood transfusions and HLA 
matching on renal transplantation in the Netherlands. 
Transplantation Proceedings. 9, 503-505.
Platt, J.L., LeBien, T , UI. 8 Michael, A.F. (1982) Interstitial 
mononuclear cell populations in renal graft rejection: 
Identification by monoclonal antibodies in tissue 
sections,
Journal of Experimental Medicine. 155, 17-30.
Platt, J.L., Ferguson, R.M., Sibley, R.K., GaJ1-Peczalska, K.J. & 
Michael, A.F. (1983) Renal interstitial cell populations 
in cyclosporins nephrotoxicity; Identification using 
monoclonal antibodies.
Transplantation. 35, 343-345.
Posey, W.C., Nelson, H.9., Branch, B. 8 Pearlman, D.5. (1978) The 
effects of acute corticosteroid therapy for asthma 
on serum immunoglobulin levels.
Journal of Allergu and Clinical Immunologu. 52, 340-348.
Pryjma, J., Munoz, J., Galbraith, P.M., Fudenberg, H. 8 Virella, 
G. (1900) Induction and suppression of Bmmunogiobulin 
synthesis in cultures of human lymphocytes: Effects 
of pokeweed mitogen and staphylococcus aureus Cowan I. 
Journal of Immunologu, 124, 555-551.
□uadracci, L.J., Ringden, 0. 8 Kryzmanski, M . (1975) The effect
of uremia and transplantation on lymphocyte 
subpopulations.
Kidneu International. 10, 179-184.
Rappaport, R.S. 8 Dodge,G.R. (1982) Prostaglandin EE inhibits the 
production of human IL-2.
Journal of Experimental Medicine, 155, 943-948.
Raska, K.Jr., Morrison, A.B. 8 Raskova, J. (1980) Humoral
Inhibitors of the Immune Response in Uremia. III. The 
Immunosuppressive Factor of Uremic Rat Serum Is a Very
169
Low Density Lipoprotein.
Laboratoru Investigation. 42, B3B-B4E.
Raska, K.Jr.,Raskova, J . ,Shea, S.M., Rrankel, R.M., Wood, R.H., 
Lifter, J., Ghobriai, I., Eisinger, R.P. 8 Homer, L.
(1983) T Cell Subsets and Cellular Immunity in End-Stage 
Renal Disease.
American Journal of Medicine. 75, 734-740.
Raskova, J. 8 Morrison, A.B. (1978) Humoral Inhibitors of the
Immune Response in Uremia. I. Effect of Serum and of the 
Supernatant of Spleen Cultures from Uremic Rats on the 
Mixed Lymphocyte Reaction.
Laboratoru Investigation. 38, 103-109.
Raskova, J . 8 Raska, K.Jr. (1981) Humoral Inhibitors of the
Immune Response in Uremia, IV. Effects of Serum and of 
Isolated Very Low Density Lipoprotein from Uremic Rats 
on Cellular Immune Reactions in Vitro.
Laboratoru Investigation. 45, 410-417.
Raskova, J. 8 Raska, K.Jr. (1983) Humoral inhibitors of the
immune response in uraemia. V. Induction of suppressor 
cells in vitro by uraemic serum.
American Journal of Pathologu. Ill, 149-155.
Raskova, J ,, Ghobriai, I., Shea, S.M., Eisinger, R.P. 8 Raska,
K.Jr. (1984) Suppressor Cells in End-Stage Renal Disease, 
Functional Assays and Monoclonal Antibody Analysis. 
American Journal of Medicine. 75, 847-853.
Riis, P. a Stougaard, J. (1959) The peripheral blood leukocytes 
in chronic renal insufficiency.
Danish Medical Bulletin. 5, 85-90.
Ringden, 8, 8 Rynnel-Daggoo, B, (1378) Activation of human T and 
B lymphocytes by protein A cf Staphylococcus Aureus. 
European Journal of Immunologu. 8, 47-52.
Rolley, R.T., Wildman, D.G., Parks, L.C., Sterrioff, 5. 8
Williams, G.M. (1978) Monitoring of responsiveness in 
dialysis-transplant patients by delayed cutaneous 
hypersensitivity tests.
Transplantation Proceedings. 10, 505-507.
Rosenkoetter, M., Reder, A. T., Gger, J.J-F. 8 Antel, J.P, (1984) 
T cell regulation cf pclyclcnally induced immunoglobulin 
secretion in humans.
Journal of Immunologu. 132, 1779-1783.
Saiki, □. 8 Ralph, P. (1981a) Synergistic effects of human B and 
T lymphocyte mitogens induce uniform, high levels of 
immunoglobulin secretion among normal donors.
Journal of Immunological methods. 45, 221-225.
170
Saiki, □. 8 Ralph, P. (ISBlb) Induction oF human immunoglobulin 
secretion. I. Synergistic effect of B cell mitogen 
Cowan I plus T cell mitogens or factors.
Journal of Immunologu. 127, 1044-1047.
Satomi, S., Tanimura, S., Kunori, T ., Taguchi, Y. 8 Kasai, M . 
C1903) Monitoring of B lymphocyte response with the 
protein-A plaque assay in kidney transplant patients. 
Transplantation. 35, 324-320.
Schwartz, R. 8 Dameshek, W . (1959) Drug induced immunological 
tolerance.
Nature(London). IBS, 1582-
Selroos, Pasternack, A. 8 Uirolainen, M . (1973) Skin test
sensitivity and antigen-induced lymphocyte transformation 
in uraemia .
Clinical Experimental Immunoloau. 14, 355-370,
Sengar, D.P.S., Rashid, A. 8 Harris, J.E. (1975) In vitro
reactivity of lymphocytes obtained from uraemic patients 
maintained by haemodialysis.
Clinical Experimental Immunoloau. 21, 238-305.
Silk, M.R. (1957) The effect of uremic plasma on lymphocyte 
transformation.
Investigative Uroloou. 5, 195-199.
Singhal, D.P., Fagnilli, L, 8 Joseph, S. (1983) Blood
transfusions induce anti idiotypic antibodies in renal 
transplant patients.
Transplantation Proceedings. 15, 1005-1008.
Smiddy, E.G., Burwell, R.G. 8 Parsons, F.M, (19S1) Influence of 
uremia on the survival of skin homografts,
Nature(London). 190, 732-734.
Smith, M.D., Williams, J.D., Coles, G.A. 8 Salaman, J.R. (1981) 
The effect of blood transfusion on T-suppressor cells in 
renal dialysis patients.
Transplantation Proceedings, 13, 181-183.
Smith, M.D., Williams, J.D., Coles, G.A. 8 Salaman, J.R, (1983) 
Blood transfusions, suppressor T cells, and renal 
transplant survival ,
Transplantation, 35, 547—550.
Smith, R.S., Sherman, W.A. 8 Middleton, E ., Jr. (1972) Effect of 
hydrocortisone on immunoglobulin synthesis and secretion 
by human peripheral lymphocyte in vitro.
International Archives of Allergu and Applied Immunoloau, 
43, 859-870.
171
Solheim, B.G., Flatmark, A ., Jervell, J. 8 Arnesen, E.(1977)
Influence of blood transfusions on kidney transplant and 
uremic patient survival.
Scandinavian Journal of Uroloou and NeobroloauCSupplD. 42,
G5-G9.
SoLibami, R.L. (1973) Antibody production and catabolism in 
uraemia.
British Journal of Experimental Patholoau. 54, 300-387.
Soulillou, J.P., Be Mouzon-Cambon, A., Dubois, C ., Blanc, M .,
P e y r a t M . A . 8 Mahieu, P. (1981) Immunological studies of
eluates of 83 rejected kidneys; Screening of antibodies 
directed against T and B lymphocytes, glomerular and 
tubular basement membranes, DNA, and IgG.
Transplantation. 32, 388-374.
Stenzel, K.H., Rubin, A.L. 8 Novogrodsky, A. (1978) Blastogénie
response to mitogens: An approach to the study of cell 
surface topography in lymphocytes from transplant 
recipients.
Transplantation Proceedings, 10, 589-591.
Stewart, E . 8 Miller, T.E, (1980) Host immune status in uraemia.
II. Serum factors and lymphocyte transformation.
Clinical Experimental Immunologu. 41, 123-129.
Stiller, C.R. 8 Sinclair, N.R.St.C. (1979)
Kidneu Transplantation : Principles and Practice.
1st Edition, 251-2G5.
Stobo, J.D. (1902) Cellular interactions in the expression and 
regulation of immunity.
Basic and Clinical Immunoloau, 4th Edition, 89-95.
Stoloff, I.L., Stout, P., Myerson, P.M. 8 Havens, Ul.P.Jr, (1958) 
Production of antibody in patients with uremia.
New England Journal of Medicine, 259, 320-323.
Tait, B.D., d ' Apice, A.J.F., Morrow, L. 8 Kennedy, L. (1984) 
Changes in suppressor cell activity in renal dialysis 
patients after blood transfusion.
Transplantation Proceedings, IB, 995-997.
Tauris, P. 8 Jorgensen, F . (1983) Plaque-forming cell response of
pokeweed mitogen stimulated frozen human lymphocytes. 
Journal of Immunological Methods, 59, 183-107.
Tauris, P. (1983a) Plaque forming cells in man. I. Basic
technical results obtained with the protein A technique. 
Scandinavian Journal of Immunoloau. 18, 241-248.
172
Tauris, P. C1983b) Plaque Forming cells in man. II. Evidence cF 
the existence cf active suppressor cells in peripheral 
blood oF normal PFC non-responders.
Scandinavian Journal of Immunoloou. IB, 249-253.
Terasaki, P.Î., Kreisler, M . 8 Mickey, M.R, (1971)
Presensitization and kidney transplant failures. 
Postgraduate Medical Journal. 47, 89-100.
Terasaki, P.I. (1984) The beneficial transfusion effect on kidnei 
graft survival attributed to clonal deletion. 
Transplantation. 37, 119-125.
Thomas, P., Mendez-Picon, G, Thomas, J., Lee, H.M. 8 Lower, R.
(1978) Effective monitoring and modulation of recipient 
immune reactivity to prevent rejection in early 
posttransplant period.
Transplantation Proceedings. 10, 537-541.
Thompson, P.A,, Jelinek, D.F. 8 Lipsky, P.E. (1984) Regulation ol 
human B cell proliferation by prostaglandin E2.
Journal of Immunologu. 133, 2448-2453,
Trienekens, P.H., Faulkner, J. 8 Bird, A.B. (1984) Addition of 
polyethylene glycol 8000 improves the sensitivity of the 
protein A plaque assay for detection of human 
immunoglobulin secreting cells.
Journal of Immunological Methods. BG, 341-347.
Truffa-Bachi, P. 8 Bordenave, G.R. (1980) A reverse haemolytic 
plaque assay for the detection and enumeration of 
immunoglobulin allotype secreting cells.
Cellular Immunologu. 50, 251-270.
Van Buren, C . , Kerman, R . , Agostino, G . , Payne, bJ. D . , Flechner,
S. 8 Kahan, B.D. (1982) The cellular target of cyclosporir 
A in humans.
Suroeru. 92, 157-174.
Van Gudenaren, A,, Hooijkas, H. 8 Benner, R. (1901) Improvement
of the protein A plaque assay for immunoglobulin secreting 
cells by using immunoglobulin-depleted guinea pig serum 
as a source of complement.
Journal of Immunological Methods. 43, 219-224.
Van Rood, J.J. (1983) Pretransplant blood transfusion.Sure: but 
how and why?
Transplantation Proceedings. 15, 915-916.
Von Lüi 1 lenbrand, E. (1983) DKT4/GKT0 ratio in the blood and in 
the graft during episodes of human renal allograft 
rej ection.
Cellular Immunoloau  ^ 77, 195-201.
173
Uyas, G.N., Fudenberg, H.H., Pretty, H.M. 8 Gold E.R. C13G0)
A new rapid method for genetic typing of human 
immunoglobulins.
Journal oF Immunoloau. 100, 274-279.
Wadee, A.A. 8 Rabson, A.R. C19B3) Binding of
phosphatidylethanolamine and phosphatidylinositol 
to 0KT8+ lymphocytes activates suppressor cell activity. 
Journal oF Immunoloau. 130, 2271-2276,
Waldmann, T.A., Broder, S., Blaese, R.M., Durm, M., Blackman, M .
& Strober, W, (1974) Role of suppressor T cells in the 
pathogenesis of common variable bypogammaglobulinaemia . 
Lancet, 2, 609—613,
Walter, S., Poulson, L.R., Friedberg, M., AFzelius, R .,
Federspiel, B.H., Larsen, H.W. 8 Petersen, K. (1977>The 
effect of blood transfusions on renal allograft survival. 
Scandinavian Journal of Urcloau and MeghroIcauCsupp1J. 42,
62-64.
Watson, M.A., Briggs, J.D., Diamantcpoulos, A.A., Hamilton,
D.N.H. 8 Dick, H.M. (1979) Endogenous cell-mediated 
immunity, blood
transfusions and outcome cf renal transplantation.
Lancet. 2, 1323-1326.
Webb, D.R. 8 Gsheroff, P.L. (1976) Antigen stimulation of 
prostaglandin synthesis and control of immune 
responses.
Proceedings of the National Academu of Science USA. 73, 
1300-1304 .
Webb, D.R. 8 Winkelstein, A. (1982) Immunosuppression,
Immunopotentiation and anti-inflammatory drugs.
Basic and Clinical Immunoloau. 4th Edition, 277-292.
Webel, M.L. 8 Pitts, R.E. (1977) The effects of corticosteroid 
concentrations on lymphocyte blastogenesis.
Cellular Immunologu, 32, 287—292.
Weeke, B ., Weeke, E. 8 Bendixen, G. (1971) The variation in 
twenty-one serum proteins before and after renal 
transplantation. I. General pattern.
Acta Medica Scandinavica. 189, 113-118.
Whisler, R.L. 8 Newhouse, V.G. (1982) Inhibition of human B 
lymphocyte colony responses by endogenous synthesised 
hydrogen peroxide and prostaglandins.
Cellular Immunoloau, 69, 34-45.
174
UJidmer, N.B., Roopenian, B.C. 8 Bach, F.H, C13B3) Cytolytic T 
lymphocyte clones with helper cell characteristics. 
Transplantation Proceedings. 15, 393-355.
Williams, G.M. C19B4) Clinical course Following renal 
transplantation.
Kidneu Transplantation. 2nd Edition, 335-354.
Wilson, W.E.C., Kirkpatrick, C.H. 8 Talmage, D.W. (19G5)
Suppression oF immunologic responsiveness in Uremia.
Annals of Internal Medicine. 62, 1-14.
Wood, R.F.M., Bolton, E.M., Thompson, J.F., Morris, P.J. 8 Mason, 
D.Y. (1993) Characterization of cellular infiltrates in 
renal allografts by fine needle aspiration. A simple 
technique using double labelling with monoclonal 
antibodies.
Transplantation Proceedings. 15, 1847-1849.
Wu, L.Y.F., Lawton, A.R. 8 Cooper, M.D. (1973) Differentiation 
capacity of cultured B lymphocytes from immunodeficient 
patients .
Journal of Clinical Investigation. 52, 3180-3189.
Zukoski, C.F., Lee, H.M. 8 Hume, D.M. (1960) The prolongation of 
functional survival of canine renal homografts by 
6-mercaptopurine.
Surgical Forum, 11, 470-472.
■■
175
+ Z > 3 H"
H CD G3 m O
3"0 W  tf H
(D 3^ VO 3 'd p.
3 trJ 3 3 3
3 0 < H- CD p.
CD tJ H 3 CO n
CO 3 CD 3
3 (t 3 3 p
3* 3^  H  CO 3
ft 3} O CD 3
CO Z 3 a  3
cn 3 CL
Hi X *• 3
O X Q H*CO to
3 Z  3 p*
a  3 O
0 M O H- 3 Q
3 V 3 o 3*
CD CD 3 3 p- CD
3 3 0 3 3
ft 3 3 H* a
H*CD H* 0 p- 0
3 3 n 3 o 3
H- CO 3 M
3 p. Q  0 3
CD < H i-ti H- a
CD 0 0 3
3 3 3 3 3
3 Z CD 3 3CL CD 3 3 O
V 3 3 Hi Hi
PJ 3  H H* 0
M 3 0 3 X 3
3 0 3 P* P*
d CO CD 0 CL*d
3 0 ti 3 3 3p. H 3  3 CD 3
3 CD 3 P* M P"
DJ 3
H- CD
O ft CO 3 3
3 CO H* 3 3 3
CD H* CO 3 3 CO
CO>• 3 0
3 <* CD 3 CO
3 P- 3
CO z 0 C
CD X •• Z 3 ap* o 0 p.
H* 7! 3  3 Z CD
3 O 3 0 a
CD H 0 3 3
I
0)
Irt
CO
H
O 
M 
X O H- P
a m 
p tj
g.
" 3
. iH 
m (t)
3
IQ
w  m
U1 CD
I o
ÿ  UI I
h{ . M  
H- Ul K) rf v_.'0
p.
3
ttf
rt-
hp.
w
M
CO hj
3 H
3 3
Ü CL in
Z
V
o H
p- 3 n
3 CO 3
ty CD
CD 3
3 3p. P-
n
g.
3
CD
'UcnU1.îiL0N.)MO'X)00'UCr»U1J::iU)K)l-JO..........  • •
w Cl Îk i> w X (n cri n x Id œ c/) D q ^
U l K J U l U l U l N J M J i k U l U 1 j 5 > . L O U > U > U l U l K ) ( j O t O K ) U i r o U ) C O M 4 : : k M
t v ) O U 1 ^ 0 U ) ' - J K > ' X ) U ) l O V D O O f - ‘ O J N ) ü O - U ' X ) C r > ' - J ' X ) ' U O O U 1 4 i k ( j O U )
O-0CÎ»VÛ'-J^ -JCT>^ -‘tD'^ CD00CX)C0^ -•tX>^ £)'J I'UU)Ul<X)LO(jJOJCn'U'UCX)OUlUlUlCX»MhJ
ONJ.fi!.OCn.^ 'jaD(jjUlOU1NJ-UOOCr>Ul
ocnkokooii-'criw
Ul'UWkDW'U^C^O
O O U l O ' J O f U C T t
os
oCD $: 
% 3
!?
CO
PJ
ap.
g s
3 t3
H-
§ § § § 1
o
pj
Q
%
I
3
pi
^ 0 0 0 0 3  % z: % z z o
CO
o
%
7) CD z: %
f-JOOf-'OOONJOlsJOOCOrOl-'NJMtO N)0»-*K)N>i-‘ 0 0
* # # # # * # # # # « « # * # # # #  I * * # * # # # *
C O . f \ W - ^ J \ m i O l O L O M A , l O ' U O C O ( j U O ' U  M j i ^ C r i L n c O ' U V D J i k
|—<J k-J I—i I ■ t I I i H—* I * %
uiu iuiuiuiaiinLTtLnLnooooooooouiuioouiuio o
w
% rt- 
O H- 
CD
a
CD
in
X
H-
O
3
S
0 3 V
H P- 3
\ 3 3 ;>pi p. P- to
'-^ 3 CD (3
3 3 M
3
a
CD
3
3
O p.
3 H
P* CO
IQ
H-
g
O
H*
M
s
cn
CD
*
H H'
--3
CO Oj 
Hi
3
CO
p*
o
g

